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Introduction to peptide synthesis - Methods and characteristics
Many paramount physiological and biochemical functions of life are 
regulated by small peptides and proteins. The range of activities attributed 
to peptides is extremely broad: from antibiotic and signalling activities of 
small peptides to catabolism, biosynthesis and regulation of cell division 
governed by large protein complexes. Whereas large proteins often have a 
role in structure, metabolism, or motion, many small peptides are involved 
in metabolic regulation or defense, which has stimulated the interest of 
the scientific community in their mode of action. Novel peptide receptors 
have been discovered and the bioactivity of their cognate peptides has 
been investigated in search for possible therapeutic applications. A wide 
range of peptide-based drugs are applied in the treatment of metabolic 
disorders and infectious diseases as well as in cancer therapy¹. The 
interest in bioactive peptides is not restricted to pharmaceutical uses, 
but also includes applications in the food and cosmetics industries2–5.
Currently, over 60 synthetic therapeutic peptides are present on the 
market⁶. Furthermore, more than 128 peptide therapeutics are in the 
clinical pipeline⁷, and with a rate of approval that is twice that of small-
molecule drugs⁴, the global market for peptide therapeutics is expected 
to grow steadily and reach over $25 billion by 2018⁸. A number of top 
selling peptide therapeutics is listed in Table 1.
The development of new applications for peptide drugs requires research 
on new delivery systems, studies on toxicity, efficacy, distribution and 
metabolism, as well as clinical research, all of which are dependent on 
effective methods for peptide synthesis. Large doses may be required 
and the high costs of current production schemes limit the availability of 
peptide drugs. Thus, besides pharmacokinetic properties also production 
methods determine the possibility to develop and use peptides as drugs. 
The main methods for peptide synthesis are briefly reviewed below, with 
a focus on chemoenzymatic processes consisting of enzymatic coupling 
of chemically prepared or activated amino acids and peptides. A key 
step in chemoenzymatic peptide synthesis is the selection, discovery 
or engineering of suitable coupling enzymes, and therefore various 
strategies to obtain peptide coupling and modification enzymes will be 








Length Sequence Indications Synthesis method




Lupron leuprorelin 2.27 9 aa Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt
advanced prostate cancer, 
breast cancer
chemical
Sandostatin octreotide acetate 1.44 8 aa H-D-Phe-c[Cys-Phe-D-Trp-Lys-Thr-Cys]-Thol, acromegaly, carcinoid syndrome chemical
Zoladex goserelin acetate 1.19 10 aa
Pyr-His-Trp-Ser-Tyr-D-Ser(OtBu)-Leu-Arg-Pro-
AzGly-NH₂
advanced prostate cancer, 
breast cancer
chemical























TABLE  1 . 
Top selling peptide therapeutics (2009-2011) 
and their synthesis method6,7
Abbreviations:  AzGly = azaglycine, Thol = threoninol, OtBu = t-butyl ester, Et = ethyl group, 
Pyr = pyroglutamic acid
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There is no single best technology for the production of peptides. Current 
methods for peptide production are chemical synthesis, production in 
recombinant systems, and chemo-enzymatic synthesis, and the method 
of choice depends on sequence, length and properties of the peptide. 
At this moment, chemical peptide synthesis is still the preferred method 
for the production of therapeutic peptides, since it allows the synthesis 
of almost any desired peptide sequence, including peptides with non-
proteinogenic amino acids. In general, chemical peptide synthesis 
includes selection of protecting groups, a deprotection and/or activation 
method, and peptide bond formation step⁹. Chemical peptide synthesis 
and coupling reactions are highly sequence dependent, and both method 
development and analysis become more critical as peptides grow in 
complexity⁴. Current peptide-based products are at the smaller end (8–10 
amino acids) of the size spectrum of bioactive peptides, but peptides up 
to 45 amino acids are also on the market10. Synthetic routes can become 
problematic due to low segment solubility and also racemization might 
be a problem. The number and amount of impurities, many of which are 
very similar to the desired product, increase with the number of amino 
acids, which dramatically influences production costs⁴. Advantages and 
limitations of the available methods are discussed below (Table 2).



















Scale g-ton mg-ton g-ton mg mg g-ton mg-ton mg
Peptide length short-medium medium-large medium-large Medium-very large medium short-large medium-large short-medium
Protection required partial-total total total none none minimal-none none none
Sequence versatility medium-high high high narrow narrow medium-high medium narrow
Non-proteinogenic amino acids yes yes yes yes yes yes some yes
Racemization some none yes none none none none none
Reaction medium organic solvent organic solvent organic solvent aqueous medium aqueous medium
organic solvent, organic 
solvent-water mixtures, 
aqueous medium
aqueous medium aqueous medium
R&D effort small very small large large large large very large huge
Development phase mature mature mature embryonic embryonic infantry maturing conceiving
Production costs high very high high -very high medium medium-high medium medium-high low
Environmental impact high very high high some some some some some
Industrial scale yes yes yes no no yes yes yes
Chemical synthesis
Peptide synthesis 
TABLE  2 . 
Methods for peptide synthesis
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FIGU RE  1 . 
Principle of solid phase peptide synthesis 
(SPPS). In the first step the solid support is 
prepared (resin and linker) and the first amino 
acid is coupled to the linker (loading). All side 
chains of amino acids are protected. In the 
second step, the Nα-terminal protecting group 
of the resin-bound peptide is cleaved off. Then, 
a second Nα- protected amino acid is activated 
in situ by addition of coupling reagents and 
a peptide bond is formed. The Nα-terminal 
protecting group of the resin-bound dipeptide 
is cleaved and another activated amino acid 
is added to the growing polypeptide chain. 
The Nα deprotection and coupling steps are 
repeated for several cycles. In the final step 
the polypeptide chain is cleaved from the resin 
and all protective groups are removed. The final 
crude product is purified by HPLC. 
Protective groups: T = temporary Nα-terminal 
protective group (tBoc = tert-butoxycarbonyl), 
Fmoc = 9-fluorenylmethyloxycarbonyl; R = side 
chain; p = permanent side chain protecting group 
(Bzl = benzyl, tBu = tert-butoxy); A = activating 

























































Solution phase synthesis (SPS) was the first method developed for peptide 
synthesis, and can include both stepwise coupling reactions and coupling 
of peptide segments. Different versatile coupling methods are available11, 
with the carbodiimide method being commonly used for peptide segment 
coupling12. Here, the coupling reagent N’,N’’-dicyclohexylcarbodiimide 
(DCC) activates the carboxylate function of an Nα-protected amino 
acid that once activated is able to form a peptide bond with an amine 
nucleophile. A coupling additive, e.g. 1-hydroxybenzotriazole (HOBt) is 
added to prevent racemization and improve efficiency. Solution phase 
peptide synthesis is a scalable method that is mainly applied for the 
synthesis of small peptides (<10 amino acids)13,12. Drawbacks are the need 
to isolate and purify the intermediates after each step and the requirement 
for protecting groups. Especially for longer peptides (> 10 amino acids) 
this renders the synthesis costly and time-consuming. Another problem 
is that racemization of the C-terminal amino acid in solution may occur, 
and preferred coupling positions therefore are Gly-Xxx or Pro-Xxx14. In 
addition, as the size of the target peptide increases, the solubility of the 
segments to couple becomes a major issue15. 
The pioneering work of Merrifield16, who introduced solid-phase peptide 
synthesis (SPPS), revolutionized the field of chemical peptide synthesis, 
especially because it allowed the development of automated synthetic 
processes. Today, SPPS is the method of choice for the synthesis of 
small- to medium-size peptides (<50 amino acids). The desired sequence 
is assembled in a linear fashion from the C-terminus to the N-terminus 
(C→N direction) by repetitive cycles of Nα-de-protection and coupling 
steps (Figure 1). Peptide coupling reagents and coupling additives are 
required for carboxylic acid activation and peptide bond formation. Solid-
phase synthesis is fast and generally racemization free because the 
coupling occurs between C-terminus of an activated amino acid and the 
N-terminus of the peptide chain attached to the solid support.
Solid-phase peptide synthesis
Solution-phase peptide synthesis
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Common strategies involve combinations of temporary (T) and permanent 
(Pn) protecting groups e.g. 
tBoc/Bzl (T/Pn) and Fmoc/
tBu (T/Pn). The latter 
is nowadays widely used, even on industrial scale, because temporary 
and permanent protecting groups are removed by different mechanisms 
(i.e. Fmoc is base labile and side chain protective groups are acid labile) 
which makes it possible to use milder conditions for removal of Nα-
terminal protecting group, final cleavage from the resin and side-chain 
deprotection than in the case where protective groups are not orthogonal. 
A summary of general strategies and protocols for solid phase peptide 
synthesis is described in a review by Amblared et al.17
Disadvantages of solid-phase peptide synthesis are that in order to reach 
high yields per cycle, reagents need to be used in excess and washed 
away, resulting in production of large amounts of reagents and solvent as 
waste (e.g. 1000 L solvent/kg of peptide drug12). Tedious and expensive 
preparative HPLC purification is needed to remove impurities with similar 
properties, which further increases production costs. In addition, peptides 
longer than 10 amino acids tend to form tertiary structures due to a 
process called hydrophobic collapse, making the further synthesis difficult.
In the so-called hybrid approach, solution-phase reactions are used to 
couple peptide segments that are usually obtained by step-wise solid-
phase synthesis (Figure 2). This way, the advantages of the solid-phase 
and solution-phase methods are combined, and it is often an attractive 
way to synthesize longer peptides18. The selection of coupling sites is 
strongly sequence dependent. Ideally, the starting peptide segments 
(i.e. 10-mers) are obtained by means of solid-phase peptide synthesis, 
and are then coupled in convergent manner (e.g. 10+10+10) using 
solution-phase chemistry. To avoid racemization Gly or Pro should be 
the C-terminal amino acids of the peptide segments. If that is not the 
case, the purification becomes troublesome and expensive. Thus, critical 
issues are solubility of the intermediates, undesired epimerization at the 
coupling positons, and troublesome isolations.



































FIGU RE  2 . 
Hybrid approach for the synthesis of a 30-mer peptide in C- to N- direction. Symmetric 
peptide segments (decapeptides) obtained by solid-phase peptide synthesis are coupled 
in a stepwise manner (10+10+10), using solution-phase chemistry. The selection of sites 
for the coupling reactions is crucial for process efficacy in terms of minimizing the risk of 
racemization and purification costs. 
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Native chemical ligation (NCL) is a relatively new synthetic method that 
enables covalent condensations of large unprotected peptide segments 
that are soluble in buffer systems. The method exploits the unique 
properties of a thioester group. The coupling of an activated acyl donor 
peptide in a form of a thioester and a nucleophile (peptide with N-terminal 
cysteine) proceeds in two steps. The first step involves a reversible thiol-
thioester exchange: the side-chain SH of the N-terminal amino acid 
(usually a cysteine) of the amino donor peptide attacks the activated 
thioester of the acyl donor. This is followed by spontaneous irreversible 
S → N acyl transfer to the final product that has a native peptide bond at 
the ligation site (Figure 3). NCL has been used to make synthetic proteins 



















FIGU RE  3 . 
Principle of native chemical ligation: 
thioester-mediated amide-forming 
chemoselective ligation of two 
unprotected peptide segments. Under 
denaturing conditions at neutral pH and 
in the presence of an exogenous thiol 
catalyst, the first step (thiol-mediated 
thioester exchange) is reversible, while 
the second step (S-to-N acyl shift) is 
irreversible and gives a native peptide 
bond at the ligation site.
The requirement for a cysteine at a coupling site is often regarded as the main 
limitation of NCL. In addition, the need for an expensive thioester segment on the 
acyl donor limits the large-scale applicability of this method. Even though modified 
methods were developed to circumvent the need for a cysteine at the coupling 
site (desulfurization, auxiliary group), NCL is not applied on industrial scale20.
Novel methods that address the thioester limitation have been developed, 
such as expressed protein ligation (EPL), which allows α-thioester segments to 
be produced recombinantly as engineered intein-domain fusion peptides that 
can later be cleaved by thiolysis and coupled to a desired target using NCL21,22 
(Figure 4). However, the method depends on N-terminal cysteine residues and 
has restrictions similar to NCL. Besides recombinant production of α-thioester 
segments, where only natural amino acids can be incorporated, α-thioester 
peptides with desired modifications can be chemically prepared using peptide 
hydrazides that can be converted to thiosters23 or by applying enzymatic 



























FIGU RE  4 . 
Principle of expressed protein ligation (EPL). The recombinantly expressed 
protein contains an intein domain and a chitin-binding domain. Once 
immobilized on a chitin affinity matrix, intein cleavage is typically induced by 
2-mercaptoethanesulfonic acid to generate a C-terminal thioester that can 
be used in native chemical ligation.
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In expressed enzymatic ligation (EEL) the EPL strategy is combined with a 
substrate-mimetic strategy. Peptide segments are produced by recombinant 
expression as in EPL and are coupled by a protease using a substrate mimetic 
approach26 (see Chapter 2). This ligation approach eliminates the need for 
cysteines at the ligation site, but as with all proteases care has to be taken to 
prevent possible hydrolysis of the peptide segments or the final product.
These non-ribosomal peptide synthetases (NRPS) are of particular interest since 
they produce bioactive polypeptides of various size and shape, including peptides 
carrying modifications such as N-methylation, cyclization, and the presence of 
D-amino acids. NRPSs are employed for large scale peptide synthesis, such as 
β-lactam antibiotic and cyclosporin production. However, they are not yet applied 
for the synthesis of non-native peptides, which is mainly due to the inability to 
tailor and re-design NRPSs for synthesis of a desired peptide sequence34,35. 
Biochemical peptide synthesis employing the cell’s natural capacity to 
synthesize peptides is attractive because of high chemo- and regioselectivity, 
lack of racemization, mild process conditions and low environmental impact27,28. 
Two methods can be distinguished: ribosomal peptide synthesis, based on 
transcription and translation of DNA coding sequences, and non-ribosomal 
peptide synthesis, employing large modular protein complexes. Unfortunately, the 
standard application of ribosomal peptide synthesis by genetically engineered 
cells is restricted to proteinogenic amino acids and to relatively long peptides 
(>50 amino acids29) because short peptides are easily degraded in the metabolic 
pathways of the recombinant host. Strategies for fermentative production of 
shorter peptides and peptides containing non-natural amino acids are being 
developed as well2,30. The restriction that fermentation is feasible only in case 
of relatively long peptides composed of natural amino acids and the high 
development costs limit the widespread use of ribosomal peptide synthesis. As a 
result, ribosomal peptide synthesis is only applied in the late drug development 
stage and is used only for the synthesis of large peptides such as insulin31 and 
human growth factor32.
To surpass the limitations of the host, cell-free translation systems can be 
considered. The system includes a DNA template that encodes the desired 
peptide, a ribosomal extract as the synthesis machinery, amino acids, and an 
energy source. Although such systems better tolerate non-natural amino acids, 
the low product yield, low RNA template stability and low translation efficiency 
require significant improvement before large-scale application is possible33. 
Whole-cell non-ribosomal peptide synthesis is mediated by dedicated multimeric 
enzyme complexes that direct the synthesis of versatile bioactive compounds 
such as antifungal and antibiotic molecules, independent of the ribosomes. 
Enzymatic peptide synthesis is based on the application of proteases or related 
hydrolytic enzymes in the reverse direction. The possibility to use proteases for 
peptide synthesis under specific reaction conditions was first predicted by Van’t 
Hoff36 and Ostwald37 in 1898. and demonstrated by Bergmann and Fraenkel-
Conrat some 40 years later38. Both stepwise coupling and segment ligation can 
be catalyzed by proteases. In the 1980s, the use of hydrolases in the reverse 
direction became a field of intensive research, mostly due to the work of Klibanov 
and coworkers who used organic solvents to trigger coupling reactions39,40. Since 
then, and stimulated by the growing importance of bioactive peptides, a lot of 
research has been devoted to finding better enzymes and optimal conditions 
for peptide synthesis. Modern approaches such as genome mining and protein 
engineering have been used for discovery and engineering of peptidases that 
can be used for synthesis.
Peptidases can catalyze the synthesis of a peptide bond in either thermodynamically 
or kinetically controlled manner41,42. The thermodynamic approach is a reversal of 
hydrolysis which is achieved by modifying reaction conditions. This approach 
is useful only if a shift of the chemical equilibrium occurs, e.g. by reducing 
water activity (solvent-free systems, addition of cosolvents, use of neat organic 
solvent) or by removing the product (extraction into organic layer, separation by 
molecular traps, precipitation)43. If peptides or amino acids with free carboxylate 
and amine groups are coupled, solvent hydrophobicity will stimulate synthesis, 
and the reaction will proceed to a degree of conversion that is dependent on the 
conditions used, especially solvent composition and pH (Figure 5). 
Fermentative peptide synthesis
Peptide bond synthesis by proteases
Enzymatic and chemoenzymatic peptide synthesis
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Kinetically controlled peptide synthesis is based on the capacity of some proteases 
to form an acyl-enzyme intermediate that can undergo, under appropriate 
conditions, deacylation by the N-terminus of an amino acid or peptide rather 
than cleavage by water. Suitable enzymes for kinetically controlled coupling are 
serine or cysteine proteases. The acyl donor is added in the form of an activated 
precursor that forms the acyl-enzyme intermediate and provides the N-terminal 
segment of the product peptide. The amine group of a nucleophilic peptide or 
amino acid reacts in an aminolytic reaction with the acyl enzyme and becomes 
the C-terminal segment (Figure 5).
In a kinetically controlled process, the nucleophile needs to act in 
competition with water to form a peptide bond instead of hydrolysis of 
the acyl-enzyme. Different nucleophiles can compete with water, e.g. 
an alcohol yields an ester in a trans-esterification reaction; a peroxide 
as nucleophile generates a peracid, and an amine nucleophile yields 
an amide. Enzymatic formation of hydrazides is also possible, as 
well as the formation of derivatives of hydroxamic acid (Figure 6). 
Compared to the thermodynamic approach, the kinetically controlled 
synthesis enables higher conversions and requires less enzyme, 
provided a good enzyme is available27. In principle, product yield 
over time goes through a maximum, and since product hydrolysis 
can also happen, the reaction will slowly proceed to equilibrium.
Due to the competing hydrolytic reaction and the possibility of product 
hydrolysis, the level of (transient) product accumulation strongly depends 
on the enzyme properties. The enzyme should have a low tendency to 
hydrolyze the acyl donor, and in case of peptide coupling, also refrain 
from hydrolyzing bonds in the peptide building blocks. An important 
parameter is the aminolysis to hydrolysis ratio (or synthesis-hydrolysis 
ratio, S/H), which should be as high as possible. In addition, the ideal 
coupling enzyme is robust in terms of its operational stability, including 
temperature stability and co-solvent tolerance.
FIGU RE  5 . 
Principle of enzymatic peptide synthesis. A Synthesis under thermodynamic control is based on 
microscopic reversibility. The overall equilibrium constant Ke will be strongly dependent on ionization 
constants of the different species and the reaction pH. B Synthesis under kinetic control. The activated 
acyl donor (Ac-X) forms a Michaelis complex [EH•Ac-X] that reacts to the acyl-enzyme intermediate 
E-Ac. The deacylation of this intermediate can be performed either by water yielding hydrolytic product 
Ac-OH and free enzyme, or by an added nucleophile (HNu) that leads to the synthetic product P and 
free enzyme via a second Michaelis complex [E-Ac•HNu]. This complex may still hydrolyze if water 
competes with bound nucleophile. Synthetic yields are determined by rate constants kac, kh1, kh2, ks, 
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FIGU RE  6 . 
Biocatalytic applications of serine peptidases. In a low water activity environment a variety 
of nucleophiles may outcompete water for cleaving the acyl-enzyme intermediate allowing 
formation of various synthetic products. Transesterification may occur with alcohol as a 
nucleophile, whereas an amine nucleophile leads to the formation of an amide bond. Other 
nucleophiles may yield hydroxamic acids derivatives or hydrazides. Hydrogen peroxide as 
nucleophile leads to peracid formation.  
An important enzyme property is also substrate specificity. Restricted substrate 
specificity, such as encountered in trypsin and chymotrypsin, can be an advantage 
since it reduces the number of possibilities for hydrolysis of a synthetic product, 
but also a disadvantage, since it reduces the flexibility in terms of peptide bonds 
that can be synthesized. Peptidases can be distinguished on basis of their 
positional specificity and recognition sequence. The precise cleavage site is 
mainly determined by favorable interactions between side chains of the amino 
acids of the peptide (designated P2, P1, P1’, P2’ etc.) and specific subsites in the 
active site (S2, S1, S1’, S2’ etc.) of the protease. The notation of sites follows the 
Schechter and Berger nomenclature44, according to the scheme shown in Figure 745. 
Although fully enzymatic step-wise synthesis of peptides is possible, in practice a 
convergent approach consisting of a combination of chemical and enzymatic steps 
is preferred. This requires the target sequence to be divided into segments that are 
independently produced (usually chemically) and can be coupled enzymatically. 
This causes a lack of general applicability, and in combination with the necessity 
to use expensive activated precursors for kinetic coupling caused reluctance 
































FIGU RE  7. 
Schechter and Berger nomenclature for the active site 
of a peptidase and its substrate. The scissile bond is 
located between P1 and P1’.
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Enzymatic synthesis of peptides by a sequential approach (stepwise addition of 
a single amino acid to the growing peptide chain), or by an economically more 
favorable convergent approach where larger peptide segments are enzymatically 
coupled, has been reported, both in water as well as in organic solvent mixtures, 
applying kinetically or thermodynamically controlled synthesis46,47. For example, 
the pentapeptide precursor (Cbz-Tyr-Gly-Phe-Gly-Gly-OEt) of the bioactive 
osteogenic growth protein was synthesized in 50% yield (3+2 segment coupling 
with papain or chymotrypsin), or in 70% yield (chymotrypsin- and thermolysin-
mediated coupling in almost dry organic solvent)48.
Since the work of Klibanov and colleagues on the use of enzymes in 
organic solvents, the field of non-aqueous enzymology has developed 
rapidly39,40. The possibility to apply enzymes in water-cosolvent systems, 
including two-phase systems, and the option to use neat organic solvents 
opened a whole range of synthetic applications of enzymes that naturally 
hydrolyze peptide bonds. The presence of cosolvents or the use of neat 
solvents may have a profound effect on reaction equilibria, making it 
possible to use hydrolytic enzymes for coupling reactions. Furthermore, 
the use of organic solvents may have advantages such as high substrate- 
and product solubility and the partitioning of substrates and products over 
different phases. On the other hand, organic solvents may cause molecular 
or (inter)phase toxicity, and disturb the stable conformation of enzymes. 
The use of cosolvents to increase peptide substrate solubility has been 
described both for thermodynamic coupling reactions and for kinetically 
controlled synthesis49,50. Moderate amounts of water-miscible cosolvents 
were to improve substrate solubility, without considerable negative effect 
on the enzyme51. The solubility of peptides in a solvent or buffer is influenced 
by their polarity, which is determined by the amino acid composition and 
the conformation of the peptide. Accordingly, peptide solubility can 
be enhanced by selecting appropriate solvent mixtures. For example, 
addition of the strongly solvating compound dimethylformamide (DMF) 
or dimethylsulfoxide (DMSO) is known to increase solubility of peptides52. 
Anhydrous organic solvents are a promising medium for peptide synthesis 
under kinetic control, since hydrolysis is avoided. Furthermore, by using 
a suitable solvent the selectivity and activity of a peptidase can be 
modulated. Only a very small amount of water is necessary for an enzyme 
to have conformational flexibility and to be catalytically active, and this 
essential water can range from a few % in organic solvent to as little as a 
monolayer53. Moreover, the effect of organic solvent on enzyme structure 
is not as detrimental as previously thought, as concluded from studies 
on subtilisin crystals in organic solvents54. Hydrophobic organic solvents 
often increase thermal stability of enzymes. For example, the half-life 
of α-chymotrypsin in aqueous solution at 55°C is 15 min55, whereas in 
octane at 100°C it is about 80 min39. Enzyme specificity, stereoselectivity, 
regiospecificity, and chemoselectivity are also affected51. 
The relaxed selectivity of enzymes in organic medium enables new 
synthetic applications of peptidases. As an example, a dipeptide 
containing either D-L, L-D or D-D peptide bonds can be synthesized 
using subtilisin in anhydrous solvent, whereas these bonds are usually 
not sensitive to peptidase-mediated hydrolysis56. This also shows that the 
specificity an enzyme exhibits in water is not necessarily maintained when 
it is used in anhydrous medium. However, enzyme activity in neat organic 
solvents can be 5,000-100,000 less than in water and to alleviate this loss 
optimized reaction conditions have to be applied (i.e. medium selection, 
water activity control, optimal enzyme preparation)57.
Reaction medium design
A remarkably solvent-stable protease is subtilisin. It showed a unique tolerance to 
hydrophilic solvents that dissolve long protected peptides, such as tetrahydrofuran 
(THF), acetonitrile, or alcohols. The synthetic potential of subtilisin Carlsberg 
(Alcalase) was recently explored by Quaedflieg and coworkers58–62. In these 
experiments, Alcalase was used in neat organic solvent in synthetic reactions 
containing activated precursors for peptide synthesis, catalyzing condensation 
of a 10-mer and a 9-mer. Although medium engineering is primarily focused on 
influencing the properties of an enzyme by adding cosolvents (activity, specificity, 
stability), it can also involve the use of frozen aqueous solutions63, use of ionic 
liquids64 or supercritical fluids and65–67 combinations thereof. In a recent attempt to 
make peptide synthesis more green, the amounts of solvent were reduced to obtain a 
slurry (in SPPS), or solvent was even completely omitted (ball-milling technology68). 
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The rate and yield of peptide synthesis reactions not only depends 
on enzyme and reaction conditions, but also on the type of reactants. 
Important aspects are the choice of the activating groups in kinetically 
controlled synthesis, the choice of terminal protecting groups in coupling 
reactions, modifications of the peptide chain that influence substrate and 
product solubility, and the selection of ligation sites if peptides are to be 
coupled. 
Compounds with good leaving groups such as carboxamidomethyl (Cam, 
glycolamide)69 or 2,2,2-trifluoroethyl (Tfe) esters70 proved to be better 
acyl donors for peptide synthesis than (m)ethyl esters (Table 3). Their 
enhanced activity is explained by strong electron-withdrawing properties 
of the leaving groups which make the carbonyl group more susceptible 
to nucleophilic attack by an active site serine. In addition, it is believed 
that some activating groups, such as in Cam esters, have the ability to 
bind to the enzyme via a hydrogen bond in the same fashion as an amide 
of a peptide backbone binds. Recently, substituted phenyl esters and 
carboxamidomethyl groups that are elongated with an amino acid amide 
were tested. These derivatives form additional binding interactions with 
the enzyme and gave better synthesis as compared to other activating 
groups71. Carboxamidomethyl groups and modified carboxamidomethyl 
activating groups are of particular interest for chemoenzymatic peptide 
synthesis since they give very good activity, are not prone to racemization 
and can be easily synthetized either chemically or enzymatically71,72. 
Recognizing the importance of binding of the acyl donor for synthetic 
performance in kinetically controlled coupling, modifications of the 
leaving group such that it better matches enzyme selectivity has been 
proposed73,74 (Table 3). In the so-called inverse substrate or substrate-
mimetic approach, a reactive group such as in a p-guanidinophenyl 
(OGp) ester forces formation of an acyl-enzyme intermediate even in the 
absence of an amino acid at the P1 position that matches the S1 pocket 
specificity. Instead, the S1 pocket is used to bind the leaving group, which 
is designed to mimic the side chain that fits in the S1 subsite, and a reactive 
acyl-enzyme is formed. Prior to deacetylation step the substrate changes 
orientation liberating S’ subsites, thus allowing nucleophilic attack. 
This approach enabled the acceptance of amino acids and peptide 
sequences that are normally not recognized by chymotrypsin or trypsin75,76. 
Work with the Glu-specific endopeptidases (V8 from Staphylococcus 
aureus and BL-GSE from Bacillus licheniformis) showed the use of 
the carboxymethyl thioester group (2-mercaptoacetate thioester) as 
substrate mimetic for a protease that is not active with arginine at the 
P1 position77,78. 
Reaction medium design
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TABLE  3 . 
Strongly activating groups for kinetic peptide 
coupling.
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Synthetic yields and synthesis rates in enzymatic peptide synthesis can 
be improved by optimizing reaction conditions, by reactant optimization, 
and by selecting the most appropriate biocatalyst47,70,79–85. Especially 
kinetically-controlled coupling reactions are critically dependent on 
enzyme properties. Suitable enzyme can be acquired commercially, 
or they may be obtained by screening for new enzymes for nature's 
biodiversity. Variants of known enzymes with improved properties may 
be constructed by protein engineering (this thesis). 
Enzyme formulation is also important, including physical or chemical 
modification. Especially immobilization is often applied as it contributes 
to enzyme stability and allows rapid separation of enzyme and reaction 
products, with the possibility to reuse the enzyme86. Due to the variations 
in selectivity of most proteases and differences in compatibility with 
reaction conditions, there is not a single peptidase that can be used for 
any coupling reaction. Rather, a toolbox of peptidases is needed in order 
to fully exploit the advantages of chemo-enzymatic peptide synthesis.
Enzyme selection and formulation References 
01 — Thundimadathil, J. Cancer treatment using peptides: current therapies 
and future prospects. J. Amino Acids 2012, 967347 (2012).
02 — Thayer, A. Improving peptides. Chem. Eng. News 89, 13–20 (2011).
03 — Thayer, A. M. Making peptides at large scale. 
Chem. Eng. News 89, 9–12 (2011).
04 — Lax, R. The future of peptide development in the pharmaceutical 
industry. PharManufacturing Int. Pept. Rev. 10–15 (2010).
05 — Mine, Y., Li-Chan, E. & Jiang, B. Bioactive proteins and peptides as 
functional foods and nutraceuticals. (Wiley-Blackwell, 2010).
06 — Vlieghe, P., Lisowski, V., Martinez, J. & Khrestchatisky, 
M. Synthetic therapeutic peptides: science and market. 
Drug Discov. Today 15, 40–56 (2010).
07 — Kaspar, A. a & Reichert, J. M. Future directions for peptide 
therapeutics development. Drug Discov. Today 18, 807–17 (2013).
08 — Research&Markets. Global Peptide Therapeutics 
Market & Pipeline Insight. (2014).
09 — Okada, Y. Synthesis of peptides by solution 
methods. Curr. Org. Chem. 5, 1–43 (2001).
10 — Craik, D. J., Fairlie, D. P., Liras, S. & Price, D. The future of peptide-
based drugs. Chem. Biol. Drug Des. 81, 136–47 (2013).
11 — Marder, O. & Albericio, F. Industrial application of coupling 
reagents in peptides. ChemInform 35, (2004).
12 — Andersson, L., Blomberg, L., Flegel, M., Lepsa, L., Nilsson, B. & Verlander, 
M. Large-scale synthesis of peptides. Biopolymers 55, 227–250 (2000).
13 — Guzman, F., Barberis, S. & Illanes, A. Peptide synthesis: chemical 
or enzymatic. Electron. J. Biotechnol. 10, 279–314 (2007).
14 — Bodanszky, M. Principles of peptide synthesis. 
(Springer Berlin Heidelberg, 1993).
15 — Lloyd-williams, P. & Giralt, E. Convergeny solid-phase peptide 
synthesis. Tetrahedron 49, 11065–11133 (1993).
16 — Merrifield, R. B. Solid phase peptide pynthesis.The synthesis of 
a tetrapeptide. J. Am. Chem. Soc. 85, 2149–2154 (1963).
3534
CHAPTER — 01 — REFERENCES 
17 — Amblard, M., Fehrentz, J., Martinez, J. & Subra, G. 
Methods and protocols of modern solid phase peptide 
synthesis. Mol. Biotechnol. 33, 239–254 (2006).
18 — Bray, B. L. Large-scale manufacture of peptide therapeutics by 
chemical synthesis. Nat. Rev. drug Discov. 2, 5–9 (2003).
19 — Dawson, P. E., Muir, T. W., Clark-Lewis, I. & Kent, S. B. Synthesis of 
proteins by native chemical ligation. Science 266, 776–779 (1994).
20 — Kent, S. B. H. Total chemical synthesis of proteins. 
Chem. Soc. Rev. 38, 338–51 (2009).
21 — Muir, T. W., Sondhi, D. & Cole, P. A. Expressed protein 
ligation : A general method for protein engineering. 
Proc. Natl. Acad. Sci. 95, 6705–6710 (1998).
22 — Machova, Z. & Beck-Sickinger, A. G. Expressed protein ligation for protein 
semisynthesis and engineering. Methods Mol. Biol. 298, 105–130 (2005).
23 — Zheng, J.-S., Tang, S., Qi, Y.-K., Wang, Z.-P. & Liu, L. Chemical 
synthesis of proteins using peptide hydrazides as thioester 
surrogates. Nat. Protoc. 8, 2483–95 (2013).
24 — Quaedflieg, P. J. L. M. & Merkx, N. S. M. Chemo-enzymatic synthesis 
of a C-terminal thioester of an amino acid or a peptide. Patent 
WO2009047354 A1 filed 12 Oct. 2008, and issued 16 Apr. 2009.
25 — Tan, X.-H., Yang, R., Wirjo, A. & Liu, C.-F. Subtiligase as a hydrothiolase for 
the synthesis of peptide thioacids. Tetrahedron Lett. 49, 2891–2894 (2008).
26 — Machova, Z., von Eggelkraut-Gottanka, R., Wehofsky, N., 
Bordusa, F. & Beck-Sickinger, A. G. Expressed enzymatic 
ligation for the semisynthesis of chemically modified proteins. 
Angew. Chem. Int. Ed. Engl. 42, 4916–8 (2003).
27 — Schellenberger, V. & Jakubke, H.-D. Protease-catalyzed 
kinetically controlled peptide synthesis. Angew. 
Chemie Int. Ed. English 30, 1437–1449 (1991).
28 — Meyer, H. P. & Werbitzky, O. How Green can the industry become 
with biotechnology?, in Biocatalysis for Green Chemistry and 
Chemical Process Development (eds. Tao, J. & Kazlauskas, R.) 23–43 
(John Wiley & Sons, Inc., Hoboken, New Jersey, USA, 2011).
29 — Meyer, H. P., Brass, J., Jungo, C., Klein, J., Wenger, J. & Mommers, 
R. An emerging star for therapeutic and catalytic protein 
production. BioProcess International 10–21 (2008).
30 — Ryu, Y. & Schultz, P. G. Efficient incorporation of unnatural amino acids 
into proteins in Escherichia coli. Nat. Methods 3, 263–265 (2006).
31 — Walsh, G. Therapeutic insulins and their large-scale manufacture. 
Appl. Microbiol. Biotechnol. 67, 151–9 (2005).
32 — Rezaei, M. & Zarkesh-Esfahani, S. H. Optimization of 
production of recombinant human growth hormone in 
Escherichia coli. J. Res. Med. Sci. 17, 681–5 (2012).
33 — Sewald, N. & Jakubke, H.-D. Peptides: Chemistry and Biology. 
3, (Wiley-VCH Verlag GmbH & Co. KGaA, 2002).
34 — Sieber, S. A & Marahiel, M. A. Molecular mechanisms 
underlying nonribosomal peptide synthesis: approaches 
to new antibiotics. Chem. Rev. 105, 715–38 (2005).
35 — Hodgson, D. R. W. & Sanderson, J. M. The synthesis of peptides and proteins 
containing non-natural amino acids. Chem. Soc. Rev. 33, 422–30 (2004).
36 — van’t Hoff, J. Über die zunehmende Bedeutung der anorganischen 
Chemie. Vortrag, gehalten auf der 70 . Versammlung der 
Gesellschaft deutscher Naturforscher und Ärzte zu Düsseldorf. 
Zeitschrift fur Anorg. Chemie 18, 1–13 (1898).
37 — Ostwald, W. Die 73 . Versammlung Deutscher Naturforscher und Ärzte zu 
Hamburg . Über Katalyse. Zeitschrift fur Elektrochemie 7, 14–16 (1901).
38 — Bergmann, M. & Fraenkel-Conrat, H. The role of specificity 
in the enzymatic synthesis of proteins: Syntheses with 
intracellular enzymes. J. Biol. Chem. 119, 707–720 (1937).
39 — Zaks,  A & Klibanov,  A. M. Enzymatic catalysis in nonaqueous 
solvents. J. Biol. Chem. 263, 3194–201 (1988).
40 — Klibanov, A. M. Improving enzymes by using them in 
organic solvents. Nature 409, 241–246 (2001).
41 — Bongers, J. & Heimer, E. P. Recent applications of enzymatic 
peptide synthesis. Peptides 15, 183–93 (1994).
42 — Bordusa, F. Proteases in organic synthesis. 
Chem. Rev. 102, 4817–4868 (2002).
43 — Nuijens, T., Quaedflieg, P. J. L. M. & Jakubke, H. in Enzyme 
Catalysis in Organic Synthesis (eds. Drauz, K., Groger, H. & May, 
O.) 675–748 (Wiley-VCH Verlag GmbH & Co. KGaA, 2012).
44 — Schechter, I. & Berger, A. On the active site of proteases. Mapping 
the active site of papain; specific peptide inhibitors of papain. 
Biochem. Biophys. Res. Commun. 32, 898–902 (1968).
45 — Schechter, I. Mapping of the active site of proteases in 
the 1960s and rational design of inhibitors / drugs in the 
1990s . Curr. Protein Pept. Sci. 6, 501 (2005).
46 — Didziapetris, R., Drabnig, B., Schellenberger, V., Jakubke, H. 
D. & Svedas, V. Penicillin acylase-catalyzed protection and 
deprotection of amino groups as a promising approach in 
enzymatic peptide synthesis. FEBS Lett. 287, 31–3 (1991).
47 — Clapés, P., Torres, J. L. & Adlercreutz, P. Enzymatic peptide synthesis in 
low water content systems: preparative enzymatic synthesis of [Leu]- and 
[Met]-enkephalin derivatives. Bioorg. Med. Chem. 3, 245–55 (1995).
48 — Liu, P., Tian, G., Lee, K.-S., Wong, M.-S. & Ye, Y. Full enzymatic 
synthesis of a precursor of bioactive pentapeptide OGP(10-14) 
in organic solvents. Tetrahedron Lett. 43, 2423–2425 (2002).
CHAPTER — 01 — REFERENCES 
3736
49 — Schellenberger, V.,  Schwaneberg, U., Jakubke, H.-D., Hansicke, A., 
Bienert, M. & Krause, E. Chymotrypsin -catalyzed segment coupling 
synthesis of D-Phe(6)-GNRH. Tetrahedron Lett. 31, 7305–7306 (1990).
50 — Nishino, N., Xu, M., Mihara, H. & Fujimoto, T. Use of 
hexafluoroisopropyl alcohol in tryptic condensation for 
partially protected precursor of α-melanocyte stimulating 
hormone. Tetrahedron Lett. 33, 3137–3140 (1992).
51 — Koskinen, A. & Klibanov, A. M. Enzymatic reactions in organic media. 
(eds. Koskinen, A. & Klibanov, A. M. ) Blackie Academic&Professional, 
an imprint of Chapmann &Hall, Glasgow, UK, 1996).
52 — Nyfeler, R. in Methods in Molecular Biology, Vol 35, Peptide 
Synthesis Protocols (eds. Pennington, M. . & Dunn, B. 
M.) 35, 303–316 (Humana Press Inc., 1994).
53 — Dolman, M., Halling, P.J., Moore, B. D. & Waldron, S. How dry are anhydrous 
enzymes ? Measurement of residual and buried 18O-labeled water 
molecules using mass spectrometry. Biopolymers, 41,313–321 (1997).
54 — Schmitke, J. L., Stern, L. J. & Klibanov,  A. M. The crystal structure of 
subtilisin Carlsberg in anhydrous dioxane and its comparison with those in 
water and acetonitrile. Proc. Natl. Acad. Sci. U. S. A. 94, 4250–5 (1997).
55 — Martinek, K., Klibanov, A. M., Goldmacher, V. S. & Berezin, I. V. The 
principles of enzyme stabilization I. Increase in thermostability of enzymes 
covalently bound to a complementary surface of a polymer support in a 
multipoint fashion. Biochim. Biophys. Acta - Enzymol. 485, 1–12 (1977).
56 — Margolin, A. L., Tai, D. & Klibanov, A. M. Incorporation of D-amino 
acids into peptides via enzymatic condensation in organic 
solvents. J. Am. Chem. Soc. 109, 7885–7887 (1987).
57 — Klibanov,  A. M. Why are enzymes less active in organic solvents 
than in water? Trends Biotechnol. 15, 97–101 (1997).
58 — Nuijens, T., Cusan, C., van Dooren, T. J. G. M., Moody, H. M., Merkx, R., 
Kruijtzer, J. A. W., Rijkers, D. T. S., Liskamp, R. M. J. & Quaedflieg, P. J. 
L. M. Fully enzymatic peptide synthesis using C-terminal tert-butyl 
ester interconversion. Adv. Synth. Catal. 352, 2399–2404 (2010).
59 — Nuijens, T., Schepers, A. H. M., Cusan, C., Kruijtzer, J. A. W., Rijkers, 
D. T. S., Liskamp, R. M. J. & Quaedflieg, P. J. L. M. Enzymatic fragment 
condensation of side chain-protected peptides using Subtilisin 
A in anhydrous organic solvents: A general strategy for industrial 
peptide synthesis. Adv. Synth. Catal. 355, 287–293 (2013).
60 — Nuijens, T., Cusan, C., Kruijtzer, J. A. W., Rijkers, D. T. S., Liskamp, R. M. J. 
& Quaedflieg, P. J. L. M. Enzymatic synthesis of C-terminal arylamides 
of amino acids and peptides. J. Org. Chem. 74, 5145–50 (2009).
61 — Nuijens, T., Kruijtzer, J. A. W., Cusan, C., Rijkers, D. T. S., Liskamp, 
R. M. J. . & Quaedflieg, P. J. L. M. A versatile and selective chemo-
enzymatic synthesis of β-protected aspartic and γ-protected glutamic 
acid derivatives. Tetrahedron Lett. 50, 2719–2721 (2009).
62 — Nuijens, T., Piva, E., Kruijtzer, J. A. W., Rijkers, D. T. S., Liskamp, R. M. 
J. & Quaedflieg, P. J. L. M. Fully enzymatic N→C-directed peptide 
synthesis using C-terminal peptide α-carboxamide to ester 
interconversion. Adv. Synth. Catal. 353, 1039–1044 (2011).
63 — Hänsler, M. & Jakubke, H. D. Nonconventional protease catalysis 
in frozen aqueous solutions. J. Pept. Sci. 2, 279–89 (1996).
64 — Wehofsky, N. Wespe, C., Cerovský, V., Pech, A., Hoess, E., 
Rudolph, R. & Bordusa, F. Ionic liquids and proteases: a clean 
alliance for semisynthesis. Chembiochem 9, 1493–9 (2008).
65 — Nakamura, K. Biochemical reactions in supercritical 
fluids. Trends Biotechnol. 8, 288–292 (1990).
66 — Rezaei, K., Temelli, F. & Jenab, E. Effects of pressure and 
temperature on enzymatic reactions in supercritical 
fluids. Biotechnol. Adv. 25, 272–80 (2007).
67 — Krishna, S. H. Developments and trends in enzyme catalysis in 
nonconventional media. Biotechnol. Adv. 20, 239–67 (2002).
68 — Declerck, V., Nun, P., Martinez, J. & Lamaty, F. Solvent-free synthesis 
of peptides. Angew. Chemie - Int. Ed. 48, 9318–9321 (2009).
69 — Miyazawa, T., Ensatsu, E., Yabuuchi, N., Yanagihara, R. & Yamada, 
T. Superiority of the carbamoylmethyl ester as an acyl donor for 
the kinetically controlled amide-bond formation mediated by 
α-chymotrypsin. J. Chem. Soc. Perkin Trans. 1 390–395 (2002).
CHAPTER — 01 — REFERENCES CHAPTER — 01 — REFERENCES 
Enzymes for peptide synthesis
Ana Toplak, Muhammad I. Arif, Bian Wu, 
and Dick B. Janssen
Biochemical Laboratory, Groningen Biomolecular 
Sciences and Biotechnology Institute,
University of Groningen, 9747 AG 
Groningen, the Netherlands
CHAPTER — 02
Part of this chapter has been published in
R. N. Patel, Green Biocatalysis 
(John Wiley & Sons, Inc., 2016)
41
Enzymes for peptide synthesis
Enzymes are widely used for peptide synthesis, both for coupling and 
for terminal activation and modification. Broad-specificity proteases of 
different mechanistic classes can be used for C-terminal activation and 
peptide ligation reactions, whereas enzymes that recognize specific 
sequences are increasingly used for selective modification and tagging. 
Protein engineering can tailor hydrolases for improved synthesis, better 
reaction medium tolerance and desired substrate selectivity. This 
chapter highlights properties of natural and engineered peptidases for 
chemoenzymatic peptide synthesis with emphasis on basic principles and 
innovations leading to new applications.
Peptidases suitable for peptide synthesis are found in a wide variety 
of organisms (Table 1). Many reports describe the use of commercially 
available enzymes isolated from biological sources, such as trypsin and 
chymotrypsin from mammalian pancreas, pepsin and chymosin from 
stomach, papain from plants, and subtilisin or thermolysin secreted 
by bacteria. Genome analysis shows that peptidases are present in all 
kingdoms of life: from Archaea and viruses to the higher eukaryotes. 
Moreover, peptidase-encoding genes comprise about 2% of the 
human genome, most of them having very specific functions, e.g. in 
hormone processing, but with unknown utility in peptide synthesis¹. The 
omnipresence of peptidases, their tremendous diversity and the myriad 
of biological functions all contribute to the continued scientific interest 
in this enzyme family. 
According to the enzyme classification system, peptidases belong to 
subgroup 4 of the hydrolases (EC 3.4.X.X). Based on the work of Rawlings 
and Barrett²  the current MEROPS peptidase database counts more than 
2400 peptidases and provides a description of their specificity, structural 
information and literature references. Peptidases are frequently classified 
according to their reaction mechanism, using the key groups involved in 
catalysis as an identifier. This gives aspartic (A), cysteine (C), glutamic 
(G), metallo (M), asparagine (N), serine (S), threonine (T), and unknown 
(U) proteases, with the letter indicated followed by an assigned number. 
Peptidases can also be classified in terms of families and clans, which 
is based on structure or sequence comparison and is a phylogenetic 
classification. The name of a clan is formed in most cases by a letter 
of the catalytic type, followed by a serial capital letter. For example, SB 
represents the subtilisin clan of serine peptidases and contains two 
families: S8 (subtilisin family) and S53 (sedolisin family). Even though 
members of the same clan have a common ancestor, sequence may have 




diverged so much that relatedness can only be detected by structural comparison. 
Not surprisingly, some phylogenetic groups comprise multiple catalytic types, 
for which the abbreviation P was proposed. More information on peptidase 
classification is given by Rawlings and Salvesen³.
One can distinguish two general types of peptidase catalytic mechanisms: 
catalysis via formation of a covalent intermediate and catalysis by activation of a 
water molecule that directly attacks the peptide bond. In case of covalent catalysis, 
the nucleophile attacking the peptide bond is a side chain hydroxyl or sulfhydryl, 
as in the serine-, threonine- and cysteine peptidases. It is a part of a classical 
nucleophile –base-acid catalytic triad, as in the serine hydrolases that provide 
the textbook example of an enzyme catalytic mechanism, or is in a functionally 
equivalent but structurally different variant thereof. For example, in papain the 
nucleophile is a cysteine occurring as a thiolate-imidazolium ion pair formed by 
a histidine acting as the base and a water molecule replacing the acidic group 
present in most serine protease catalytic triads. The formation of acyl-enzyme 
intermediates in serine hydrolases and related enzymes makes them suitable 
for application in kinetically controlled synthesis reactions (Chapter 1, Figure 5). 
Metallo-, glutamic- and aspartic proteases, on the other hand, do not form covalent 
intermediates, but activate a water molecule that directly attacks the carbonyl 
carbon of the peptide bond and displaces the amide nitrogen⁴. These enzymes are 
often the preferred catalysts for thermodynamically controlled coupling (Chapter 
1, Figure 5). An example of a metalloprotease applied for peptide synthesis is 
thermolysin, which contains a HExxH+E motif that coordinates a zinc ion and a 
water molecule. Zinc polarizes the carbonyl group and facilitates deprotonation of 
the water nucleophile that attacks the carbonyl group of the substrate. Catalysis is 
facilitated by the glutamic acid, which accepts a proton from the zinc-bound water 
and transfers a proton to the leaving group. In the majority of aspartic peptidases, 
of which gastric pepsin is the best-known example, a pair of aspartic residues act 
together to activate a water molecule. In glutamic peptidases, a pair of glutamic 
acid residues plays a similar role. The water directly attacks the peptide bond, and 
the reaction in peptide synthesis follows the reverse mechanism. 
The serine, cysteine, aspartic and metalloproteases all have been applied in 
peptide synthesis. Nevertheless, shortcomings still exist and at industrial scale 
chemoenzymatic peptide synthesis is certainly not always the preferred method. 
Since the properties of the catalyst to a large extend determine the feasibility 
of industrial application, the discovery and engineering of better variants is an 
intensive field of research.
Classical enzymes employed for peptide coupling of the serine hydrolase family are 
chymotrypsin, trypsin and subtilisin. Chymotrypsin and trypsin are secreted in the 
mammalian gut as inactive precursors, which are activated by autoproteolysis and 
structural reorganization. The possibility to use chymotrypsin for peptide synthesis 
is known  since the 1930s⁵. Most early examples concern peptide synthesis using 
amides or (m)ethyl esters as acyl donors, and free amino acids, their amides, 
short peptides, or short peptide amides as nucleophilic acyl acceptors. These 
studies revealed that a high pH, a high nucleophile concentration, and low product 
solubility stimulate formation of synthetic product. Ethyl esters appeared suitable 
acyl donors in kinetically controlled conversions, and amino acid amides act better 
as nucleophilic acyl acceptors than the free amino acids⁶. Furthermore, tripeptides 
often performed better than dipeptides or amino acids as acyl acceptors. 
Trypsin and chymotrypsin are often used in the presence of cosolvents, which are 
added to increase substrate solubility, both in case of thermodynamic coupling 
and for kinetically controlled synthesis, and especially for longer peptides. For 
example, condensation of tri and heptapeptide segments, forming a Trp³-Ser⁴ 
linkage, in a kinetically controlled manner using α-chymotrypsin in 48% (v/v) DMF 
allowed over 97% conversion to a D-Phe-containing analog of gonadotropin 
releasing hormone ([D-Phe⁶]GnRH) on multi-gram scale (Figure 1)⁷. Reactions 
with trypsins in organic solvent have also been explored. The thermodynamically 
controlled segment condensation of octa- and pentapeptide segments yielded an 
α melanocyte-stimulating hormone precursor with an Arg⁸-Trp⁹ ligation site. This 
conversion was catalyzed by trypsin in nearly dry organic solvent mixture (Figure  2)⁸.
Chymotrypsin and trypsin have restricted substrate specificity. This can be an 
advantage since it reduces the number of possibilities for hydrolysis of a synthetic 
product, but also a disadvantage, since it restricts the diversity of ligation sites that 
can be generated. Overall, the leaving group specificity (P1’, P2’) of trypsin and 
chymotrypsin in hydrolytic reactions matches that of the nucleophile selectivity 
in synthetic conversions6,9. Chymotrypsin-catalyzed synthetic reactions are less 
sensitive to the nature of the acyl donor than to the nature of the nucleophile. 
Trypsin accepts positively charged amino acids at the P1 site (Arg, Lys) whereas 
chymotrypsin prefers bulky hydrophobic groups at the P1 and P1’ positions. 
Chymotrypsin, trypsin and related enzymes
Serine and cysteine proteases for peptide synthesis
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Proteases of the trypsin family have recently been applied for synthesis of peptides 
that self-assemble to nanofibrous structures and for preparing biomaterials. An 
example is the chymotrypsin-catalyzed polymerization of the amphiphilic peptide 
Lys-Leu-OEt to an alternating oligomer that forms a hydrogel10. Furthermore, 
chymotrypsin was used for the synthesis of poly-L-cysteine, a material for the 
selective chelation of SH-reactive metal ions under mild conditions and in high 
yields (80%)11.
A trypsin-related bacterial enzyme that was tested in coupling reactions is the 
lysine-specific serine protease I from Achromobacter lyticus. The enzyme is 
secreted and widely used in sequence analysis of proteins12. It was also used in a 
chemoenzymatic route for the production of human insulin from porcine insulin. 
Since this lysyl endopeptidase cleaves only after Lys, it could be applied for 
replacing the C-terminus of the insulin B-chain from -Lys-Ala (porcine C-terminal 
sequence) to -Lys-Thr (human C-terminus) in a two-step or a single-step reaction. 
Using the B chain as acyl donor and Thr-OtBu in DMF-ethanol mixtures as the 
nucleophile, a high conversion (85-90%) was obtained13,14. Trypsin could also be 









FIGU RE  1 . 
Example of bioactive peptide synthesis under 
kinetic control using α-chymotrypsin in 
water-cosolvent medium. The gonadotropin 
releasing hormone analog [D-Phe⁶]GnRH was 














FIGU RE  2 . 
Example of bioactive peptide synthesis 
under thermodynamic control 
using trypsin. The α-melanocyte-
stimulating hormone precursor was 
synthetized in 95% yield using trypsin 
in an almost dry mixture of DMF and 
hexafluoroisopropylalcohol in 48 h⁸. 
Protective groups: CHO = formyl group, 
ClZ = 2-chlorobenzyloxycarbonyl.
Subtilisins have a similar catalytic mechanism as chymotrypsin but the catalytic 
triad is ordered in a different way along the sequence, and the enzymes are not 
phylogenetically related. Subtilisins are secreted by various soil-dwelling Bacillus 
strains. They comprise the largest group of commercial proteases and account for 
more than half of the world total sales of enzymes, mainly for use in detergents. 
Well-known commercial variants include subtilisin Carlsberg (also known as 
Alcalase), substilisin BPN’ (used in many protein engineering studies), and subtilisin 
E. Siezen et al.15 introduced the term subtilases for subtilisin-like peptidases. 
Genome analysis revealed that subtilases occur in all kingdoms of life. Subtilases 
from the phylogenetic group of subtilisins are widely explored for the synthesis 
of short peptides, which is much less the case for subtilases belonging to the 
thermitase and proteinase K groups. However, subtilisins were reported to be less 
suitable for peptide synthesis than chymotrypsin and trypsin due to their high 
hydrolytic activity. This triggered research on subtilisin thiol variants, which can 
form a thioester intermediate with reduced sensitivity to hydrolysis as compared 
to the aminolysis reaction required for peptide coupling. 
Subtilisin-like enzymes
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Furthermore, subtilisin has a much broader substrate range, implying that it 
detects a larger number of proteolytic target sites in substrates and product than 
chymotrypsin and trypsins. 
Due to the high stability of these enzymes, peptide synthesis using subtilisin BPN’ 
and subtilisin Carlsberg can be carried out in neat organic solvent instead of water 
and water-cosolvent mixtures, effectively avoiding hydrolysis of the activated 
precursor and of the product16. The use of anhydrous organic solvents also 
suppresses unwanted side reactions, and can influence enzyme stereoselectivity, 
regiospecificity, and chemoselectivity, which may allow unexpected conversion16,17 
such as coupling of activated 9-aa and 10-aa peptides carrying protecting groups 
from chemical peptide synthesis, resulting in the formation of a protected 19 aa 
peptide18–20.
Like chymotrypsin, subtilases can catalyze reactions leading to special peptides. 
Proteinase K catalyzed the polymerization of L-Phe in the presence of tris(2-
aminoethyl)amine to form branched oligo-(L-phenylalanine), which showed self-
assembly to form fluorescent fibers21.
Of the serine exopeptidases, especially carboxypeptidase Y from Saccharomyces 
cerevisiae has been used in synthetic applications. This carboxypeptidase is 
an α/β-hydrolase fold enzyme, also with a Ser-Asp-His catalytic triad, but in 
a topology that is different from that of trypsin and subtilisin family enzymes. 
Carboxypeptidase Y catalyzes dipeptide coupling in aqueous medium22. Like with 
chymotrypsin, such synthetic reactions are best performed at basic pH. Protein 
engineering studies have revealed that the enzyme has a rather low selectivity for 
the P1' site, preferring hydrophobic groups, but also Lys and Arg are accepted. 
Selectivity can be influenced by mutations. Reducing the number of enzyme-
substrate hydrogen bonds by mutating residue E65 to Ala was beneficial for the 
aminolysis reaction23. 
Other serine hydrolases
Prolyl aminopeptidases (PAP) are exopeptidases that hydrolytically cleave off 
an N-terminal Pro from peptides. The enzymes belong to the α/β hydrolase fold 
proteins. A prolyl aminopeptidase from Streptomyces thermoluteus carrying the 
active site mutation S144C was used as a catalyst for the synthesis of proline-
containing peptides. Dipeptide synthesis was obtained with an amino acid methyl 
or benzyl ester as the acyl donor and prolyl-OBz as the nucleophile24. Under 
alkaline conditions cyclization and polymerization of prolyl-OBz was observed.
Aminopeptidases
In view of the growing importance of β-peptides, Kohler and coworkers explored 
the synthetic applicability of β-peptide specific aminopeptidases produced 
by strains of Sphingosinicella and Ochrobactrum anthropi. These enzymes 
(DmpA) belong to the P1 serine peptidase family, are distantly related to Ntn-
hydrolase family, and cleave N-terminal β-amino acids from β- and α/β-peptides. 
In synthetic applications, oligomerization of β-amino acids occurred to produce 
up to octameric peptides as well as formation of α- and β-amino acid containing 
dipeptides with an N-terminal β-amino acid. Furthermore, the BapA enzyme 
from Sphingosinicella. xenopeptidilytica 3-2W4 could couple various β-amino 
acids to the N-terminus of short peptide25. A similar incorporation of N-terminal 
D-amino acids during small peptide synthesis was reported with a Streptomyces 
aminopeptidase26.
Peptidases accepting ß-amino acids
Few microbial proteases acting on D-peptides are known. The alkaline D-peptidase 
(ADP) from Bacillus cereus is related to DD-carboxypeptidase and β-lactamases. 
These enzymes have an accessible groove in which the nucleophilic serine and 
other catalytic amino acids are located. This D-peptidase could be applied for 
the synthesis of the 92-amino-acid peptidyl prolyl cis–trans isomerase from E. 
coli by condensation of two peptide segments, of which the 35 amino acid acyl 
D-amino acid specific peptidases
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donor was activated as the 4-guanidinophenyl (OGp) ester27. Thus the D-amino 
acid selective enzyme was used for preparing a protein composed of L-amino 
acids and making the product insensitive to hydrolysis by the coupling enzyme.
The use of papain in peptide synthesis is well established28–30. Papain can be 
used for the preparation of dipeptides and tripeptides, in aqueous medium 
with cosolvent addition (up to 40%) and at high pH to promote synthetic 
activity. The enzyme is a sulfhydryl protease with no homology to the trypsin 
or subtilase families of hydrolases. Since the catalytic nucleophile is a cysteine 
and because thioesters are relatively more prone to aminolysis than oxoesters, 
the enzyme could be very attractive for synthesis. However, unlike with the thiol 
variants of some serine hydrolases, the proteolytic activity is still high and the 
broad substrate range of proteolysis makes peptide substrate and product 
hydrolysis more problematic than with trypsin or chymotrypsin. Extensive 
enzyme engineering studies on papain are lacking, probably due to the laborious 
procedure for isolation of active papain from inclusion bodies formed in E. coli. 
The enzyme has a rather broad substrate range with slight preference for Lys and 
Arg in the S1 pocket and for hydrophobic aromatic residues in the S2 pocket. 
The S1’ pocket is not selective which allowed the synthesis of dipeptides with 
non-proteinogenic amino acids29. To overcome the S1 preference, the substrate-
mimetic approach described above was explored with the OGp leaving group 
in dipeptide synthesis30. Segment condensations with papain have also been 
reported, e.g. enkephalin segment coupling (2+3) was achieved in 50% yield 
using equimolar amounts of acyl donor (PhAc-Tyr-Gly-OMe) and nucleophile 
(H-Gly-Phe-Leu-OtBu) at pH 9.0 in buffer with 20% methanol31. Similar yields 
were obtained in low water systems such as buffer containing acetonitrile 4% (v/v). 
The synthetic potential of papain in low water systems has been explored with acyl 
donors bearing the carbamoylmethyl (Cam) leaving group. Dipeptide synthesis 
proceeded in >80% yield, and yields up to 60% were obtained for the synthesis of 
bioactive peptides like dermorphin-(1-4) (Boc-Tyr-D-Ala-Phe-Gly-NH2). Papain is 
also used as a versatile protease in polymer chemistry for the synthesis of amino 
acid oligo- and co-oligomers of α-hydroxy acids and amino acids32. Homologs 
of the classical Papaya papain that have been tested for peptide synthesis are 
plant-derived enzymes such as bromelain and ficain. Bromelain extracted from 
pineapple could be applied in Met- and Leu-enkephalin synthesis in a low water 
system, reaching 97% yield33. Ficain isolated from Ficus glabrata latex was tested 
in di- and tripeptide synthesis in frozen water medium28, and was used in synthesis 
of Lys and Met oligomers starting from the respective ethyl esters34. 
Another papain-like enzyme that has been tested in peptide synthesis is clostripain 
from Clostridium histolyticum. It has a remarkable specificity for arginine in 
the S1 pocket and for proline in the S1’ pocket and can be produced using a 
recombinant system in E. coli 28. Synthesis of dipeptides such as Cbz-Arg-Pro-NH₂ 
and Cbz-Arg-D-Leu-NH₂ has been reported. Moreover, the substrate-mimetic 
approach using the OGp activating group broadened acyl donor specificity to 
non-proteinogenic acyl donors such as β-Ala and 4-phenylbutyric acid ester, 
with yields of over 86% when coupled with different nucleophiles in aqueous 
medium35. The broad specificity of the S1’ pocket allowed synthesis of various 
peptide isosters, using Bz-Arg-OH and a range of acyl acceptor amines36. Animal 
tissue is a source of papain-related lysosomal cysteine peptidases that have 
been used in di- and tripeptide synthesis. Due to the insufficient homogenic 
preparations of cathepsin B, earlier reports of its synthetic activity have to be 
taken with caution37. The availability of a recombinant production system for 
human cathepsin B will allow experiments with pure enzyme. The endopeptidase 
cathepsin L from parasite Fasciola hepatica was expressed in yeast and used in 
the kinetically controlled synthesis of Cbz-Phe-Arg-Ser-NH₂ starting from Cbz-
Phe-Arg-OMe and H-Ser-NH₂ in an aqueous medium38. 
Sulfhydryl peptidases
For coupling of larger peptide substrates, sortases, which are responsible for 
covalent anchoring of surface proteins to the peptidoglycan of Gram-positive 
bacteria, can be employed. Sortase A (SrtA, MEROPS peptidase family C60) is 
a cysteine peptidase isolated from Staphylococcus aureus that has emerged 
as a powerful tool for protein bioconjugation and transpeptidation reactions39. 
During catalysis, recognition of the R-LPXT-G motif (R= protein, X=any amino 
acid) is followed by thiolate nucleophile attack and cleavage of the Thr-Gly 
amide bond. The acyl-enzyme complex (R-LPXT-SrtA) is cleaved by a peptide 
with an N-terminal glycine of the pentapeptide groups in peptidoglycan, yielding 
a covalent protein-peptidoglycan bond. This sortagging reaction can serve in 
applications such as protein labeling, protein-protein fusion, protein cyclization 
and protein immobilization. Recently, the use of sortase for the conversion 
Sortase
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of a QALPETGEE peptide to its hydrazide derivative QALPET-NHNH₂ was 
reported. Such a peptide hydrazide can act as acyl donor in peptide coupling. 
Via formation of a hydrazide, this sortase reaction allowed fusion of a deoxy-D-
ribose 5-phosphate aldolase segment (amino acids 1-239) with the 17 amino 
acid C-terminal segment, producing catalytically active enzyme connected by an 
LPAA linker. Similar reactions were possible with substituted hydrazines, allowing 
labeling of proteins containing the sortase motif with fluorescent probes40.The 
efficiency of the sortase-mediated reactions depends on the flexibility and 
accessibility of the region comprising the recognition motif. Sortase engineering 
and mutant selection for better motif recognition has been reported41. Details 
regarding sortase mechanism and applications of the enzyme can be found in an 
excellent review by M. Ritzefeld39.
The metalloprotease thermolysin has been widely used for peptide synthesis42,43. 
Thermolysin is produced and secreted by the thermophilic bacterium Bacillus 
thermoproteolyticus. Catalysis involves water activation by a zinc ion that is 
coordinated by side chains of two histidines and a glutamate. Thermolysin 
specificity is defined predominantly by its S1’ pocket that accepts large 
hydrophobic residues, but also polar and charged residues. In the S1 pocket 
hydrophobic residues are preferred, and Leu>Ala>Phe>Gly is the preference order 
for the S2 and S2’ pockets. This hydrolytic specificity of thermolysin is reflected 
in its synthetic specificity. Many related so-called thermolysin-like proteinases 
(TLPs) from various Gram-positive strains have been described³, including neutral 
proteases from Bacillus subtilis, and some of these variants are applied in peptide 
synthesis. Several metalloenzymes acting as carboxy- or aminopeptidase have 
also been characterized but these variants have not been extensively used in 
peptide synthesis. A bovine carboxypeptidase A44  and orange carboxypeptidase 
C45 have been applied for dipeptide synthesis in water-organic solvent mixtures, 
both under thermodynamic and under kinetic control.
With thermolysin and related metalloproteases, peptide synthesis is carried 
out under thermodynamic control where the reversal of hydrolysis is achieved 
by modifying reaction conditions in such a way that the equilibriums shifts to 
synthesis. Thermolysin has been employed in numerous di- and tripeptide 
coupling reactions i.e. for the synthesis of artificial sweetener aspartame (L-α-
Asp-L-Phe-OMe) on multi-ton level. Unlike the chemical route, which requires 
optically pure starting materials and gives substantial formation of byproducts, 
the enzymatic synthesis is an elegant and environmental friendly method. The 
reaction is performed under mild conditions and is both regioselective (only the 
α-carboxyl group reacts) and stereoselective (for L-Phe), thus allowing the use of 
racemic acyl acceptor (D,L-Phe-OMe). The D-isomer of Phe forms a precipitate 
with Cbz-L-α-Asp-L-Phe-OMe, thereby changing the equilibrium in favor of 
synthesis. After deprotection, D-Phe can be racemized and recycled (Figure 3). 
This is an example of substrate-induced precipitation for thermodynamic control 
of peptide synthesis. 
Thermolysin-like enzymes




FIGU RE  3 . 
Chemoenzymatic peptide synthesis of aspartame using thermolysin 
under thermodynamic control. The coupling reaction is stereo- 
and regioselective. The unreacted isomer D-Phe-OMe forms 
a precipitate with the product, shifting the equilibrium toward 
the synthesis. After precursor isolation and hydrogenolysis, 
the D-isomer is chemically racemized and can be re-used46,47.
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Another example of thermolysin-catalyzed peptide synthesis is the production 
of precursors of enkephalins16. Also coupling of non-natural amino acids, such 
as halophenylalanines, is possible48. Similar to α-chymotrypsin and papain, 
thermolysin has been used for peptide polymerization49. Using the reversibility of 
thermolysin-catalyzed peptide bond formation, dynamic combinatorial libraries of 
peptides could be established and screened for the formation of nanostructures 
with special properties50.
A prominent aspartic protease related to pepsin is chymosin, produced in the 
calf stomach for casein hydrolysis. Its use as a catalyst in peptide synthesis 
has been described, again in thermo-dynamically catalyzed coupling reactions, 
where linkages are introduced in hydrophilic regions of the target peptides. 
Carboxybenzoyl (Cbz) and p-nitroanilides were used as amine- and acyl-
protecting groups, respectively. Using DMF to keep the substrates in solution 
and acetate buffer at low pH (5.3) to stimulate synthesis, coupling products were 
formed and precipitated53. This way, several tetra- to hexapeptides were produced. 
The recombinant overexpression of chymosin in E. coli, yeast and, for industrial 
production, in filamentous fungi is well established. Consequently, chymosin 
variants could be obtained by protein engineering, and mutants with higher pH 
optimum and higher thermostability have been described54. The use of these 
enzymes in peptide synthesis remains underexplored.
Aspartic proteases form a group of proteolytic enzymes that catalyze peptide 
bond cleavage by acid-base catalysis and activation of a water molecule for 
nucleophilic attack on the amide carbon. Crystal structures of mammalian and 
fungal enzymes are known. In pepsin, the best studied aspartic protease, catalysis 
proceeds by water activation and leaving group protonation. Both involve an 
aspartate, which explains the low pH optimum of around 4. The two aspartic acid 
residues are situated around a hydrophobic cleft that can accommodate 7 amino 
acids (the S4-S3’ subsites). The active site is covered by a flexible flap, which 
contributes to S1 subsite specificity.
Since the catalytic cycle does not include an acyl-enzyme intermediate, attempts 
to use pepsin for synthesis have been focused on thermodynamically controlled 
conversions51. Conversions can be done with addition of organic solvent to 
increase medium hydrophobicity and shift the equilibrium to synthesis. Synthesis 
of several tri- and hexapeptides by pepsin in buffer containing 18% DMF reached 
yields of 30-78%. Pepsin can also be used in two-phase systems. The synthetic 
yields are determined by enzyme specificity, equilibrium of the coupling reactions, 
as well as by partitioning of substrates and products over the two phases. Pepsin 
has a substrate preference for hydrophobic peptides but in coupling reactions 
of Cbz-Xaa-Phe-OH and Phe-OMe a better yield was observed with hydrophilic 
groups in the P2 position52,53. Hydrophobic peptides and some non-proteinogenic 
substrates are well accepted in the S1’ pocket, which may render pepsin a useful 
catalyst for the synthesis of non-natural peptides51. In case immobilized enzyme 
is used, it is preferable to keep the substrate and products in solution to avoid 
problems with separation of products from the catalyst. For this reason, DMF has 
been added as a solubilizing agent, benefiting from the fact that pepsin is highly 
resistant to denaturing conditions. 
Aspartic proteases in peptide synthesis
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recombinant yeast system available for rat enzyme 
P1=Tyr, Trp, Phe, Leu
P1’ nonspecific
used in synthesis of bioactive peptides in water-organic 
solvent mixtures and ionic liquids; substrate mimetic 
mediated coupling of long segments6–9,55; amino acid 




bovine, porcine, murine pancreas
recombinant systems: E. coli, P. pastoris, S. cerevisiae
P1=Arg, Lys
P1’ nonspecific
synthesis of bioactive peptides in water and water-






recombinant production in E. coli 
P1=large, non-branched hydrophobic residues 
preferred
P1’= Gly > Ser, Lys, Ala > Arg > Gln, Thr, Val, Met, 
Asn > His > Ile, Trp > Glu > Asp, Leu.Pro
bioactive peptide synthesis in neat organic solvent and 
water-organic solvent mixtures; 
amino acid oligomerization18–20; engineered thiol variants 




secreted from fungus Tritrachium album P1=aromatic, hydrophobic residues
P1’=similar to subtilisins
[Leu] enkephalin peptide synthesis in organic solvent in 


















papaya plant latex(Carica papaya), recombinant 
production in S. cerevisiae and E. coli
P1=Arg, Lys; P2=aromatic hydrophobic
P1’= large hydrophobic
kinetically controlled peptide synthesis; synthesis of 
bioactive peptides in organic solvent (demorphin, 
enkephalin); amino acid oligomerization32; di- and tri-
peptide synthesis with peptidomimetic leaving group28–31,33
TABLE  1 . 
Peptidases used for chemoenzymatic enzymatic peptide synthesis.






secreted by Bacillus thermoproteolyticus, 
recombinant in E. coli
P1’ = large hydro¬pho¬bic, also polar and 
charged residues, 
P1= hydrophobic residues, P2, P2’= Leu > Ala > 
Phe > Gly, P3’=basic residues




secreted by Geobacillus stearothermophilus, 
recombinant production in E.coli
similar to thermolysin, P1’=Phe thermostable variant boilysin in dipeptide Cbz-Asp-X-OMe 





ecreted by Pseudomonas aeruginosa, 
recombinant production in E.coli and Pichia
P1’=hydrophobic or aromatic residues;Phe > Leu 
> Tyr > Val, Ile > Ala
P1,P2’=Ala
dipeptide synthesis, including substrates as norvaline and 
norleucine, Cbz-Ala-Phe-NH₂ synthesis65 
vimelysin, 
clan MA 
secreted by Vibrio sp. T1800; recombinant 
production in  E.coli 
P1’=Phe aspartame precursor synthesis in the presence of 30% 




Bos taurus; recombinant production in yeast P1’=large, hydrophobic residues dipeptide synthesis in low water systems, 27% highest 
yield obtained44
D,D-dipeptidase Brevibacillus borstelensis BCS-1; 
recombinant production in E.coli 
P1’=D-amino acid Cbz-L-Asp–D-AlaOBzl alitame sweetener precursor 
synthesis67
aminopeptidase SSAP Streptomyces septatus, recombinantly produced in  E. coli broad specificity, inactive towards 
N-protected peptides
various dipeptide methyl esters starting from free acyl donor 





porcine, recombinant production in E. coli P1 and P1’=hydrophobic residues, 
P2=hydrophilic residues
various di- and -tri-peptides in two phase systems, 




calf stomach (bovine, camel), recombinant production 
in:  E. coli, yeast and filamentous fungi
P1 and P1’=hydrophobic residues tetra- and hexapeptide synthesis at pH 5.3 in 20% v/v 
DMF54









extraction from Ficus glabrata latex P1= Gly, Ser, Glu, Tyr, Phe; P2=hydrophobic side 
chains
Lys-Met ethyl ester oligomer synthesis; short peptide 





recombinant production in E. coli and 
Bacillus subtilis 
P1=Arg, P1’= D-amino acids, Pro di-and tripeptide synthesis in frozen aqueous medium; 




Fasciola hepatica, recombinant production in yeast P2=large hydrophobic residues, P1’= Ser > Ala 
> Lys > Asn > Gln




Staphylococcus aureus, E. coli expression system available LPXT-G, X= any amino acid peptide and protein labeling, cyclization and 
immobilization, protein-protein fusion, cell surface 
labeling39,62
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The restricted applicability of commercially available proteases for peptide 
coupling reactions warrants the continuous importance of mining natural 
resources for enzymes with novel properties, such as a broad substrate range, 
acceptance of non-proteinogenic amino acids, high coupling efficiency, and 
robustness under reaction conditions. 
Protease discovery 
With current protocols less than 1% of the existing microorganisms can be 
isolated in the laboratory, therefore metagenomic approaches comprising 
cloning and sequence- or function-based screening can contribute to rapid 
biocatalyst discovery. Genes can be discovered that are very different from 
those with established function. For example, using metagenomics a metallo-
protease was discovered that has less than 30% similarity to any known protease68. 
The potential of metagenomics was recently also demonstrated for variants of 
subtilisin. In total 51 different subtilisins were discovered, each carrying 2-8 
substitutions that are distant from the active site but affect temperature stability 
and substrate specificity69. It seems likely that these approaches can discover 
variants with altered characteristics in peptide synthesis.
Metagenomics
Whereas subtilisin Carlsberg, subtilisin BNP' and subtilisin E display moderate 
temperature stabilities, several thermostable proteases of the subtilase 
superfamily have been obtained from extremophilic organisms. Examples are 
aqualysin I from Thermus aquaticus and thermitase from Thermoactinomyces 
vulgaris. Although over 30 of such characterized thermophilic peptidases are 
known, only few have been applied in peptide synthesis. The serine peptidase 
form Thermus aquaticus Rt41A (PreTaq) was applied in kinetically controlled 
synthesis of Bz-Ala-Tyr-NH₂ with modest yield (26%) using immobilized enzyme 
in DMF (90% v/v), Bz-Ala-OMe as acyl donor and a large excess of Tyr-NH₂ as 
the nucleophile at 40°C and pH 1070. Two serine peptidases of the subtilase family 
from the hyperthermophilic organisms Thermus aquaticus and Deinococcus 
geothermalis were also applied in peptide synthesis under harsh conditions such 
as high temperature (60 and 80°C) in anhydrous solvent with addition of DMF as 
cosolvent (40% v/v) (Chapter 5). 
Proteases from thermophiles
The hypothesis that extracellular enzymes of organic-solvent tolerant 
microorganisms should exert resistance to such organic solvents led to the 
discovery of a solvent-tolerant metallo-protease called pseudolysin produced 
by the bacterium Pseudomonas aeruginosa. Organic solvent tolerance of this 
metallo-protease was attributed to a disulfide bond (Cys30-Cys58) and to 
the presence of charged residues at the enzyme surface (Y45, N201). In the 
thermodynamic approach using medium with 50% DMF, the enzyme could 
effectively synthetize the dipeptide Cbz-Arg-Leu-NH2 (78% yield), and the 
aspartame precursor Cbz-Asp-Phe-OMe (89% yield) in the presence of 50% 
DMSO71. Similarly, the opioid peptides endomorphin-1 (Tyr-Pro-Trp-Phe-NH₂)72 
and endomorphin-2 (Tyr-Pro-Phe-Phe-NH₂)73 were synthesized by the organic-
solvent-tolerant metallo-proteases from Pseudomonas aeruginosa and Bacillus 
cereus, respectively. Both peptidases tolerated up to 50% (v/v) of DMSO and DMF 
and conversions yielded endomorphin-2 with 80% overall yield. The se enzymes 
are all structurally related to thermolysin. Recently, a novel subtilisin-like serine 
peptidase has been discovered in Pseudomonas mendocina ymp by genome 
mining and described (Chapter 6).
Solvent-tolerant proteases
Halophilic microorganisms that evolved to survive low water activity conditions 
are promising for discovery of peptidases that survive under harsh conditions. 
A halophilic serine peptidase from Halobacterium salinarum was reported to 
catalyze synthesis of di- and tripeptides, e.g. producing Ac-Phe-Gly-Leu-NH₂ 
form Ac-Phe-OEt as acyl donor in 76% yield in the presence of 33% (v/v) DMF, 
20 equivalents of the nucleophile dipeptide amide and 2.8 M NaCl74. 
Proteases from salt-resistant organisms
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The acyl donor specificity of the enzyme is quite broad, but the nucleophile 
preferred at S1' is Gly, Ala or another small hydrophobic group. Although 
promising, the synthetic potential of halophilic peptidases is still poorly exploited, 
and biochemical information on such enzymes is scarce.
An even more stable variant of subtilisin BPN’, subtilisin 8397 (M50F,N76D,G169A, 
Q206C,N218S) was designed and used in glycopeptide synthesis57 and the 
synthesis of a peptide heptamer in 50% DMF80. Further mutagenesis to increase the 
stability in the presence of DMF revealed K43N and K256Y as important mutations. 
In addition, the mutations M222A and Y217W broadened the P1’ specificity of this 
subtilisin. The authors also report regioselective transesterification, transacylation, 
and amidation of peptide esters81. 
Protein engineering of enzymes for peptide synthesis has mainly focused on 
improving the synthesis:hydrolysis ratio of serine hydrolases used in kinetically 
controlled peptide synthesis and on studies aimed at re-engineering enzyme 
specificity. Other targets are improving the resistance to organic solvents and 
tailoring the hydrolytic activity, but only a few of these engineered enzymes were 
tested later as catalysts in peptide coupling. 
Proteases engineered for improved synthesis
Extensive work on stabilizing subtilisins by mutagenesis has been carried out. 
Thermostability and organic cosolvent tolerance are often positively correlated. 
Stabilizing mutations include introduction of groups that form salt bridges, 
expanding the internal hydrogen bonding, improving hydrophobic interactions, 
and internal crosslinking by disulfide bonds75–77. An excellent overview on subtilisin 
BPN’ engineering is given by P. Bryan78. The synthetic potential of a DMF-tolerant 
subtilisin BPN’ mutant was tested. This enzyme, subtilisin 8350, carries mutations 
N218S (improved hydrogen bonding), G169A (improved hydrophobic interaction 
and conformational restriction), M50F (improved hydrophobic interaction), Q206C 
(better van der Waals interactions), N76D (improved Ca2+ binding and hydrogen 
bonding) and Y217K (better H bonding). The enzyme catalyzed synthesis of 
several bioactive peptides in 50% DMF under kinetic control, including enkephalin 
release factor (Tyr-D-Arg, 70% yield), chemotactic peptide (Met-Leu-Phe-
NHCH₂C₆H₅, 95% yield), [Leu]-enkephalinamide and dermorphin in yields above 
70%. The enzyme also catalyzed oligomerization of Met-OMe (formation of a 
50-mer) where the degree of polymerization was influenced by the amount of 
DMF added79. 
Solvent-resistant and thermostable subtilase mutants
Thermolysin has been subjected to extensive protein engineering studies aimed 
at enhancing thermostability82. Such studies yielded mutants (D150A, D150E, 
D150W, I168A, and N227H) that had improved activity in aspartame synthesis 
as compared to the wild type63. Engineering the thermostability of stearolysin, 
a protease from Geobacillus stearothermophilus CU21 that is 86% sequence 
identical to thermolysin, resulted in an extremely stable 8-fold variant that was 
active at 100°C and in the presence of denaturants. This enzyme, termed boilysin, 
had comparable specificity as thermolysin in synthesis of dipeptides (Cbz-Asp-
X-OMe (X= Phe, D-Phe, Ala, Ile, Leu, Met, Tyr or Val)) and increased activity at 
elevated temperatures and at low calcium concentrations64.
Thermostable thermolysin variants
Protein engineering methods aimed at increasing the aminolysis to hydrolysis 
ratio of peptidases have focused on replacing the active site serine by a cysteine. 
Early studies on thiol-subtilisin83 and seleno-subtilisin⁵⁸ demonstrated increased 
aminolysis to hydrolysis ratio in peptide synthesis in aqueous medium or in DMF-
containing buffers. Thiol- subtilisin is a weak peptidase, and can only rapidly cleave 
esters. Since thio- and selenol-acyl-enzyme intermediates undergo aminolysis 
faster than oxo-esters, these enzymes are particularly useful for the synthesis of 
amide bonds. However, the esterolytic activity is lower than that of the wild-type 
enzyme and the modified enzymes are oxidant-sensitive. Mutagenesis of subtilisin 
BPN’ with concomitant introduction of the mutations S221C and P225A yielded 
a variant more suitable for peptide synthesis84. 
Increasing aminolysis to hydrolysis ratios by protein engineering
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This variant of subtilisin mutant was termed subtiligase. It forms acyl-enzyme 
intermediates only with acyl donors activated as esters, and the glycolate 
phenylalanyl amide functionality was selected as an activating group. The 
specificity of subtiligase has been studied, but the ligation efficiency is still 
not absolutely predictable, as it does not directly reflect subsite specificities85. 
By screening tripeptides as acyl acceptor, it was found that especially the P1’ 
specificity influences ligation efficiency. The potential of subtiligase is clear from 
the chemoenzymatic synthesis of intact and catalytically active ribonuclease A 
(124 amino acids) by sequential ligation of six segments in the C→N direction 
with 10% overall yield on milligram scale86. Further mutagenesis of subtiligase 
included the introduction of stabilizing mutations (M50F, N76D, N109S, K213R, 
N218), yielding a denaturant-resistant variant87. In addition, random mutagenesis 
at 25 positions around the active site of subtiligase and screening the coupling 
activity of a phage-displayed enzyme library yielded variants with modified 
selectivity. By screening for attachment of a labeled peptide to its N-terminus, 
two subtiligase mutants were identified (M124L,L126V and M124L, S125A) with 
improved ligase activity88. The applicability of subtiligase is broad, and it has been 
used for selective labeling of proteins by coupling a peptide to the N-terminus 
of a target protein89. Subtiligase has also been used for kinetically controlled 
peptide backbone cyclization. The cyclization of peptides of length 12-31 amino 
acids activated as the C-terminal OCam phenylalanylamide ester was performed 
in aqueous solution90.
A peptide ligase, termed peptiligase has been recently reported (Chapter 7). This 
highly engineered, thermostable and Ca2+ independent subtilisin BPN’ variant, 
carries the S221C and P225A mutations that resulted in improved synthetic 
properties over state of the art enzyme subtiligase.
Variants of trypsin with increased aminolysis rate in substrate-mimetic mediated 
peptide synthesis have been obtained by mutating active site residues and 
residues in the S1 subsite. A variant called trypsiligase was described by Bordusa 
and coworkers91. It carries the mutations D189K (reduces Arg and tolerates Tyr 
specificity in the S1 subsite), K60E (introduces Arg selectivity in the S1' subsite) 
and N143H, E151H (introduces Zn-dependent His specificity in the S2' subsite), 
and thus recognizes the Y↓RH sequence motif. 
The enzyme could be applied to process proteins carrying an YRH- linker at the 
N-terminus, and the resulting RH- N-terminus could be labeled by acting as a 
nucleophilic substrate in tryptiligase acyl-enzyme formed from an OGp-activated 
acyl donor84. Trypsiligase adopts a partially disordered inactive zymogen-like 
conformation, and is activated by addition of the peptide substrate and zinc ions. 
Trypsiligase has also been applied in C-terminal protein modification, e.g. PEG-
or dye-labeling of a protein C-terminus containing trypsiligase recognition YRH 
motif92. A Fab segment derived from a therapeutic antibody used in breast cancer 
treatment was extended at the C-terminus of its heavy chain with a tag containing 
the YRH- recognition sequence. This was followed by functionalization using PEG- 
or dye-labeled RHAK peptide as a nucleophile in a transpeptidation reaction. 
Trypsiligase-mediated protein modification offers an alternative to other enzyme-
mediated peptide modification reactions, such as those catalyzed by subtiligase, 
sortase A, and transglutaminase.
Mutagenesis studies on the chymotrypsin-like protease B from Streptomyces 
griseus (SGBP) revealed ligation activity when the active site serine was 
replaced by Ala or Gly (S195A/G)93. The ligation is proposed to proceed through 
a histidine-involved acyl-enzyme intermediate. The stability of the enzyme was 
improved by introducing mutations with stabilizing effects (S195G and T213L), 
yielding streptoligase94 .
Protein engineering of trypsin-like proteases
Alongside structure-based engineering and directed evolution, computational 
protein design is becoming a powerful tool for tailoring enzymes to specific 
biotechnological applications. Recently, a de novo designed peptide ligase 
based on a 33 α-helical peptide that forms a coiled coil, has been reported95. 
Furthermore, a peptidase with designed specificity towards α-gliadin has been 
developed using computational methods by D. Baker and coworkers96. The 
rapid developments in this field suggest that computational methods will soon 
contribute to the redesign of peptidases for synthetic applications.
Computational design
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Success in chemoenzymatic peptide synthesis and peptide modification 
is critically dependent on the selection of correct enzyme-substrate 
combinations. Many classical proteases have been successfully used in 
peptide synthesis, and key factors are medium engineering and substrate 
engineering. The latter includes selection of coupling sites for enzyme-
mediated segment condensation, and selection of leaving groups in 
kinetically controlled synthesis. Strongly activating leaving groups that 
allow formation of high-energy intermediates that yield stable products 
in subsequent aminolysis reactions expand the application scope. Many 
reactions can be done in the presence of cosolvents to increase peptide 
solubility or in neat organic solvent to suppress peptide hydrolysis. This 
requires highly stable enzymes, which have been obtained by protein 
engineering. Neat organic solvents may change enzyme selectivity, and 
broaden the range of reactions that can be performed. When working 
in aqueous conditions, the use of thiol-subtilisins is advantageous and 
allows efficient segment coupling. 
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Enzymes from extremophiles offer the opportunity to expand the range of 
reaction conditions for biocatalytic conversions. The wealth of microbial 
genome sequence information allows the exploration for genes encoding 
proteins with expected high thermostability and/or organic solvent 
tolerance. In this work, we report the cloning and screening for functional 
expression in E. coli of robust subtilases identified by genome mining. 
Extreme ecosystems in terms of temperature, pressure, salinity and 
pH represent a valuable resource of microorganisms that produce 
exquisite enzymes¹. The high stability of such thermozymes (enzymes 
from extreme thermophiles) is of great importance for developing new 
industrial applications2,3. Thermozymes not only show resistance to 
high temperatures, but often also tolerate harsh conditions such as the 
presence of denaturants and organic solvents⁴. Industrial processes 
that operate under these conditions benefit from enhanced substrate 
solubility, lowered liquid viscosity, increased diffusion rates of substrates 
and products, as well as from favorable equilibrium shifts in certain 
endothermal reactions. In addition, thermostable enzymes tend to be more 
resistant to proteolysis⁵, and may be compatible with heat-treatment aimed 
at reducing microbial contamination6,7. Robust microorganisms in terms of 
resistance to harsh environments are also important for the biodegradation 
of environmental pollutants. Such bioremediation organisms are used 
for sanitation of contaminated areas (heavy metals, organic solvents, 
radioactive compounds) and might also be a source of valuable enzymes.
Subtilisins are serine proteases from Bacillus strains; they comprise the 
largest group of commercial proteolytic enzymes⁸ and account for more 
than half of the world total sales of enzymes⁹. They are extensively used 
in food, textile, detergent, pharmaceutical and leather industries10–13.  A 
few thermostable subtilisin homologs (subtilases) have been isolated and 
characterized, for example from Archaea  (e.g. pyrolysin14, stetterlysin15, 
pernisine16, Tk-SP17, Tk-1689 and Tk-subtilisin18,19), and from thermophilic 
bacteria (fervidolysin20, Ak.1 protease21,  Rt41A proteinase22,23, aqualysin 
I24, islandisin25 and thermitase26). In order to discover novel thermostable 
subtilases that resist harsh process conditions, we explored available 
genome sequences from thermophiles, hyperthermophiles and some 
bioremediation organisms for homologs of subtilisin E.
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Since cultivation of extremophiles is associated with potential difficulties, 
cloning and expression of protease genes into a mesophilic host that is 
easy to grow (E. coli, B. subtilis, yeast) is of importance for biochemical 
investigation, protein engineering studies and practical enzyme 
production. Another possible advantage of using a mesophilic host is 
that enzyme isolation can be based on the difference in thermostability 
between host proteins and the target thermozyme27. Unfortunately, 
expression levels in mesophilic hosts using standard expression systems 
rarely exceed a few mg per L of culture. In case of proteases, autocatalytic 
processing and secretion may be specific bottlenecks19,28. Most subtilases 
are synthesized as a precursor with a pre- and a prosequence which 
are present as an N-terminal extension of the mature catalytic protein. 
Occasionally, there is a C-terminal extension as well. The N-terminal 
presequence serves as a signal peptide for the translocation through 
the cell membrane. By serving as intramolecular chaperone and inhibitor 
of the proteolytic activity the prosequence is involved in folding of the 
mature enzyme28,29. The C-terminal prodomain is involved in secretion 
to the extracellular medium in the original host29,30, whereas in E. coli it 
facilitates the translocation of the enzyme to the outer membrane. It can 
be removed during a heating step, as shown for aqualysin I31,32. 
Here, we describe the genome mining for novel extremophilic subtilases, 
their cloning, and functional expression of 10 novel subtilases in E. coli.
Materials and methods 
Chemicals and reagents — Restriction enzymes were from New England 
BioLabs (Beverly, MA, USA). The PCR system was supplied by Finnzymes (Vantaa, 
Finland), and the LigaFast ligase system and trypsin were from Promega (Madison, 
WI, USA). All chemicals and subtilisin A type VIII (Carlsberg, Alcalase) were 
purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Bacterial strains and plasmids — Genomic DNA of Thermus aquaticus 
Y51MC23 was from Lucigen (Middleton, WI, USA). Pseudomonas mendocina strain 
ymp genomic DNA was a kind gift from Prof. J.L. DuBois (Notre Dame University, 
IN, USA) and genomic DNA of Geobacillus thermodenitrificans NG80-2 was a 
kind gift from Prof. X. Liu (Nankai University, Tianjin, China). Cells of Deinococcus 
geothermalis (DSM11300) and C. proteolyticus (DSM5265) were purchased from 
DSMZ (Braunschweig, Germany). E. coli strain C43(DE3) was used for cloning 
and expression and was from Lucigen (Middleton, WI, USA). Cloning plasmids 
included pBADMycHisA (Invitrogen, San Diego, CA, USA), pBADMycHisA(NdeI) 
with the NcoI site of pBAD mutated to an NdeI site, pET28a+, pET20b+ (Novagen, 
Merck KGaA, Darmstadt, Germany) and pBAD-MBP, a derivative of plasmid 
pBADMycHisA(NdeI) with an additional maltose binding protein (MBP) gene 
to which the 5’end of the target gene is connected via a linker; and optional 
C-terminal hexahistidine tag also connected via a linker. 
Cloning of the protease genes — The genes for putative extremophilic 
proteases were cloned using either cells or genomic DNA as the template. 
CloneManager 7 (Sci-Ed Software) was used to design PCR primer pairs. In 
primer design the stop codon was omitted or replaced by another amino acid, 
and the start codon was modified to ATG, if necessary. A PCR protocol for GC-rich 
sequences was established: the 50 µl reaction mixture contained 2 µl template 
DNA, 1x GC-buffer (Finnzymes), 0.2 mM deoxynucleoside triphosphates (New 
England Biolabs), 0.4 µM of each primer with 0.02 U/µl of Phusion polymerase 
(Finnzymes) and 3% DMSO. Amplification was performed with a thermocycler 
(PEQlab) programmed for 5 min at 98ºC initial denaturation, followed by 35 cycles, 
each cycle consisting of 30 s at 98ºC, 30 s at 50-68ºC, 45 s at 72ºC, with a 
final 10 min extension at 72ºC. The PCR products were ligated in the respective 
restriction enzyme-treated vectors (pBADMycHisA, pBADMBP, pET28a+ or 
pET20b+) and transformed to E. coli C43(DE3) (see Table 1 and Table 2). 
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washed, suspended in buffer (50 mM Hepes∙NaOH, pH 7.5, 10 mM CaCl₂), and 
disrupted by sonication. The total cell lysate was divided and subjected to heat 
treatment at two temperatures (50°C and 70°C). Samples were taken after 2 h 
and 20 h of incubation. 
Qualitative protease activity determination — Proteolytic activities of 
cell extracts and purified enzyme samples were monitored on 5% skim milk LB agar 
plates. Samples were added to wells in the agar and proteolytic activity was scored 
after overnight incubation at 37ºC by inspection for clearing zonesHepes∙NaOH, 
pH 7.5, 10 mM CaCl₂), and disrupted by sonication. The total cell lysate was 
divided and subjected to heat treatment at two temperatures (50°C and 70°C). 
Samples were taken after 2 h and 20 h of incubation. 
The sequence of the cloned genes was confirmed by DNA sequencing (GATC, 
Konstanz, Germany).
Cloning of the proteolysin gene — The gene coding for the complete 
preprosequence of proteolysin (EMBL accession no. YP_002247839) was 
amplified by whole-cell PCR on C. proteolyticus cells using the forward primer 
5 ’- G CCCG CG CC ATATG A A A A AG ATAC TAT TA AC AC TG GT TATCG -3 ’
(NdeI site underlined) and the reverse primer 
5 ’- C AC AC ACG A AG C T T T TATG GTGTCC AGT T TAC TG C AG C ATAC-3 ’ 
(HindIII site underlined, stop codon changed to Leu codon in bold). The PCR 
products were ligated in NdeI- and HindIII-treated pBAD-MBP vector, and 
transformed to E. coli C43(DE3). This yielded a recombinant plasmid termed pBAD-
MBP-PrlA encoding the maltose binding protein, the signal peptide, the N-terminal 
prosequence, the mature protein and a putative C-terminal region ending with a 
linker (LKLGPEQKLISEEDLNSAVD) and a hexahistidine tag. The genes for other 
putative extremophilic proteases were cloned in a similar manner using either 
cells or genomic DNA as the template (Table 3.2 and 3.3). The sequence of the 
cloned genes was confirmed by DNA sequencing (GATC, Konstanz, Germany).
Activity screening on plates — For testing protease expression, transformants 
were grown on LB-agar plates (10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl, 
15g/L agar) containing 1% skim milk, appropriate antibiotic and inducer (0.025% 
L-(+) arabinose or 0.2 mM IPTG (isopropyl β-D-1-thiogalactopyranoside)) for 48 h 
at 30°C. Activity was apparent from halo formation around colonies. Colonies were 
also subjected to heat treatment (1-2 h at 80°C) to identify bacteria expressing 
proteases that require high-temperature maturation. 
Expression, processing and isolation of subtilases — E. coli C43(DE3) 
cells containing an expression construct were grown overnight at 37°C in LB 
medium supplemented with 0.1% glucose and ampicillin (100 µg/ml). The 
overnight culture was used to inoculate (0.1% v/v) 50-100 ml TB medium (12 
g/L tryptone, 24 g/L yeast extract, 0.4% (v/v) glycerol, 72 mM K₂HPO₄, 17 mM 
KH₂PO₄) containing ampicillin (100 µg/ml) or kanamycin (50 µg/ml) and cells were 
grown at 4 different temperatures (17, 24, 30 and 37°C) for various times (24 h for 
37 and 30°C and 48 h for 24 and 17°C). Subtilase synthesis was induced when 
the OD600 reached 0.8 by adding 0.25% arabinose or 0.3 mM IPTG, followed 
by cultivation with shaking. The cells were harvested (4°C, 15 min at 6,000 x g), 
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In the search for the homologs of subtilisin E in extremophiles, the 
whole preprosequence of subtilisin E (P04189) was used as a query 
in BLASTp searches. The target database comprised of sequenced 
hyperthermophiles (Archaea), thermophiles (Bacteria) and bioremediation 
organisms from Pseudomonas and Deinococcus genera (Bacteria) 
available in December 2008. Through genome mining we identified 73 
hits (BLASTp S-value ≥ 80-cut off) from 36 different organisms (Table 
1). In detail, 13 hits were found in 9 archaeal organisms and 60 hits in 
27 bacterial strains. From this number, unavailable organisms and known 
proteases reported by other groups were dismissed resulting in 50 
remaining potential hits (6 hits from 6 different Archaea and 44 bacterial 
hits from 18 organisms).The selected genes were PCR-amplified from 
cells or from isolated genomic DNA. In total 23 genes coding for putative 
proteases from 18 different microorganisms were inserted into in several 
cloning vectors using restriction cloning. Constructs were transformed 
into the cloning strain E. coli TOP10 and into E.coli C43(DE3) as the 
expression strain (Table 2 and Table 3). 
Results and discussion BACTER IA N U MBER OF H ITS
Acidothermus cellulolyticus 11B 1
Anaerocellum thermophilum DSM 6725 1
Anoxybacillus flavithermus WK1 2
Clostridium thermocellum DSM 4150 1
Coprothermobacter proteolyticus DSM 5265 1
Deinococcus geothermalis DSM 11300 4
Deinococcus radiodurans R1 4
Fervidobacterium nodosum Rt17-B1 3
Geobacillus kaustophilus HTA426 2
Geobacillus sp. G11MC16 3
Geobacillus sp. WCH70 3
Geobacillus sp. Y412MC10 3
Geobacillus thermodenitrificans NG80-2 3
Halothermothrix orenii H 168 4
Heliobacterium modesticaldum Ice1 1
Natranaerobius thermophilus JW/NM-WN-LF 2
Peudomonas mendocina ymp 1
Symbiobacterium thermophilum IAM 14863 3
Thermoanaerobacter pseudethanolicus ATCC 33223 1
Thermoanaerobacter sp. X514 2
Thermoanaerobacter tengcongensis MB4 2
Thermobifida fusca YX 1
Thermosipho africanus TCF52B 2
Thermosipho melanesiensis BI429 1
Thermotoga lettingae TMO 1
Thermotogales bacterium TBF 19.5.1 1
Thermus aquaticus Y51MC23 3
Thermus thermophilus HB8 4
27  strains 60
ARCHAE A N U MBER OF H ITS
Archaeoglobus fulgidus DSM 4304 1
Desulfurococcus kamchatkensis 1221n 1
Methanosaeta thermophila PT 1
Pyrobaculum aresenaticum DSM13514 1
Pyrobaculum islandicum DSM4184 1
Pyrococcus furiosus DSM 3638 1
Thermococcus kodakarensis KOD1 3
Thermococcus onnurineus NA1 3
Thermofilum pendens Hrk5 1
9 strains 13
Genome mining
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Accession number Organism Source
% Sequence 
Identity to subtilisin E
Restriction 






gDNA 39 NcoI-ApaI pBADMycHis (NdeI) E. coli C43(DE3) active inactive
YP_001189588.1 Pseudomonas 
mendocina ymp
gDNA 36 NdeI-HindIII pBADMycHis (NdeI)
pET28a+
E. coli C43(DE3) active confirmed, 






DSM5265 35 NdeI-HindIII pBADMycHis (NdeI)
pBADMBP
pET28a+
E. coli C43(DE3) active confirmed,










gDNA 32 NdeI-HindIII pBADMycHis (NdeI)
pBADMBP
pET28a+




DSM9562 32 NdeI-HindIII pBADMycHis (NdeI) E. coli C43(DE3) inactive NT
YP_604447.1 Deinococcus 
geothermalis 
DSM11300 31 NdeI-HindIII pBADMycHis (NdeI) E. coli C43(DE3) active confirmed DgSbt Chapter 5
YP_001471655.1 Thermotoga 
lettingae TMO
DSM14385 30 NdeI-HindIII pET20b+ E. coli C43(DE3) inactive NT




30 NdeI-HindIII pBADMycHis (NdeI) 
pET28a+
E. coli C43(DE3) active confirmed,






DSM 6725 26 NcoI-ApaI pBADMycHis (NdeI) E. coli C43(DE3) inactive NT
NP_285606.1 Deinococcus 
radiodurans R1




gDNA 25 NdeI-HindIII pBADMBP
pET28a+ 
E. coli C43(DE3) active confirmed,






DSM 9562 28 NdeI-HindIII pBADMycHis (NdeI) E. coli C43(DE3) inactive NT
YP_001665698.1 Thermoanaerobacter 
pseudethanolicus
DSM 2355 28 NdeI-HindIII pBADMycHis (NdeI) E. coli C43(DE3) active* NT
YP_288282.1 Thermobifida fusca YX gDNA 21 NdeI-HindIII pBADMycHis (NdeI) E. coli C43(DE3) inactive NT
ZP_03496757.1 Thermus aquaticus 
Y51MC23
gDNA 23 NdeI-HindIII pBADMycHis (NdeI) E. coli C43(DE3) active* confirmed
ZP_03496880.1 Thermus aquaticus 
Y51MC23
gDNA 22 NdeI-HindIII pBADMycHis (NdeI) E. coli C43(DE3) active* confirmed
YP_143552.1 Thermus 
thermophilus HB8
DSM 579 24 NdeI-HindIII pBADMBP E. coli C43(DE3) inactive NT
TABLE  2 . 
Cloning of putative proteases with ≥ 21% sequence identity to subtilisin E 
(P04189) originating from thermophilic and radiophilic Bacteria.
*  activity observed after 1-2 h additional heating step at 80°C ; NT, not tested
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Accession number Organism Source
% Sequence 
Identity to subtilisin E Restriction Sites Vector Expression host Plate activity Flask expression
YP_001154254.1 Pyrobaculum 
aresenaticum 
DSM 13514 37 NdeI-EcoRI pBADMBP E. coli C43(DE3) inactive NT
NP_579399.1 Pyrococcus furiosus DSM 3638 37 NdeI-EcoRI pBADMBP E. coli C43(DE3) inactive inactive
YP_931297.1 Pyrobaculum 
islandicum 
DSM 4184 36 NdeI-HindIII pBADMBP E. coli C43(DE3) inactive inactive
NP_070481.1 Archaeoglobus 
fulgidus 
DSM 4304 39 NdeI-HindIII pBADMBP E. coli C43(DE3) inactive NT
YP_843693.1 Methanosaeta 
thermophila PT
DSM 6194 29 NdeI-HindIII pBADMycHis(NdeI) E. coli C43(DE3) inactive NT
TABLE  3 . 
Cloning of putative proteases with ≥ 29% sequence identity to subtilisin E 
(P04189) originating from hyperthermophilic Archaea.
NT, not tested
Transformed E. coli strains expressing active subtilases were identified on 1% 
skim milk plates containing an appropriate inducer and antibiotic. Some of the 
putative proteases were cloned in different vectors to identify a generic plasmid 
for subtilase expression. A set of 6 strains with different inserts showed activity 
after 48 h incubation at 30°C on skim milk plates (Table 2 and 3, column 8). Since 
processing of thermophilic proteases may require an elevated temperature as 
shown for aqualysin I32 plates were incubated at 80°C for additional 1-2 h after 
the initial scoring for protease production. Three additional strains were identified. 
One more subtilase was identified in a small-scale liquid culture test. Thus, in total 
10 genes encoding active protease were identified. 
Strains with proteolytic activity on plate were tested for expression and activity 
in liquid cultures (Table 2 and 3, column 9). Typical expression tests involved 
cultivation at 4 different temperatures (17, 24, 30 and 37°C) with 0.25% arabinose 
or 0.3 mM IPTG as inducer. To allow autocatalytic processing of the precursor 
of thermophilic proteases, protease activities were assayed on total cell lysate 
incubated at 50°C after 2 h and 20 h. In parallel, a fraction of total cell lysate was 
incubated at 70°C and activity after 2 h and 20 h incubation was tested. More 
detailed expression tests of strains showing activity were then used to determine 
which recombinant vector gives the highest titer of protease. 
In addition, processing conditions were optimized for four novel proteases and 
results are reported in the respective chapters (Table 2).
Alongside establishing the properties of novel proteases described in 
the upcoming chapters, initial characterization tests were performed 
for four additional proteases. Two proteases originating from Thermus 
(ZP_03496757.1 and ZP_03496880.1) were recombinantly produced 
in E. coli C43(DE3). The activity was solely found in the culture medium 
obtained after 24 h incubation at 37°C in the presence of 0.25% arabinose 
as inducer. In addition, recombinant expression was confirmed for two 
Geobacillus thermodenitrificans NG80-2 proteases YP_001125483.1 
(NG483Sbt) and YP_001124317.1 (NG317Sbt). Expression of NG483Sbt 
subtilase required 24 h incubation at 30°C after induction with arabinose 
(0.25%) in the late log-phase. For isolation, a heating step was used (15 h 
65°C). The re-suspended insoluble fraction showed activity in skim-milk 
plate assay after the heating step. On the other hand, optimal expression 
conditions for NG317Sbt subtilase included 48 h incubation at 17°C 
after induction with 0.1 mM IPTG in the late log-phase. This protease is 
located in the cytoplasm and in the total membrane fraction. By applying 
the heating step (50°C for 2 h) to the re-suspended insoluble fraction 
and cell-free extract followed by centrifuge step resulted in enriched 
protease activity in the respective supernatants. Functional expression 
of several bacterial subtilases (Table 2) was not observed in liquid cultures 
in spite of confirmed activity on plates. Further broader expression 
studies (autoinduction medium, addition of metal ions) should help.Since 
activity on plates does not always correspond to expression of active 
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Members of the subtilisin group are only found in microorganisms and include 
mostly enzymes from Bacillus, where the subgroup of true subtilisins is best known33. 
Enzymes of this subgroup lack  disulfide bonds and have two characteristic Ca2+ 
binding sites called Ca1 (strong binding) and Ca2 (weak)34. Only few described 
members of the subtilisin group (aerolysin, pernisine and Tk-subtilisin) originate 
from hyperthermophilic organisms. The subtilisin-like proteases are expressed as 
precursors containing an N-terminal presequence, an N-terminal prosequence 
and a mature catalytic domain. Long C-terminal extensions are rare, but were 
predicted in some subtilases studied here by inspection of sequence alignments 
(Chapter 6 on Pseudomonas subtilase, PmSbt).
Thermitase is an extracellular, thermostable serine protease from the thermophilic 
microorganism Thermoactinomyces vulgaris and its family includes other 
subtilases originating from thermophilic organisms. The thermostability and the 
structure of thermitase were studied in detail26,35. There are two strong calcium 
binding sites and one weak calcium site. In the following chapters, four subtilases 
that cluster in the thermitase family were functionally expressed in E. coli (Figure 
1). The biochemical characterization of a subtilase from Coprothermobacter 
proteolyticus is described in Chapter 4.
The members of the pyrolysin family are characterized by low sequence identity 
to subtilisins and carry sequence insertions and a long C-terminal domain. Two 
putative thermostable subtilases are clustered in this group, namely NG317Sbt 
(YP_001124317.1) and subtilase from Thermoanaerobacter pseudoethanolicus 
(YP_001665698). 
Proteinase K is alkaline protease secreted by the mold Engyodontium album, and 
is similar to thermitase which is also heat stable and contains a cysteine close 
to the active site36. Proteinase K has two disulfide bonds, and like subtilisins it 
binds two calcium ions, albeit in different topology. Aqualysin I is another well-
studied member of the proteinase K family whose crystal structure is solved36. Two 
extremophilic subtilases called TaqSbt and DgSbt are clustered in this family and 
were identified and characterized in detail (Chapter 5).
FIGU RE  1 . 
Phylogenetic tree based on sequence alignment of literature described subtilases and functionally 
expressed subtilases of this study (indicated with an asterisk). The figure was generated with Geneious 
v5.6 software. 
subtilases in liquid cultures, probably due to specific growth and processing 
conditions, we tested the expression in liquid culture for few putative subtilases 
that were inactive in the plate assay.  Two archaeal subtilases NP_579399.1 from 
Pyrococcus furiosus and YP_931297.1 Pyrobaculum islandicum were tested this 
way. Regrettably, we could not functionally express any of the putative archaeal 
proteases in our expression systems. Further immunoblotting assays can indicate 
whether these enzymes are expressed at all.A phylogenetic classification divides 
peptidases in terms of families and clans. For example, SB represents the subtilisin 
clan of serine peptidases and contains two families: S8 (subtilisin-like protease 
family) and S53 (sedolisin family). Siezen et al. reported33 over 200 subtilisin-
like proteases he termed subtilases. They were found in all kingdoms of life. By 
identifiying the structural core elements, the authors suggest further classification. 
The subtilase superfamily enzymes can be grouped into six families: proteinase 
K, thermitase, subtilisin, pyrolysin, kexin, and lantibiotic peptidase. The majority 
of active extremophilic proteases selected by us belong to the thermitase family, 
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In our expression experiments two bottlenecks occurred. First, cloning of GC-rich 
sequences was successful for only 46% of the genes. For future projects, gene 
synthesis can provide a straightforward solution. 
Another bottleneck is functional expression in recombinant host in case processing 
steps and secretion are needed to obtain active protease19. The full preprosequence 
of 24 subtilases was cloned into pBAD or pET-based vectors. From these 24 
cloned genes, nine active subtilases were detected by plate screening and one 
enzyme was found in small-scale liquid culture screening. Furthermore, although 
promising as hyperthermophilic proteases, none of the archaeal subtilases 
could be obtained in the active recombinant form from transformed E. coli cells. 
Another observation is that overexpression in E. coli was modest in all cases, 
with maximal levels of 5-50 mg per L of culture medium.  At the moment, it is 
impossible to predict from the protein sequence whether a putative subtilase 
will be expressed and active in a selected host if close homologs with confirmed 
activity are unknown. The use of different recombinant system may also boost 
expression, as in the example of aqualysin I, where a recombinant expression level 
of 1 g/L using Pichia pastoris is reported37. The fact that subtilases of this research 
originate from extremophiles and require processing steps to become active may 
present an additional obstacle in obtaining new extremophilic subtilases using E. 
coli as a host.
Despite these limitations, in total ten putative extremophilic subtilases were 
functionally expressed using E. coli and found to be active. In the following 
chapters, the expression and properties of are described.
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Through genome mining of extremophiles we identified a gene encoding 
a putative serine protease of the thermitase subgroup of subtilases 
(E.C. 3.4.21.66) in the thermophilic bacterium Coprothermobacter 
proteolyticus. The gene was functionally expressed in Escherichia coli and 
the enzyme which we called proteolysin, was purified to near homogeneity 
from crude cell lysate by a single heat-treatment step. Proteolysin has 
a broad pH tolerance and is active at temperatures of up to 80°C. In 
addition, the enzyme shows good activity and stability in the presence 
of organic solvents, detergents and dithiothreitol, and remains active 
in 6 M guanidinium hydrochloride. Based on its stability and an activity 
profile, proteolysin can be an excellent candidate for applications where 
resistance to harsh process conditions is required.
Extreme environments in terms of extreme temperature, pressure, salinity 
and pH represent valuable resources of unique genes and biocatalysts. 
These extreme habitats detrimental to the most mesophiles support 
the life of unusual organisms (extremophiles). With increased thermal 
stability, thermozymes (enzymes from hyper- and thermophiles) are 
valuable in developing novel bioindustrial routes1,2. In the search for novel 
thermostable endoproteases, we explored available genome sequences 
from thermophiles, hyperthermophiles and some bioremediation 
organisms for homologs of subtilisin E. We proceed with cloning and 
screening of putative subtilases (Chapter 3) and focus on an active 
subtilase from Coprothermobacter proteolyticus, a Gram-positive 
anaerobic extreme thermophile. This organism exhibits proteolytic activity 
and the organism was proposed as a candidate for thermophilic organic 
solid waste degradation, making characterization of its proteases of 
special interest3.
Here, we describe the heterologous expression of this novel protease, its 
isolation by one-step heat purification, and its biochemical properties. The 
results show that this protease, which we termed proteolysin, is a highly 
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Materials and methods 
Chemicals and reagents — Chemicals and reagents as well as cloning of 
proteolysin is described in Chapter 3. In addition, recombinant plasmid lacking 
sequence for the C-terminal hexahistidine tag (PrlAs) was made using the reverse 
primer 5’-CACACACGAAGCTTTAATG¬GTGTCCAGTTTACTGCAGCATAC-3’ 
(HindIII site under¬lined, stop codon in bold). A proteolysin mutant (PrlAd) harboring 
the substitutions Cys182Ala and Cys201Ala was obtained by site-directed 
mutagenesis using the QuikChange kit (Stratagene) and pBAD-MBP-PrlA as template. 
Expression, processing and isolation of proteolysin — E. coli C43(DE3) 
cells containing an expression construct were grown overnight at 37°C in LB 
medium (10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl) supplemented with 
0.1% glucose and ampicillin (100 µg/ml). The overnight culture was used to 
inoculate (0.1% v/v) TB medium (12 g/L tryptone, 24 g/L yeast extract, 0.4% 
(v/v) glycerol, 72 mM K₂HPO₄, 17 mM KH₂PO₄) containing ampicillin (100 µg/
ml) and cells were grown at 37°C. Proteolysin synthesis was induced at 17ºC 
when the OD600 reached 0.8 by adding 0.25% arabinose, followed by cultivation 
for 48 h at 17ºC with shaking. The cells were harvested (4°C, 15 min at 6,000 x 
g), washed, suspended in buffer (50 mM Hepes∙NaOH, pH 7.5, 10 mM CaCl₂) and 
disrupted by sonication. The total cell lysate was subjected to heat treatment at 
80°C for 3 h and centrifuged (4°C, 45 min at 30,000 x g). The supernatant was 
concentrated with an Amicon YM30 ultrafiltration membrane (Millipore, Billerica, 
MA, USA), followed by buffer exchange to 50 mM Hepes∙NaOH, pH 7.5, 10 mM 
CaCl₂. Protein concentrations were determined by the Bradford assay using 
bovine serum albumin as the standard. The mature protein was stored at - 80°C.
SDS-PAGE and immunoblotting — Samples of total cell lysate taken during 
proteolysin processing were analyzed on 12% SDS-PAGE gels. Proteins were 
transferred to a nitrocellulose membrane (Amersham Biosciences) using a 
semidry blotting apparatus (Bio-Rad, Hercules, CA, USA). Immunodetection was 
performed using antiserum against the hexahistidine tag, a secondary horseradish 
peroxidase-coupled antiserum and the ECL system from Amersham Biosciences 
according to the instructions of the manufacturer. Photographs were taken using 
a Fujifilm LAS-3000 imaging system.
Enzyme assays — Proteolytic activities of cell extracts and purified enzyme 
samples were monitored on 5% skim milk LB agar plates. Samples were added to 
wells in the agar and proteolytic activity was scored after overnight incubation at 
37ºC by inspection for clearing zones. For further analysis, an azocasein assay⁴ 
and an amidolytic assay⁵ were employed. For the first, an azocasein solution 
(1.25% (w/v) in Hepes∙NaOH buffer (100 mM, pH 7.5) containing CaCl₂ (1 mM)) 
was used as the substrate. After 20 min incubation with enzyme at a selected 
temperature, trichloroacetic acid was added to quench the reaction (4%, v/v). 
The mixture was cooled on ice for 10 min and spun down in a tabletop centrifuge 
(4°C, 10 min, 14, 000 x g). Next, NaOH was added to the supernatant to 0.4 M 
final concentration and the absorbance was measured at 440 nm. Reactions were 
performed in triplicate. One unit of activity (U) is defined as the amount causing 
a change of one absorbance unit (AU) per min. In the amidolytic activity assay 
1 mM N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide (N suc-AAPF-pNP) was used 
as the substrate, added from a 20 mM stock solution in DMSO. Reactions were 
performed in Hepes∙NaOH buffer (100 mM, pH 7.5) containing CaCl₂ (1 mM) and 
DMSO (10%, v/v) at 40ºC and 70ºC. The release of p-nitroaniline was monitored 
by spectrophotometry at 410 nm (ε= 9.4 mM-1 • cm-1 (at 40ºC), ε= 11.5 mM-1 • 
cm-1 (at 70ºC). One unit is defined as the amount of activity that produces 1 
µmol p-nitroaniline per min. For determination of kinetic parameters, the substrate 
concentration was varied from 0.03 - 3 mM. 
The pH optimum and cosolvent tolerance were determined with the amidolytic 
assay, using Britton-Robinson universal buffer (0.04 M acetic acid, 0.04 M H₃BO₃, 
0.04 M H₃PO₄) in a pH range of 3.0 – 12.0 (NaOH)). The concentration of cosolvents 
(DMSO, DMF or ethanol) was varied from 10 to 60% (v/v). Enzyme activities were 
normalized to the activity in the presence of 10% of the respective cosolvent. 
The selectivity of proteases was measured with oxidized insulin B chain. The 
substrate was dissolved to 10 mg/ml in 0.05 mM NH₄HCO₃, pH 8.0. Substrate 
to enzyme ratios were set to 1200 or 2400 (w/w). The reaction was started by 
addition of enzyme, and continued at 37°C and 60°C. Samples were taken at 0 
min, 5 min and 24 h, conversion was stopped by adding 5% TFA, and peptides 
were analyzed by LC-MS/MS to determine the cleavage preference of proteolysin 
and subtilisin A. 
Inhibitors, surfactants, denaturants and metal ions — The effects of 
surfactants and denaturants were tested by adding these compounds to reaction 
mixtures. The serine protease inhibitor phenylmethylsulfonyl fluoride (PMSF), EDTA, 
and iodoacetate were tested at concentrations of 5 and 10 mM. Metal ions were 
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proteolysin, trypsin and keratin were added. In cleavage specificity experiments, 
the sequence of oxidized insulin B chain was added to the database. Matches to 
proteolysin- or insulin-derived peptides were accepted if they could be assigned 
with a confidence of identification probability higher than 99%. 
For intact protein analysis, samples were mixed 1:1 (v/v) with matrix solution 
consisting of saturated with α-cyano-4-hydroxycinnamic acid (14 mg/ml) in a 
3:1:2 (v/v/v) mixture of formic acid/water/2-propanol (FWI) (pH 1.3), and analyzed 
after spotting on a stainless-steel MALDI target. Mass spectra were recorded by 
MALDI-TOF on the Applied Biosystems proteomics analyzer mentioned above, 
which was operated in linear positive ionization mode. Bovine serum albumin was 
used for calibration. 
Enzymatic peptide synthesis — For synthesis of the dipeptide Cbz-Phe-
Phe-NH₂ an isopropanol-precipitated enzyme preparation (IPREP suspension 
(20% w/v) for details see Chapter 5) in anhydrous acetonitrile was mixed with 
N-terminally protected acyl donor Cbz-Phe-OCam (50 mM), the C-protected 
nucleophile H-Phe-NH₂ (1.5 equiv., 75 mM), and heat-activated 3Å crushed 
molecular sieves (200 mg/mL). The reaction mixture (0.1 mL) was shaken for 24 h 
at 400 rpm at 37°C. The reaction was quenched (0.5 mL of acetonitrile-water (3:1, 
v/v), 1% formic acid) and filtered, followed by analysis by HPLC-UV (detection at 
220 nm, details are given in Chapter 5). 
added as chloride salts of calcium, magnesium, manganese and nickel. Enzyme 
was preincubated with the respective reagents dissolved in 100 mM Hepes∙NaOH, 
pH 7.5, for 1 h at 37°C, and residual activities were determined in duplicate with 
the amidolytic assay at 40°C where CaCl₂ was omitted from the assay buffer. The 
activity in the same buffer without potential inhibitor added was set at 100%.
Thermostability — The fluorescence-based thermal stability assay described 
by Ericsson et al.⁶ was used to determine apparent melting temperatures of 
the proteins. Protein solutions (15 µl) in buffer (25 mM Hepes∙NaOH, pH 7.5, 1 
mM CaCl₂, 20% glycerol) were incubated with PMSF (2.5 µl of 100 mM stock in 
ethanol) for 10 min at room temperature. A solution of 7.5 µl of 100 x Sypro Orange 
(Molecular Probes, Life Technologies, San Diego, CA) dye was added to the 
samples in a thin walled 96-well PCR plate. The plates were sealed with Optical-
Quality Sealing Tape and heated in an iCycler iQ Real Time PCR Detection System 
(BioRad, Hercules, CA, USA) from 20 to 99°C at a heating rate of 1.1°C/min. The 
wavelengths for excitation and emission were 490 and 575 nm, respectively. 
Fluorescence changes were monitored with a charge-coupled device (CCD) 
camera and the derivative of the fluorescence change against time was used to 
obtain the Tm, app. Enzyme thermostability was also determined by incubating the 
enzyme in Hepes∙NaOH buffer (100 mM, pH 7.5) containing CaCl₂ (1 mM) at 70, 
80, 90 and 100°C for different time periods. Thermostability in the presence of 
DTT (10 mM) at 70°C was also determined for pretreated enzyme with 10 mM DTT 
(1h incubation at 25°C). The residual activity was determined in duplicate with the 
amidolytic assay after cooling to 40°C.
Sulfhydryl groups — For quantitative determination of sulfhydryl groups in 
proteolysin, Ellman’s test was used as described by Riener et al.⁷.
Peptide analysis by mass spectrometry — To allow confirmation of the 
identity of isolated proteolysin, a protein band was excised from a 12% SDS gel 
and tryptic digestion was performed according to Saller et al.⁸. For LC-MS/MS 
analysis, tryptic peptides of proteolysin or oxidized insulin B chain digests were 
first diluted in 0.1% TFA, separated on capillary C18 LC column and analyzed on 
MALDI-TOF/TOF 4800 Proteomics Analyzer (Applied Biosystems, Foster City, 
CA, USA) as described by Saller et al.⁸. Peptide identification was carried out 
using the program Protein Pilot 4.0 (ABsciex, Foster City, CA, USA) searching 
against the UniProtKB/Swiss-Prot protein database, to which the sequences of 
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To discover thermostable subtilisin-like enzymes (subtilases) that might 
resist harsh process conditions, the entire preprosequence of subtilisin 
E (EMBL AAA22742) was used as a query in Blast searches of sequences 
of thermophilic bacteria, Archaea and bioremediation organisms (BLASTp, 
Chapter 3). 
We selected the protease from Coprothermobacter proteolyticus for 
further studies since the source organism exhibits high proteolytic activity⁹ 
and grows at high temperature. The expressed protease has quite high 
sequence identity with subtilisin E (35%) and thermitase (46%). According 
to Siezen’s classification of the subtilase superfamily10, this enzyme, which 
we termed proteolysin (PrlA), clusters in the family of thermitase (Chapter 
3, Figure 1).
Inspection of sequence alignments of proteolysin with previously 
characterized subtilases revealed that the catalytic residues are fully 
conserved, i.e. the catalytic triad (Asp51, His94, and Ser267) and the 
oxyanion hole (Asn187) (Figure 1). A structural model of proteolysin 
based on the crystal structure of thermitase (1THM) was constructed 
with Yasara11. The model showed that proteolysin can adopt the same fold 
as subtilisin E. The active site geometry appears to be conserved and two 
calcium sites (Ca1 and Ca2) present in thermitase are likely to be present 
in proteolysin as well. Additional surface loops in the model originate 
from two sequence insertions (Asn55-Lys65 and Asp231-Asp243). Two 
cysteines (Cys182 and Cys201) are positioned in the inner core of the 
proteolysin model and fit the criteria for disulfide bond formation12,13. 
These cysteines are not conserved in the most homologous subtilases.
Genome mining
Results
                                   90        100       110       120      130
                          ...|....|....|....|....|....|....|....|....|....|.
proteolysin          82  LPQGKAADVVMNQLKNDPNVEYVEPNYIAHAFDVPNDTFFNPYQWNFYDY 
thermitase            1   --------------------------------YTPNDPYFSSRQYGPQK- 
subtilisin E         75  AAAATLDEKAVKELKKDPSVAYVEEDHIAH-------EYAQSVPYGISQ- 
subtilisin BPN’       76  AASATLNEKAVKELKKDPSVAYVEEDHVAH-------AYAQSVPYGVSQ- 
subtilisin Carlsberg  74  AAKAKLDKEALKEVKNDPDVAYVEEDHVAH-------ALAQTVPYGIPL- 
aqualysin I         96  GFAAEMAPQALEAFRQSPDVEFIEADKVVR-----AWATQSPAPWGLDRI 
proteinase K         74  GFAATLDENMVRVLRAHPDVEYIEQDAVVT-----INAAQTNAPWGLARI 
Clustal Consensus             1                                               :. 
                                  140       150      160     170      180
                          ...|....|....|....|.... |....|....|....|....|....|
proteolysin       132 GMTSNGYVSNYGIQAVSAWNITK-GAGVKVAIIDTGVAYENYGAYTKAPD 
thermitase           17  ------------IQAPQAWDIAE-GSGAKIAIVDTGVQSN-------HPD 
subtilisin E      116 ------------IKAPALHSQGYTGSNVKVAVIDSGIDSS-------HPD 
subtilisin BPN’    117 ------------IKAPALHSQGYTGSNVKVAVIDSGIDSS-------HPD 
subtilisin Carlsberg 115 ------------IKADKVQAQGFKGANVKVAVLDTGIQAS-------HPD 
aqualysin I       141 DQRD--------LPLSNSYTYTATGRGVNVYVIDTGIRTT-------HRE 
proteinase K       119 SSTS--------PGTSTYYYDESAGQGSCVYVIDTGIEAS-------HPE 
Clustal Consensus                                 * .  : ::*:*:            : 
                                   190       200        210       220           
                          ....|....|....|....|. ...|....|....|....|....|....
proteolysin       181 LANTLFDTANAYDFVNNDTHA-NDDNSHGTHVAGTIAQSTNNGMGAAGIA 
thermitase          48  LAG---KVVGGWDFVDNDSTP-QNGNGHGTHCAGIAAAVTNNSTGIAGTA 
subtilisin E      148 LN-----VRGGASFVPSETNPYQDGSSHGTHVAGTIAALNN-SIGVLGVS 
subtilisin BPN’     149 LK-----VAGGASMVPSETNPFQDNNSHGTHVAGTVAALNN-SIGVLGVA 
subtilisin Carlsberg   147 LN-----VVGGASFVAGEAYN-TDGNGHGTHVAGTVAALDN-TTGVLGVA 
aqualysin I       176 FGG------RARVGYDALGGNGQDCNGHGTHVAGTIGGVTY------GVA 
proteinase K       154 FEG------RAQMVKTYYYSS-RDGNGHGTHCAGTVGSRTY------GVA 
Clustal Consensus                     :         .            : ..**** **  .          * : 
                                 280       290       300           310    
                          ..|....|....|....|....|....|...    .|....|....|...
proteolysin       273 SSGSTTLQNAIQYAYNKGVVIVCASGNDRRS----TVSYPAAYTQCIAVG 
thermitase       137 TVGNSGLQQAVNYAWNKGSVVVAAAGNAGNT----APNYPAYYSNAIAVA 
subtilisin E      235 PTGSTALKTVVDKAVSSGIVVAAAAGNEGSSGSTSTVGYPAKYPSTIAVG 
subtilisin BPN’     236 PSGSAALKAAVDKAVASGVVVVAAAGNEGTSGSSSTVGYPGKYPSVIAVG 
subtilisin Carlsberg   233 PSGSTAMKQAVDNAYARGVVVVAAAGNSGSSGNTNTIGYPAKYDSVIAVG 
aqualysin I       258 -GVSTALDNAVKNSIAAGVVYAVAAGNDNAN---ACNYSPARVAEALTVG 
proteinase K      240 -GYSSSVNSAAARLQSSGVMVAVAAGNNNAD---ARNYSPASEPSVCTVG 
Clustal Consensus                        .: :. .       * : . *:**            *.   .  :*. 
                            320       330       340       350       360    
                          .|....|....|....|....|....|....|....|....|....|...
proteolysin       319 STRFDGTRARYSNYGSALDIVAPGGDTSVDQNHDGYGDGILQQTFAEGSP 
thermitase        183 STDQNDNKSSFSTYGSVVDVAAPG--------------SWIYSTYPTST- 
subtilisin E      285 AVNSSNQRASFSSAGSELDVMAPG--------------VSIQSTLPGGT- 
subtilisin BPN’     286 AVDSSNQRASFSSVGPELDVMAPG--------------VSIQSTLPGNK- 
subtilisin Carlsberg    283 AVDSNSNRASFSSVGAELEVMAPG--------------AGVYSTYPTST- 
aqualysin I       305 ATTSSDARASFSNYGSCVDLFAPG--------------ASIPSAWYTSDT 
proteinase K       287 ASDRYDRRSSFSNYGSVLDIFGPG--------------TSILSTWIGG-- 
Clustal Consensus                    :    . :: :*. *. ::: .**                : .:   . 
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                           370        380      390        400      410    
                          .|....|....|....|....|....|....|....|....|....|...
proteolysin       369 TDFAYYFFQGTSMASPHVAGVAALVLSAHPTYTNEQVRTALQSTAKDLGT 
thermitase        217 ----YASLSGTSMATPHVAGVAGLLASQGRSASN--IRAAIENTADKISG 
subtilisin E       319 ----YGAYNGTSMATPHVAGAAALILSKHPTWTNAQVRDRLESTATYLGN 
subtilisin BPN’    320 ----YGAYNGTSMASPHVAGAAALILSKHPNWTNTQVRSSLENTTTKLGD 
subtilisin Carlsberg  317 ----YATLNGTSMASPHVAGAAALILSKHPNLSASQVRNRLSSTATYLGS 
aqualysin I       340 ---ATQTLNGTSMATPHVAGVAALYLEQNPSATPASVASAILNGATTGRL 
proteinase K       320 ---STRSISGTSMATPHVAGLAAYLMTLG-KTTAASACRYIADTANKGDL 
Clustal Consensus                     .*****:***** *.       . :       : . : 
                           420       430        440      450       460    
                          .|....|....|....|....|....|....|....|....|....|...
proteolysin       419 AGWDKYYGYGLVNAYAAVNWTP---------------------------- 
thermitase        262 TG--TYWAKGRVNAYKAVQ------------------------------- 
subtilisin E       366 SF---YYGKGLINVQAAAQ------------------------------- 
subtilisin BPN’     367 SF---YYGKGLINVQAAAQ------------------------------- 
subtilisin Carlsberg  364 SF---YYGKGLINVEAAAQ------------------------------- 
aqualysin I       388 SG----IGSGSPNRLLYSLLSSGSGSTAPCTSCSYYTGSLSGPGDYNFQP 
proteinase K       367 SN----IPFGTVNLLAYN----------------------------NYQA 
Clustal Consensus    :        *  * 
FIGU RE  1 . 
Partial sequence alignment of proteolysin, thermitase, 
subtilisin Carlsberg, subtilisin E, subtilisin BPN’, 
proteinase K and thermostabile subtilase aqualysin I. The 
numbering of amino acids corresponds to proteolysin 
sequence. The start of the mature protein is marked in 
red.  Conserved residues, i.e., the catalytic triad (Asp51, 
His94, and Ser267) and oxyanion hole Asn186 are 
marked in dark gray. Cysteines, if present, are yellow. 
Sequence insertions characteristic for proteolysin are 
highlighted in green.
For the production of proteolysin in E. coli, plasmid pBAD-MBP-PrlA was 
constructed. A DNA segment encoding maltose binding protein (MBP) was fused 
to the 5’ end of the region encoding the preprosequence to improve solubility 
of the precursor, and sequence for a C-terminal hexahistidine tag was added to 
facilitate purification. The recombinant fusion protein was expressed in E. coli 
strain C43(DE3). No significant activity was detected in the culture fluid. After 
sonication of the collected cells, a total cell lysate (TCL) was obtained, which 
contained little proteolytic activity. Proteolysin processing and maturation 
required a heat treatment step. The processing could be performed at 70°C for 
12 h or at 80°C for 3 h. We observed some product already after 1 h of heat 
treatment at 80°C, but only after 3 h of heat treatment a single protein band of 
approximately 40 kDa was obtained on SDS-PAGE gels (Figure 2). For routine 
enzyme isolation, a heat treatment step of 180 min at 80°C was used. The yield 
of purified proteolysin from a 1 L culture was 20 mg. The enzyme had a specific 
activity of 4 U/mg in the amidolytic assay. The results show that proteolysin was 
not secreted and processed by the E. coli host, and that the precursor protein was 
autocatalytically converted to mature enzyme upon heat treatment.
Production, processing and isolation of proteolysin using E. coli
FIGU RE  2 . 
Time course of proteolysin heat 
processing at 80°C. Panel A, 
Time-dependent heat activation 
at 80°C. Assays were done with 
N-suc-AAPF-pNA as the substrate. 
Panel B, electrophoretic analysis of 
proteolysin heat activation. TCA-
precipitated samples were analyzed 
on a 12% SDS-polyacrylamide 
gel. Lanes: 1, molecular weight 
markers (GE Healthcare); 2, cell-free 
extract; 3-10, heat treatment at 
80°C for 1h (lane 4), 2 h (lane 5), 
3 h (lane 6), 4 h (lane 7),  5 h (lane 
8), 7 h (lane 9) or 7 (lane 10).
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The predicted amino acid sequence of the unprocessed recombinant 
proteolysin comprises 857 amino acids with a calculated total molecular 
mass of 92.8 kDa. The observed mass of the mature protein was 34,973 ± 
3 Da, as determined by MALDI-TOF. To confirm the identity of the protein 
and to determine the N-terminus after maturation, tryptic digestion was 
performed and peptides were analyzed by MALDI-TOF/TOF. The peptide 
coverage was 67%, but no peptide segments were found in the Met1-
Phe113 region. The molecular mass of the mature protein suggests that 
the sequence starts at Asp114 and ends with three additional amino acids 
(Leu328, Lys329, and Leu330) originating from the linker between the 
protein and the hexahistidine tag. Immunoblot analysis with antibodies 
against the hexahistidine tag confirmed its removal upon maturation of 
the protein (data not shown). Moreover, sequence alignment to thermitase 
supports Asp114 as the start of the mature protein.
To exclude an influence of the linker and hexahistidine tag on proteolysin 
processing, a gene encoding native proteolysin (termed PrlAs) including 
the stop codon was constructed. It was expressed and PrlAs was 
produced under the same conditions as above. The expression level and 
processing profile of the PrlAs, as well as its thermostability, were not 
impaired. The enzyme showed a similar activity as PrlA.
Azocasein and N-succ-AAPF-pNA were used as the substrate for 
determination of temperature effects. Proteolysin hydrolyzed azocasein 
with optimal activity at 85°C, whereas subtilisin A was most active at 70°C 
under the conditions applied (Figure 3). The kinetic stability of proteolysin 
was investigated by following the loss of activity during incubation of the 
purified enzyme at high temperatures (70, 80, 90 and 100°C), using the 
amidolytic assay (Figure 4). Proteolysin appeared very stable at 70°C. 
Even after 20 h of incubation, the protein retained 35% of its initial activity 
towards N-suc-AAPF-pNA. In contrast, subtilisin A was completely 
inactivated after 1 h incubation at 70°C. 
Temperature profile and thermostability of proteolysin
FIGU RE  4 . 
Thermostability of proteolysin and subtilisin A. Enzymes were incubated at temperatures of 70°C 
(   ), 80°C (  ), 90°C (  ) or 100°C (Δ). The remaining activity at different times was determined 
with N-suc-AAPF-pNA as the substrate. Panel A , Proteolysin, PrlA; Panel B, Proteolysin, PrlAd; 
Panel C, subtilisin A. 
FIGU RE  3 . 
Temperature profile of 
subtilisin A ( ), proteolysin 
PrlA ( ), and proteolysin 
variant PrlAd (  ). The 
apparent temperature 
optimum was determined 
in duplicate using the 
azocasein assay.
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The thermostability of proteolysin was also determined using the Sypro Orange 
assay. For this, enzyme activity was inhibited with PMSF. An apparent transition 
temperature (Tm,app) of 81 °C was observed, again indicating that the enzyme is 
much more thermostable than subtilisin A, for which a Tm,app of 60 °C was measured.
A homology model for proteolysin was constructed with Yasara. The structural 
model suggested that a disulfide bond might be formed between Cys182 and 
Cys201, which are the only cysteines in the protein. Ellman’s assay revealed the 
presence of 22 μmol of free sulfhydryls per mg of purified enzyme, in agreement 
with a sulfhydryl to enzyme ratio of 0.7. In a modified Ellman’s test using cystamine⁷, 
a sulfhydryl to enzyme ratio of 0.5 was found. These data suggest the occurrence 
of a disulfide bond or destruction of free sulfhydryls by a β-elimination reaction 
that may occur during heat treatment step14. To determine if the presence of 
a putative disulfide bond contributes to thermostability, a mutant carrying the 
substitutions Cys182Ala and Cys201Ala was constructed. The resulting variant 
(PrlAd) was expressed and produced under the conditions mentioned above, 
giving a four-fold lower protein yield as compared to proteolysin PrlA. PrlAd 
hydrolyzed azocasein with optimal apparent activity at around 90°C, slightly 
higher than what was found with the wild-type (Figure 2). The thermostability of 
variant PrlAd was only slightly affected by the mutations (Figure 4). Whereas the 
double mutant was more stable at low temperatures (70°C), the wild type showed 
slower inactivation at temperatures above 80°C. The presence of DTT (10 mM) 
reduced the half-life at 70°C by three-fold for both enzymes (PrlA and PrlAd, data 
not shown). This suggests that the Cys182-Cys201 pair does not contribute to 
the high thermostability of proteolysin.
The catalytic properties of the novel protease were examined with N-suc-AAPF-
pNP, a short peptide (oxidized insulin B chain), and azocasein (24.6 kDa), which 
is an azo-dye conjugate of casein, a large globular protein widely used in the 
food industry as a source of biologically active peptides15. The optimum pH of 
proteolysin was determined at 40ºC and 70ºC using N-suc-AAPF-pNP as the 
substrate (Figure 5). Proteolysin appeared active over a broad pH range (7.0-9.0) 
and showed maximal activity at approximately pH 8.0.
Catalytic properties
FIGU RE  5 . 
pH profile of proteolysin PrlA. Britton-Robinson buffer 
was used in a pH range 3.0-12.0 (adjusted with NaOH). 
The reactions were performed in duplicate at 40°C 
(panel A) and 70°C (panel B). Data were fitted using 
SigmaPlot software. 
The steady-state kinetic parameters of proteolysin PrlA, PrlAd and subtilisin 
A were determined with N-suc-AAPF-pNA and compared with those of 
other subtilases (Table 1). At 40ºC proteolysin PrlA had a lower catalytic 
efficiency than its mesophilic counterparts. At elevated temperature, a 
four-fold increase of the kcat of proteolysin was accompanied by a similar 
increase in Km, suggesting that the higher catalytic activity at elevated 
temperature is accompanied by less tight substrate binding. Interestingly, 
at 70°C the proteolysin variant lacking two cysteines (PrlAd) exhibited a 
catalytic efficiency of 335 mM-1∙s -1, which is 5-fold higher than that of 
the wild-type enzyme and similar to the kcat/Km of subtilisin A with the 
same substrate at 40ºC. Subtilisin A and the mutant proteolysin had 
similar activities at 70°C, but subtilisin was not very stable at this high 
temperature and its activity was lost after 1 h incubation (Figure 4).
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25±1 0.41±0.07 62 110±5 1.58±0.13 69 37±1 0.57±0.04 65 this work
Proteolysin 
PrlAd
111±4 0.33±0.03 335 248±24 1.96±0.3 126 124±6 0.66±0.07 189 this work
Subtilisin A 551±62 1.1±0.3 489 539±70 1.06±0.3 508 40±3 1.57±0.25 23 this work
Aqualysin I 33 1.2 27.5 ND ND ND ND ND ND 16
Subtilisin 
BPN’
480 0.29 1655 ND ND ND ND ND ND 16
ND, not determined
TABLE  3 . 
Kinetic parameters of proteases measured with N-suc-AAPF-pNA as the substrate. Reaction 
temperatures were 40°C or 70ºC.  For assays in the presence of DTT, proteolysins were 
preincubated with 10 mM DTT at 25ºC for 1 h, after which activities were determined. All 
incubations were performed in 100 mM Hepes∙NaOH buffer, pH 7.5, containing 1 mM CaCl₂, 10% 
DMSO (v/v) and where indicated 10 mM DTT.
At 40°C, both proteolysin PrlA and PrlAd showed slightly higher kcat values 
in the presence of the reducing agent dithithreitol (DTT), but the increase in 
Km suggests weaker substrate binding (Table 1). High concentrations of DDT 
sometimes inactivate enzymes by metal chelation or by reducing essential 
disulfide bonds. Proteolysin and the mutant lacking two cysteines tolerated 
DTT concentrations up to 10 mM, indicating that in mature proteolysin the 
two cysteines do not form a DTT-reducible disulfide bond that is important 
for activity.
Oxidized insulin B chain was used as the substrate for determining the cleavage 
specificity of proteolysin. The reactions were performed at 37°C and the hydrolysis 
products were analyzed by LC-MS/MS. The primary cleavage site of proteolysin 
was found between Ala14 and Leu15 (Figure 6). Prolonged incubation (24 h) 
revealed additional cleavage sites after Phe1, Asn3, Gln4, Leu17, Cys19, Phe24, 
Phe25, Tyr25 and Lys29, which shows that proteolysin has a relaxed cleavage 
site specificity. 
For subtilisin A, the primary cleavage site was between Leu15 and Tyr16 and 
prolonged incubation resulted in complete degradation of the substrate chain. 
The cleavage profile of proteolysin acting on insulin B chain did not change when 
the reaction temperature was raised to 60°C, whereas subtilisin A was inactivated 
after a prolonged incubation. When compared to other thermostable subtilases, 
proteolysin shares the primary cleavage site preference with pernisine17 and 
shows a slight preference for hydrophobic amino acids residues at the P1 position, 
which is similar to other thermostable subtilases18.
Cleavage specificity
FIGU RE  6 . 
Cleavage sites of proteolysin in oxidized insulin B chain. The diagram shows 
peptides identified by LC-MS/MS after 5 min and 24 h incubations with 
proteolysin at 37°C. Major and minor cleavage sites are denoted by large and 
small arrowheads, respectively.
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In most thermostable subtilases a bound calcium ion is essential for enzyme 
stability19. The number of calcium-binding sites varies from zero (Tk-SP) to seven 
(Tk-subtilisin)20. The structural models suggest that proteolysin may have two 
strong calcium-binding sites which are also present in thermitase21. Therefore, 
the effect of various cations on the amidolytic reaction was tested. The results 
showed that bivalent metal cations increased the activity of proteolysin (Figure 
7), whereas the metal chelator EDTA (10 mM) decreased the activity to 87%. The 
serine protease inhibitor PMSF completely abolished the activity of proteolysin.
The addition of cosolvents such as DMSO or DMF can be used to improve the 
solubility of peptides. Therefore, we tested the tolerance of proteolysin to DMSO, 
DMF and ethanol. Amidolytic assays were performed in the presence of various 
levels of cosolvents in the range of 10-60% (v/v). Proteolysin exhibits higher 
organic solvent tolerance than subtilisin A (Figure 8). However, even though 
subtilisin A is more susceptible to inactivation by cosolvents than proteolysin, the 
higher catalytic activity towards the model substrate compensates for this and 
subtilisin A still displays a higher catalytic activity in the presence of cosolvents. 
Surface-active compounds or denaturing agents can be added to protein-
containing substrates in order to increase substrate availability. We observed that 
proteolysin can tolerate up to 6 M guanidinium hydrochloride, which gave a 40% 
reduction of activity after 1 h incubation at 40ºC. Subtilisin A was completely 
inactivated under the same conditions. The anionic surfactant SDS (10%, w/v) 
and the cationic surfactant CTAB (5%, v/v) reduced the activity of proteolysin, but 
Metal ions and inhibitors Proteolysis under harsh conditions
FIGU RE  7. 
The effect of different agents on proteolysin PrlA 
activity. The residual activity after 1 h incubation at 
37°C with the compound indicated was measured with 
N-suc-AAPF-pNP as the substrate in duplicate. Activity 
with 10 mM additive is indicated with black bars, with 5 
mM as grey bars. Activity with surfactants is indicated 
with white bars. 
FIGU RE  8 . 
Cosolvent tolerance. The effect of DMSO, DMF, and 
ethanol on the activity of proteolysin (black bars) and 
subtilisin A (grey bars). Activities were determined using 
the amidolytic assay at 40ºC. Activities are normalized to 
the activity in the presence of 10% cosolvent. 
CHAPTER — 0 4 Proteolysin
113112
the non-ionic surfactant Tween 20 (10%, v/v) activated proteolysin up to 178%. 
Moreover, after 1 h of incubation in the presence of the oxidizing agent hydrogen 
peroxide (15% v/v), the residual activity dropped to 10% (Figure 7).
The possibility to use the proteolysin for biocatalytic peptide synthesis under 
anhydrous conditions was tested. A possible method for the preparation of 
dry enzyme is precipitation of the enzyme from buffer by an organic solvent i.e. 
isopropanol. Proteolysin, PrlA showed modest synthetic activity yielding 34% of 
dipeptide (Cbz-Phe-Phe amide) in neat acetonitrile after 24 h incubation at 37°C.
In this work, we describe the purification and biochemical characterization of 
proteolysin, one of the two putative extracellular proteases encoded in the 
genome of the extreme thermophile C. proteolyticus22. The organism was isolated 
from a thermophilic digester (55°C) fermenting tannery waste and cattle manure23, 
and plays an important role in biogas production by releasing hydrogen that is 
used by methanogenic organisms22. 
Proteolysin belongs to the thermitase subgroup of the superfamily of subtilases. 
Produced as a precursor in E. coli cells, it requires processing for conversion to 
the mature form. The isolated yield of proteolysin produced in the mesophilic 
host E. coli was about 20 mg/L culture, which is sufficient for characterizing the 
enzyme and mutants thereof. The enzyme can be rapidly isolated by simultaneous 
processing and purification in a single heat-treatment step. Like many extracellular 
enzymes from thermophiles24, proteolysin is active at temperatures higher than the 
optimum growth temperature of its C. proteolyticus host (63°C). Proteolysin can 
hydrolyze the large globular protein azocasein at temperatures as high as 90ºC. 
The activity towards the synthetic substrate N-suc-AAPF-pNA is comparable to 
that of other thermophilic subtilases25–27. At elevated temperature (70-80ºC), the 
enzyme is stable and displays a higher catalytic activity than at 40ºC. By replacing 
both cysteines we obtained a variant with five-fold increased catalytic efficiency 
at 40°C and with a similar thermostability and temperature/activity profile as the 
wild-type PrlA. When used in chemoenzymatic peptide synthesis in neat organic 
solvent, proteolysin PrlA was active, however the yield of dipeptide Cbz-Phe-Phe 
amide was poor as compared to other subtilases (Chapter 5).  
Thermostability is often correlated with high tolerance to organic solvents28. 
Proteolysin indeed tolerated organic cosolvents in hydrolytic reactions much 
better than commercially available subtilisin A. Because of its thermostability, 
relaxed specificity and resistance to routinely used protein denaturants and 
DTT, proteolysin is a candidate for proteomics studies when protein digestion 
at extreme conditions is required. Heat pretreatment and the use of additives 
such as surfactants, organic solvents, and urea are commonly used to improve 
protein solubility and facilitate complete digestion, e.g. for peptide mapping29,30. In 
conclusion, the convenient production in E. coli, the high thermostability, the broad 
pH range, and its high tolerance to surfactants and cosolvents make proteolysin 
an attractive candidate for proteolysis under demanding reaction conditions. 
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Biocatalytic peptide synthesis will benefit from enzymes that are active at 
low water levels in organic solvent compositions that allow good substrate 
and product solubility. To explore the use of proteases from thermophiles 
for peptide synthesis under such conditions, putative protease genes of 
the subtilase class were cloned from Thermus aquaticus and Deinococcus 
geothermalis and expressed in E. coli. The purified enzymes were highly 
thermostable and catalyzed efficient peptide bond synthesis at 80°C and 
60°C in neat acetonitrile with excellent conversion (>90%). The enzymes 
tolerated high levels of N,N-dimethylformamide (DMF) as a cosolvent 
(40%-50% v/v), which improved substrate solubility and gave good 
conversion in 5+3 peptide condensation reactions. The results suggest 
that proteases from thermophiles can be used for peptide synthesis 
under harsh reaction conditions. 
The discovery of novel peptide receptors and of bioactive peptides 
that modulate receptor- and enzyme activity have resulted in a growing 
importance of peptides for the pharmaceutical, food and cosmetics 
industries1–4. Synthesis of bioactive peptides can be performed chemo-
enzymatically by enzymatic coupling of peptide segments obtained by 
solution- or solid-phase peptide synthesis (SPPS). For these conversions, 
a protease is applied in the synthetic direction5. In kinetically controlled 
coupling reactions, an activated acyl donor reacts with the enzyme 
and forms an acyl-enzyme intermediate that provides the N-terminal 
segment of the peptide product. If selectivity at the N-terminus is too 
restricted, substrate mimetics or strong leaving groups may be applied6. 
The intermediate undergoes an aminolytic reaction with the amine 
terminus of a nucleophilic peptide that becomes the C-terminal segment 
of the product. If these coupling reactions are carried out in an aqueous 
environment, the nucleophile needs outcompete water to cleave the acyl-
enzyme intermediate and form a peptide bond; otherwise hydrolysis of the 
acyl-enzyme by water will occur. The influence of enzyme properties and 
reaction conditions on synthesis/hydrolysis ratios in aqueous systems 
is well explored for other applications of hydrolytic enzymes in coupling 
reactions7,8. Solely synthetic product without acyl donor hydrolysis should 
also be obtained when water is omitted from the reaction mixture, i.e. 
by using neat organic solvents9,10. This obviously requires stability of the 
enzyme during preparation and use of water-free protein11.
Enzymatic coupling of peptide segments in organic solvents requires a 
broad-substrate-range enzyme that is stable and active in the absence of 
water. The industrial serine protease from Bacillus licheniformis (subtilisin 
A, subtilisin Carlsberg, Alcalase) has been used with success in peptide 
synthesis in neat organic solvent12,13 with substrates carrying multiple 
side-chain protective groups to enhance solubility14. 
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Peptide solubility may also be enhanced by increasing the reaction temperature 
and/or by the addition of an adequate cosolvent, such as dimethylformamide 
(DMF). Many enzymes show high thermal stability in anhydrous medium15, but 
chemo-enzymatic peptide synthesis in neat organic solvent systems is generally 
performed at modest reaction temperatures, i.e. 25°C -37°C 10,14,16–19. The use of 
higher temperatures is rare (50°C20). DMF can be added to increase substrate 
solubility in enzymatic coupling reactions21,22, but it may negatively affect enzyme 
activity and, dependent on the substrate, the activity of subtilisin in neat DMF may 
be strongly reduced23. Protein engineering has been used to increase aqueous 
DMF resistance24–26, but it remains to be established if such variants are active in 
peptide synthesis in anhydrous media mixed with DMF. 
Enzymatic coupling at elevated temperatures in anhydrous medium with DMF as 
cosolvent would combine benefits of suppressed hydrolysis by the absence of 
water and increased substrate solubility due to high temperature and the presence 
of DMF. Since solvent stability and enzyme thermostability are often correlated27,28, 
we decided to explore subtilisin-related enzymes from thermophilic organisms for 
peptide coupling under anhydrous conditions. We report the identification of two 
highly thermostable proteases and their synthetic performance in peptide synthesis 
at high temperature in acetonitrile-DMF solvent mixtures. In addition, we report 
the use of thermostable subtilases on preparative scale in economically favored 
peptide elongation in the N→C direction in a tandem reaction with an amidase.
Materials and methods 
Chemicals and reagents — Chemicals and reagents are listed in Chapter 3. 
Organic solvents were dried over 3 Å 4-8 mesh molecular sieves (Sigma-Aldrich, 
St. Louis, MO, USA), activated by heating at 200 °C. Peptide amides were obtained 
from Sigma-Aldrich and Bachem (Bubendorf, CH). C-terminal carbamoylmethyl 
(Cam, glycolamide) esters of peptides were synthesized by SPPS as reported by 
de Beer et al.29.
Enzyme production — Cloning of the novel subtilases is described in Chapter 
3. For the production of proteases the recombinant plasmids pET28a(+)-TAQ and 
pBADMycHisA(NdeI)-DG were introduced in E. coli C43(DE3) and transformants 
were grown at 37°C for 16 h on Luria Bertani (LB) agar plates containing an 
antibiotic (50 µg/mL kanamycin or 100 µg/mL ampicillin). Colonies were 
inoculated into 5 mL of LB broth containing 0.1% glucose and antibiotic. After 
16 h of incubation at 37°C, 0.1 % (v/v) of the cultures were inoculated into 1 
L of Terrific Broth (12 g/L tryptone, 24 g/L yeast extract, 0.4% (v/v) glycerol, 
17 mM KH₂PO₄ and 72 mM K₂HPO₄) containing the appropriate antibiotic. For 
TaqSbt protease production the medium was supplemented with 1% glucose and 
protease synthesis was induced in the late log phase with 0.3 mM IPTG, followed 
by continued growth at 37ºC for 24 h with shaking at 200 rpm. In the case of 
DgSbt production, cultures were grown at 37ºC until they reached the late log 
phase, cooled down and induced at 17ºC with 0.25% L(+)-arabinose. Growth was 
continued for 48 h at 17ºC with shaking at 200 rpm. 
The protocol for protease processing and isolation was modified from the 
literature30 to a one-step protocol. Cells were harvested (4°C, 15 min, 6,000 
x g), suspended in 50 mM Hepes∙NaOH, pH 7.5, containing 10 mM CaCl₂, and 
disrupted by sonication. For autocatalytic processing and purification the total 
cell lysate was subjected to heat treatment for 12 h at 65ºC in the same Hepes 
buffer (Figure 2). During this step most proteins except for the protease are either 
degraded by proteolysis or precipitated by heat denaturation. After removal of 
denatured protein by centrifugation (4°C, 45 min, 30,000 x g), the supernatant 
was concentrated with an Amicon YM10 ultrafiltration membrane (Millipore, 
Billerica, MA, USA), followed by buffer exchange to 50 mM Hepes∙NaOH, pH 
7.5, containing 10 mM CaCl₂. Protein concentrations were determined by 
the Bradford assay using bovine serum albumin as a standard. The protocol 
yielded up to 25 mg of DgSbt protease or 50 mg of TaqSbt protease from a 
1 L culture. The processed proteins gave a single band of 28 kDa on an SDS-
polyacrylamide gel (estimated purity >80%). The proteins were stored at -80°C. 
Active subtilases were also isolated from the heat-treated centrifuged cell-free 
extract by precipitation with ammonium sulfate (70% sat. at 4°C, 30 min stirring 
at 4°C). The precipitate was collected by centrifugation (4°C, 15 min, 30 000 
x g), washed with 80% acetone to remove remaining lipophilic compounds, 
re-suspended in 20 mM Hepes∙NaOH, pH 7.5, containing 1 mM CaCl₂ and 
20% glycerol, and used for anhydrous enzyme preparation as described 
below. If required, glycerol was removed by exchanging the buffer on a HiPrep 
26/10 desalting column (GE Healthcare Bio-Sciences, Pittsburgh, PA, USA). 
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Preparation of anhydrous enzyme for synthesis reactions — Enzyme 
in 20 mM Hepes∙NaOH, pH 7.5, containing 1 mM CaCl₂ and supplemented with 
sucrose (10 mg/mL) as lyoprotectant, was used for lyophilization. Anhydrous 
enzyme samples were prepared using several dried solvents in the same way as 
for isopropanol31. Briefly, to obtain isopropanol-precipitated and rinsed enzyme 
preparations (IPREP), organic solvent was added to the enzyme solution in buffer 
(20 mM Hepes∙NaOH, pH 7.5, containing 1 mM CaCl₂ and 20% glycerol) to a ratio 
of 1:3, 1:6 or 1:9 (v/v, aq/solvent) until formation of a precipitate was observed. 
After vortexing, the precipitate was collected in a tabletop centrifuge (room 
temperature, 5,000 rpm, 5 min) and remaining liquid was removed. The pellet 
was twice suspended in the same organic solvent, followed by vortexing and 
centrifugation. Subsequent drying in a Speedvac at room temperature for 20 
min gave a white powder (IPRED) that was active when redissolved in buffer. The 
dry enzyme was stable for at least one month when stored at room temperature 
(20-25°C). The IPRED preparations could be easily suspended in dry solvents, 
without a strong tendency to aggregate. Anhydrous preparations of subtilisin A 
were obtained by precipitation with t-BuOH as described by Chen et al.32.
Active site titration with the irreversible serine protease inhibitor 
phenylmethanesulfonyl fluoride (PMSF) was used to determine the concentration 
of active enzyme present in enzyme samples. To 190 µL of PMSF solution of 
varying concentration (0-75 µM), prepared by mixing fresh 3 mM stock in ethanol 
and buffer (100 mM Hepes∙NaOH, pH 7.5, with 1 mM CaCl₂), 10 µL of enzyme 
solution (approx. 0.4 mg/mL) was added. The mixture was vortexed and incubated 
for 10 min at room temperature. The remaining activity was then measured in the 
standard amidolytic assay as described below. 
Enzyme characterization — Homology models of both subtilases were 
constructed with Yasara33 based on the aqualysin I structure (PDB: 4DZT, 98% 
sequence identity) for TaqSbt and based on proteinase K structure (PDB: 2B6N, 
59% sequence identity) for DgSbt. 
General proteolytic activities were measured at several temperatures by following 
the release of soluble sulfanilamide-azopeptides from azocasein in a UV/VIS 
spectrophotometer at 440 nm, as described previously34. Amidolytic activity was 
quantified by following the release of p-nitroaniline from the standard proteolytic 
substrate N-succinyl-Ala-Ala-Pro-Phe p-nitroanilide (N-suc-AAPF-pNA) at 40°C 
in 100 mM Hepes∙NaOH, pH 7.5, containing 1 mM CaCl₂, 10 % (v/v) DMSO and 
substrate (0.3-4 mM)34. Residual activities of heated samples were assayed after 
cooling. For thermostability measurements, the thermofluor method35 was applied 
as described in Chapter 4.
MALDI / TOF / TOF analysis — For mass spectrometry based protein 
identification, the samples of TaqSbt and DgSbt were analyzed by SDS-
PAGE. After Coomassie staining, bands corresponding to 28 kDa were excised, 
digested with trypsin as reported previously34, and analyzed by LC-MS. Mass 
spectrometry was carried out with a MALDI-TOF/TOF 4800 Proteomics Analyzer 
(Applied Biosystems, Foster City, CA, USA) in the m/z range 600-4000. Peptide 
identification was done using the program ProteinPilot 4.0 (ABsciex, Foster City, 
CA, USA) against UniProtKB/Swiss-Prot protein sequence database36 to which 
the sequences of trypsin and keratin were added. Trypsin specificity and default 
parameters were used for the search. 
For intact protein analysis, samples were prepared using the ultra-thin layer 
method for MALDI37 and mass spectra were recorded by MALDI-TOF on the 
Applied Bio-systems proteomics analyzer mentioned above, which was operated 
in linear positive ionization mode. Bovine serum albumin was used for calibration.
Enzymatic peptide synthesis — Tests to examine enzymatic synthesis of the 
dipeptide Cbz-Phe-Phe-NH₂ were carried out by mixing the IPRED suspension 
(10% w/v) in the desired anhydrous solvent or solvent/cosolvent mixture with the 
N-terminally protected acyl donor Cbz-Phe-OCam (50 mM) and the C-protected 
nucleophile H-Phe-NH₂ (1.5 equiv., 75 mM) in the same solvent and dried for 1 h 
over heat-activated 3Å crushed molecular sieves. Dry molecular sieves were also 
added to the reaction mixture (200 mg/mL, 0.1-0.2 mL), which was shaken for 
at least 24 h at 400 rpm at 60 or 80°C. Samples (20 µL) were taken at different 
times, quenched (0.5 mL of acetonitrile-water (3:1, v/v), 1% formic acid) and 
filtered before HPLC analysis.DMF tolerance was tested by performing enzymatic 
synthesis of Cbz-Phe-Phe-NH₂ as described above on 100 µL scale using IPRED 
enzyme preparations (10% w/v) containing 11 µM active TaqSbt and 25 µM active 
DgSbt subtilases, 25 mg/mL 3 Å molecular sieves and various concentrations of 
DMF (0-100% v/v). The mixtures were incubated at 60°C for 1 h, quenched (100 
µL DMSO and 0.5 mL acetonitrile-water (3:1, v/v), 1% formic acid solution), filtered 
and analyzed by HPLC-UV (220 nm, see below).
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Reaction conditions for establishing the substrate scope of DgSbt and 
TaqSbt in peptide synthesis were slight variations, as indicated in the text, of 
the following protocol for heptapeptide synthesis (Ac-Asp-Phe-Ser-Lys-
Leu-Ala-Phe-NH₂). To the TaqSbt or DgSbt IPRED preparation (110 mg), 
both 0.5 ml of water-free substrate solution mixture (20 mM acyl donor and 
30 mM nucleophile dissolved in DMF: acetonitrile: Et₃N (1:0.98:0.02)) and 
10 mg 3 Å molecular sieves were added. The reaction mixture was incubated 
for 24 h at 60°C, and samples (20 µL) were taken, quenched with DMSO (80 
µL), followed by a short centrifugation step to remove molecular sieves and 
enzyme. Conversions were estimated by HPLC-UV (220 nm, see below). 
Water content in reaction mixtures was determined by Karl-Fischer titration 
(702SM Titrino, Metrohm). Water content typically was 0.12-0.13%, which mostly 
originated from enzyme, irrespective of the use of fresh or stored dried enzyme.
Preparative scale bioconversions — Kinetic coupling of Z-Gly-Tyr-
OMe with H-Phe-NH₂ using DgSbt protease was performed as follows. To the 
Stenotrophomonas maltophilia amidase (PAM)38 reaction mixture containing 
N-protected acyl donor Z-Gly-Tyr-OMe (8 mmol) in acetonitrile (1.5 ml), 
C-terminally protected Phe-NH₂ (10 equiv. 80 mmol) was directly added, as well as 
90 mg IPREP (isopropanol rinsed enzyme precipitate) containing 4 mg of DgSbt 
and activated 3Å crushed molecular sieves (200 mg/ml). The reaction mixture was 
shaken at 400 rpm, 60°C. Samples were taken and quenched with DMSO (1:3, v/v). 
Reaction was stopped after 21 days. 
Kinetic coupling of Z-Gly-Tyr-OMe with H-Phe-NH₂ using TaqSbt protease was 
done as follows. In a parallel coupling reaction, to the purified N-protected acyl 
donor Z-Gly-Tyr-OMe (28 mmol) in acetonitrile (3 ml), C-terminally protected Phe-
NH₂ (10 equiv. 280 mmol) was added, followed by 35 mg IPREP enzyme preparation 
(2.2 mg of TaqSbt enzyme) and activated 3Å molecular sieves powder (100 mg/
ml). The reaction mixture was shaken at 400 rpm at 60oC. Samples were taken 
and quenched with DMSO (1:3 v/v). After 6 days the reaction was stopped and 
analyzed. Conversions were estimated by HPLC and further identified by LC/MS. 
HPLC and LC/MS — Peptide coupling reactions were analyzed by HPLC. The 
DMSO-formic acid-quenched samples (20 µL) were loaded on a Gemini-NX C18 
5µm 110A column (250x4.60 mm, Phenomenex). The solvent system consisted 
of 0.01% formic acid in water (eluent A) and 0.08% formic acid in acetonitrile 
(eluent B). The gradient program was: 0-13.5 min linear gradient from 10%-50% 
eluent B in A, continued for 6.5 min at 50% eluent B, then 10 min at 10% eluent 
B. Separation was carried out at 25°C, with detection at 220 nm. For dipeptide 
synthesis reactions, the response factors of starting material (Cbz-Phe-OCam), 
hydrolytic product (Cbz-Phe-OH) and synthetic product (Cbz-Phe-Phe-NH₂) 
were determined, and yields were calculated. In case of other synthetic reactions, 
where product was not available, the conversion was calculated based on the 
consumption of the acyl donor substrate and the formation of the hydrolytic 
product, where acyl donor and hydrolytic product were assumed to have similar 
response factors. The latter was confirmed by complete enzymatic hydrolysis of 
the model substrate Ac-Asp-Phe-Ser-Lys-Leu-OCam, which showed that the 
OCam group did not significantly contribute to absorbance at 220 nm. 
The identity of synthetic products was confirmed on an LC/MS ion-trap system 
(LCQ Fleet, Thermo Scientific Waltham, MA, USA). The quenched reaction mixture 
or collected HPLC peak was loaded on an Alltech C18 3µ column (3 µm, 100x4.6 
mm), with the same solvent system as for HPLC analysis. The elution gradient was 
as follows: 100% A for 2 min, 30 min linear to 40% B in A, followed by 5 min 40% B 
and 10 min 100% A, or alternatively applying 80% solvent B (for dipeptide analysis). 
Detection was at 220 nm and by ESI-MS operated in a positive ionization mode. 
We previously reported results of genome mining to obtain novel thermostable 
endoprotease homologs of subtilisin E34. Among the six active subtilases that were 
reported, TaqSbt from Thermus aquaticus Y51MC23 (subtilase ZP_03495941) 
and DgSbt originating from Deinococcus geothermalis (subtilase YP_604447) 
were functionally expressed in E. coli. 
TaqSbt has 98% sequence similarity to aqualysin I from Thermus aquaticus YT-
139 and 59% to commercial subtilase Rt41A (PreTaq) from Thermus sp.40, whereas 
identity of DgSbt to these protein sequences is 52% and 54%, respectively. 
Sequence alignment (Supplementary info) suggests that both enzymes are 
synthesized as a precursor consisting of an N-terminal signal sequence followed 
by a prodomain, the mature enzyme domain and an additional C-terminal 
Results and Discussion
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prodomain, which is characteristic for the aqualysin I-type subtilases41. The 
C-terminal prodomain used for translocation in the natural host can be omitted 
or will be removed autocatalytically during the heat treatment step through an 
intermolecular cleavage mechanism42.
According to Siezen’s classification of the subtilases43, TaqSbt and DgSbt are 
clustered in the proteinase K subgroup (Chapter 3, Figure 1). From sequence 
alignments (Figure 1) and homology models we observed that the overall 
subtilase fold and the topological position of the catalytic triad are conserved 
in TaqSbt (numbering from the first amino acid of the ORF; residues Asp166, 
His197, Ser349), and in DgSbt (numbering from the first amino acid of the ORF; 
Asp171, His203, Ser355), as is the oxyanion hole (residues Thr348, Ser349 and 
Asn284 in TaqSbt; Thr354, Ser355 and Asn290 in DgSbt). Two disulfide bonds 
(Cys194-Cys226; Cys290-Cys321) with aqualysin I topology44, as well as the 
two calcium binding sites of aqualysin I45,46 are predicted for the TaqSbt model. 
In the DgSbt model, disulfide bonds with identical topology are also predicted 
(Cys200-Cys232, Cys296-Cys327), but only one calcium binding site was found. 
Both proteases were successfully cloned and expressed in E. coli C43(DE3) using 
pBADMycHisA(NdeI) and pET28a+ vector systems. 
Heat-shock activation and purification could be applied to E. coli cell-free 
extract to quickly isolate the thermostable enzymes (Supplementary info). 
Proteolytic activity was detected and was isolated from the heat-treated 
extracts of E. coli cells. The yield of pure TaqSbt with the pET system reached 
50 mg/L of culture, with a specific activity of 12 U/mg in the amidolytic 
assay, whereas the pBAD system for DgSbt production gave 25 mg of 
pure protein per L of culture with a specific amidolytic activity of 0.5 U/mg. 
Subtilase identity was confirmed by mass spectrometry of the whole proteins and 
by mass analysis of tryptic segments prepared by digesting proteins extracted 
from a polyacrylamide gel. The processing sites could be assigned by inspecting 
protein sequence alignments and from molecular weights of intact protein and of 
tryptic segments determined by MALDI/TOF/TOF. The protein sequence analysis 
and the observed molecular weight of 28, 2492 ± 3 Da for TaqSbt correspond 
well to the calculated value of 28,2496 Da for the 296 amino acid long protein 
starting with Ala133 and ending with Ser428 (numbering from the first amino acid 
of the ORF), implying TaqSbt is one Gly residue shorter than aqualysin I (MW 
calc. 28,3067 Da) at the C-terminus. In addition, the determined molecular weight 
of 28,163 ± 3 Da in combination with the results of protein sequence analysis 
suggest that Ala133 (numbering from the first amino acid of the ORF) is the first 
amino acid and Gly417 the last amino acid of the mature DgSbt.  
The thermostability of both enzymes was investigated by measuring the loss of 
amidolytic activity during incubation of the purified enzyme at high temperatures 
(70, 80, 90 and 100°C) (Figure 1). Although DgSbt was stable at 70°C (t1/2 = 
2 h), TaqSbt is clearly the more thermostable protease, with only 30% loss of 
activity after 1 h incubation at 90°C. The biphasic nature of the curves suggests 
some protease heterogeneity, which could be due to differences in degree of 
disulfide bond formation or metal binding. In the azocasein assay, DgSbt showed 
at temperature optimum of 69°C and TaqSbt gave an optimum at 92°C (Figure 2). 
Thermostability was also measured by determining apparent melting temperatures 
(Tm,app) of PMSF-inhibited enzyme with the thermofluor method. The results 
showed that DgSbt had a Tm,app of 72°C, whereas the Tm,app of TaqSbt could not 
be measured because the upper temperature limit of 99°C appeared too low for 
full TaqSbt denaturation. The higher stabilities in the thermofluor assays are in 
agreement with autodigestion being inhibited by the presence of PMSF. 
Biochemical and catalytic properties
FIGU RE  1 . 
Thermostability of TaqSbt (Panel A) and DgSbt (Panel B). 
DgSbt was incubated at temperatures of 70°C (  ), 80°C (  ), 
or 90°C (  ), whereas TaqSbt was incubated at 90°C (  ) and 
100°C (Δ). The remaining activities at different times were 
determined after cooling to the standard assay temperature 
using N-suc-AAPF-pNA as the substrate. The reactions were 
performed in duplicate 
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FIGU RE  2 . 
Temperature profile of DgSbt and TaqSbt. The apparent temperature optimum was determined in 
duplicate using the azocasein assay. 
The optimum pH was determined at 40ºC using N-suc-AAPF-pNP as the substrate. 
TaqSbt appeared active over a broad pH range (6.5-9.5), whereas DgSbt showed 
maximal amidolytic activity at approximately pH 8.0 (data not shown). The steady-
state kinetic parameters of TaqSbt and DgSbt were also determined and compared 
with those of other subtilases (Table 1). The thermostable subtilases aqualysin I, 
TaqSbt and DgSbt catalyzed hydrolysis of N-suc-AAPF-pNA with lower efficiency 
at 40ºC than subtilisin A. Although the kcat values of thermostable proteases were 
in the same range, differences were found in substrate affinity, which was 2-6-









TaqSbt 25±3 0.62±0.16 47 this work
DgSbt 23±3 3.6±0.7 6.5 this work
Subtilisin A 551±62 1.1±0.3 489 34
Aqualysin I 33 1.2 27.5 46
TABLE  1 . 
Kinetic parameters of proteases. All reactions were performed in 100 mM 
Hepes∙NaOH buffer, pH 7.5, containing 1 mM CaCl₂ and 10% DMSO (v/v) at 40°C 
using N-suc-AAPF-pNA as the substrate.
The effects of various metal ions, protease inhibitors and detergents on TaqSbt 
and DgSbt activity were determined by measuring residual amidolytic activity after 
1 h preincubation under appropriate conditions (Table 2). The presence of Ca2+ 
slightly increased the activity of both subtilases. High concentrations of the metal 
chelator EDTA decreased the activity of TaqSbt to 68% and of DgSbt to 40%, 
confirming the need of Ca2+ ions for activity. The serine protease inhibitor PMSF 
abolished the activity of both proteases, confirming that both DgSbt and TaqSbt 
are serine proteases.
Salts, inhibitors, detergents Concentration
% Residual activitya
DgSbt TaqSbt
None - 100 100
Ca2+ 10 mM 120±13 128±1
SDS 10% (w/v) 78±3 98±3
CTAC 12.5% (w/v) 2.5±0.1 6.4±0.5
Tween 20 10% (w/v) 73±4 58±4
PMSF 10 mM 1.1±0.2 0.5±0.9
EDTA 20 mM 41±3 68±5
iodoacetamide 10 mM 108±9 130±5
DTT 10 mM 69±10 99±15
urea 6 M 149±11 178±16
Gdm•HCla 6 M 26±1 88±4
urea (70°C) 6 M 2.0±1.9 64±1
Gdm•HCl (70°C) 6 M 0.7±1.2 9.1±0.3
a  Gdm, guanidinium chloride
TABLE  2 . 
Effect of different agents on TaqSbt and DgSbt activity. Enzymes were incubated for 1 h at 
40°C or 70°C (where indicated) in 100 mM Hepes∙NaOH buffer, pH 7.5, supplemented with 
the agent indicated. Remaining activities were measured in triplicate with N-suc-AAPF-pNA 
as the substrate.
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Both subtilases tolerated the anionic surfactant SDS and non-ionic Tween 20 
with some loss of activity, whereas a cationic surfactant inactivated the enzymes. 
Surprisingly, incubation with 6 M urea at 40°C activated both proteases, whereas 
the more thermostable TaqSbt remained active after incubation with 6 M urea at 
70°C, showing the extreme stability of the enzyme. This exceptional stability of the 
novel subtilases in the presence of high concentrations of EDTA, SDS, Tween 20, 
urea and guanidinium hydrochloride (Gdm•HCl) as compared to the engineered 
chaophilic protease47 and hyperthermophilic protease Tk-SP48 makes the 
enzymes interesting candidates for application under harsh process conditions.
The possibility to use the proteases DgSbt and TaqSbt for biocatalytic peptide 
synthesis under anhydrous conditions was investigated. A possible method for 
the preparation of dry enzyme powder is precipitation of the enzyme from buffer 
by an organic solvent49.Initial synthetic reactions were carried out with enzyme 
precipitated with t-butanol as reported for subtilisin A32, and synthesis of Cbz-
Phe-Phe-NH₂ was tested with Cbz-Phe-OCam ester as acyl donor and a H-Phe-
NH₂ as nucleophile in 1:1.5 molar ratio in neat tetrahydrofuran (Figure 3). Prior 
to enzyme addition, the mixture was supplemented with dried molecular sieves 
(crushed, 3Å) to absorb any remaining water. Under these conditions, TaqSbt 
gave 1% of synthetic product and DgSbt 11% of synthetic product after 24 h 
incubation. Thus, the dried enzymes were active in peptide synthesis under 
anhydrous conditions, which prompted us to test various alternative solvents.



















FIGU RE  3 . 
Protease-catalysed dipeptide synthesis (Cbz-Phe-Phe-NH₂) in neat organic solvent. Starting 
materials include neat organic solvent, 50 mM acyl donor in the form of the carboxamidomethyl ester, 
nucleophile amide (75 mM) 3Å molecular sieves and water-free protease preparation. 
To examine which conditions are most suitable for dry enzyme preparation, several 
water-miscible organic solvents were used to prepare precipitated enzymes 
that were subsequently tested in synthetic reactions. In addition, enzyme co-
lyophilized with sucrose was tested (Table 5.3). Hydrolytic activities of enzyme 
preparations, apart from enzyme precipitated with acetonitrile, were preserved 
when the dried enzymes were resuspended in buffer and re-tested, suggesting 
that little irreversible denaturation or inactivation occurs and overall activity is well 
maintained during preparation of anhydrous enzyme. 
Enzyme Activity % after lyophilizationb Activity % after precipitation
acetonitrile t-butanol isopropanol acetone
Syn Hyd Syn Hyd Syn Hyd Syn Hyd Syn Hyd
DgSbt 29 86 15 33 49 66 82 72 44 100
TaqSbt 27 116 1 41 37 70 88 91 4 95
a  Synthetic activities (Syn) were determined for 
    Cbz-Phe-Phe-NH₂ 
synthesis in acetonitrile at 60°C as yields after 30 min. Retained 
hydrolytic activity (Hyd) was determined after redissolving the 
enzyme in buffer with the amidolytic assay. Hydrolytic activity of 
untreated enzyme was set to 100%. 
b  Lyophilization was performed after addition of 10 % sucrose  
   (wt/wt of protein).
TABLE  3 . 
Synthetic performance of  lyophilized enzyme and anhydrous 
enzyme preparations obtained by precipitation with organic 
solvents.a
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Synthetic activity was observed with all enzyme preparations, with conversions after 
30 min in the range of 1 to 88%, confirming that the novel thermostable proteases 
can act as efficient catalysts for peptide production in anhydrous media. Although 
acetonitrile was a good solvent for synthetic reactions (see below), it gave low 
activities when used for enzyme precipitation. Precipitation with acetone, which 
is often used for protein precipitation, also gave modest synthetic activity. The 
highest synthetic activity was observed with the isopropanol precipitated samples 
of the DgSbt and TaqSbt proteases, with product synthesis up to 88% (Table 
3). Drying of these isopropanol-precipitated and -rinsed enzyme preparations 
(IPREP) in a Speedvac gave a stable white powder (IPRED) that could be stored as 
active biocatalyst at room temperature. This enzyme was used in further peptide 
synthesis experiments. Water content of blank reactions (no enzyme) was 0.04%, 
and reactions with IPRED preparations added had 0.12-0.13% water, showing that 
lyophilized enzyme still contains some bound water.
High reaction temperatures can offer several advantages in enzymatic peptide 
synthesis, including better mass transfer, elevated substrate and product 
solubility, and increased reaction rates. Therefore, dipeptide synthesis in 
anhydrous acetonitrile was attempted at elevated temperature (60°C, 37°C for 
comparison), using IPREP as the catalyst. Again, highly efficient peptide synthesis 
was observed with TaqSbt and DgSbt when monitored in time. Reactions reached 
90-100% conversion to synthetic product, also at 60°C (Figure 4), which in case 
of TaqSbt and DgSbt gave higher conversion rates than at 37°C. Since TaqSbt 
has optimal activity at about 90°C, peptide synthesis was attempted also at 80°C; 
again full conversion to dipeptide product was observed. At 37°C, the initial rates 
of synthesis with the fastest thermostable subtilase (TaqSbt) were lower than with 
subtilisin A, but the activity of TaqSbt was enhanced 2.6-fold by increasing the 
temperature to 60°C. Although the activity was still lower than that of subtilisin 
A at 37°C, subtilisin A gave incomplete conversion which we attribute to thermal 
inactivation during the reaction (Figure 4).
FIGU RE  4 . 
Temperature effect on Cbz-Phe-Phe-NH2 synthesis using the 
thermostable TaqSbt and DgSbt enzymes and subtilisin A. Reactions 
were performed in acetonitrile at 37°C and at 60°C as indicated in 
Materials and Methods. Symbols: (     ), starting material Cbz-Phe-OCam; 
(   ), synthetic product Cbz-Phe-Phe amide; (   ), hydrolysis product 
Cbz-Phe-OH. 
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The solubility of a peptide in a solvent or buffer is mainly influenced by its polarity, 
which is determined by the amino acid composition, and its conformation. Highly 
hydrophobic solvents will decrease the solubility of peptides bearing polar groups. 
Peptide solubility can be enhanced by selecting appropriate solvent mixtures. For 
example, addition of the strongly solvating compound dimethylformamide (DMF) is 
known to increase solubility of peptides and DMF is used as a solvent in chemical 
solution- or solid-phase peptide synthesis. On the other hand, enzymes usually 
operate only in a restricted range of solvent hydrophobicities50,51. Therefore, the 
levels of hydrophilic solvents (logP < 2) in reaction mixtures are usually kept low. 
Moreover, in a recent study it was shown that stability of subtilisin A is inversely 
proportional to the amount of hydrophilic solvent in acetone/dodecane mixtures 
used in the reaction52.
To investigate the effect of different cosolvents on peptide synthesis with the 
isolated thermostable proteases, we measured peptide coupling in solvent 
mixtures containing 40% DMF and 60% (v/v) of different cosolvents with varying 
logP values (Table 4). Reactions were done at high temperature (60 and 80°C). In 
these experiments, the product yields measured after 1h and 24 h were highest in 
case of acetonitrile-DMF mixtures, and lowest in tetrahydrofuran -DMF mixtures. 
The synthetic yield was not correlated to the logP value of the solvent added to 
DMF. With both enzymes, the best conversions were obtained with DMF mixtures 
containing acetonitrile (polar aprotic) or a polar protic solvent such t-butanol. 
No difference in performance or cosolvent preference was observed when using 
either fresh IPREP or dry IPRED powder (not shown). 
40%DMF-
60% solvent
b.p. (°C) type logPb logPmixture
Synthetic product Cbz-Phe 
Phe-NH₂ formed (%)a
TaqSbt (80°C) DgSbt (60°C)
1h 24h 1h 24h
Acetonitrile 82 polar aprotic -0.39 -0.42 32 53 37 90
Dioxane 101 non polar -0.25 -0.35 3 11 21 76
Isopropanol 73 polar protic 0.17 -0.18 1 11 4 92
Tetrahydrofuran 66 polar aprotic 0.47 -0.04 2 3 7 45
t-Butanol 85 polar protic 0.58 0.02 12 47 26 91
Toluene 111 non polar 2.72 1.04 7 31 19 79
Hexane 69 non polar 3.76 1.54 8 14 11 54
TABLE  4 . 
Solvent screen for Cbz-Phe-Phe-amide synthesis. Reactions 
were done in the presence of 40% DMF  at 60 and 80°C in 
mixtures containing 10 wt% of IPREP, corresponding to final 
concentrations of 11µM for TaqSbt and 25 µM for DgSbt.
a  The amount  of hydrolytic product after 1 h reaction 
time was less than 3%, except in a reaction with TaqSbt in 
acetonitrile (17%). After 24 h, hydrolytic product was <10%, 
except in a reaction with DgSbt in tetrahydrofuran (13%) and 
TaqSbt in acetonitrile (32%).
b Calculated using Advanced Chemistry Development 
Software V11.02 (ACD/Labs).  For binary mixtures logPmixture 
values were calculated as reported by Laane et al.50.
Enzyme
DMF present (vol%)
0 20 40 60 80 100
Syn (%) Syn (%) Syn (%) Syn (%) Syn (%) Syn (%)
TaqSbt 50 37 21 8 2 0
DgSbt 52 25 24 12 6 1
TABLE  5 . 
DMF tolerance of TaqSbt and DgSbt during synthesis of 
Cbz-Phe-Phe-NH₂. Reactions were  performed  using 10 
wt% of IPRED  for 1 h at 60°C in an anhydrous acetonitrile-
DMF cosolvent system. In 0.1 mL reaction the concentrations 
of active enzyme were 11 µM (TaqSbt) and 25 µM (DgSbt). 
Enzymatic hydrolysis was less than 10%.
In subsequent experiments, DMF-acetonitrile cosolvent mixtures were used to 
optimize the amount of DMF, and several levels of DMF were tested (Table 5). 
Although DMF reduces the enzyme activity, a range of DMF concentrations at 
elevated temperature were reasonably well tolerated by the thermophilic subtilases 
and only at concentrations exceeding 80% DMF (v/v) enzymes lost all activity.
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In kinetically controlled peptide coupling reactions, the acyl donor is usually 
applied in an activated form, e.g. as an ester. A simple ester, such as a methyl 
ester, can be used with TaqSbt and DgSbt38, but the use of highly activated 
carbamoylmethyl (Cam, glycolamide) or trifluoroethyl (Tfe) esters can increase the 
rate of peptide synthesis53 and expand the protease substrate scope14. To test the 
activity with different peptides, several reactions were attempted on small scale 
(Table 6). The acyl donors tested included peptide Cam esters of variable size, a 
single amino acid, a dipeptide and a pentapeptide. As mentioned above, excellent 
conversions to the dipeptide product Cbz-Phe-Phe-NH₂ was obtained with Cbz-
Phe-OCam as acyl donor and Phe-NH₂ as the nucleophile (Figure 3). Hydrolysis 
was negligible. This well-accepted acyl donor with a hydrophobic residue of Phe at 
P1 position was below for reactions with sterically demanding nucleophiles. When 
more difficult acyl donors bearing a Pro or Ile at the P1 position were attempted, 
only TaqSbt gave reasonable conversion, with formation of the synthetic products 
Cbz-Val-Pro-Val-NH₂ and Cbz-Val-Ile-Val-NH₂ up to 35% and 18%, respectively 
(Table 6). The acyl donor Ac-Asp-Phe-Ser-Lys-Leu-OCam is insoluble in pure 
acetonitrile. By dissolving it in solvent mixture with 50% (v/v) DMF, which is tolerated 
by both subtilases, a coupling reaction was possible (Table 6). DgSbt was more 
efficient in these coupling reactions with long acyl donors and gave hexameric 
product, heptameric product and octameric product in yields of 55 – 88%. TaqSbt 
performed best in heptamer synthesis. The reactions with these long acyl donors 
were only possible in the presence of DMF as cosolvent, which solubilized the 
substrate. Inspired by the broad substrate scope with acyl donors, we tested 
nucleophiles that vary in size and composition, including a peptide with sterically 
demanding amino acids and a peptide containing a D-amino acid at P2’ position. 
Nucleophilic peptides with hydrophobic residues at P1´(Phe, Ala) or P2´ (Phe), 
such as H-Phe-NH₂ or H-Ala-Phe-NH₂, were well accepted (Tables 4 and 6). They 
could be coupled to a short acyl donor like Cbz-Phe-OCam with 82% formation of 
synthetic product (Cbz-Phe-Ala-Phe-NH₂) using DgSbt. The longer nucleophiles 
were also coupled to a pentameric acyl donor (Ac-Asp-Phe-Ser-Lys-Leu-OCam), 
and the highest conversion to octamer (84%) was observed in case of DgSbt.
Even a sterically hindered peptide with proline at P1’ was accepted as a 
nucleophile if used at high concentration. High concentrations of nucleophile 
may not only outcompete remaining water (if present), but also increase the rate 
of formation of the coupling product if deacylation is slow. TaqSbt catalyzed the 
reaction of Cbz-Phe-OCam as acyl donor with H Pro-NH₂ with good conversion 
to the dipeptide Cbz-Phe-Pro-NH₂ (Table 6). A nucleophile containing a D-amino 
acid at the P2´ position was accepted by both enzymes and could be coupled 
to Cbz-Phe-OCam resulting in tetrapeptide product, again in good yield. 
Substrate scope
































88 82 6 76 68 8
Cbz-Phe-
OCam (50)
































89 84 5 16 16 <1
Reaction conditions: a  40% DMF, 15 mg IPRED, 150 µL reaction, 100 mg/mL Å3 sieves, Et₃N 1.5 µL, 72 h; | b 
40% DMF, 15 mg IPRED, 150 µL reaction, 100 mg/mL Å3 sieves, Et₃N 1.5 µL, 72 h; | c  40% DMF, 15 mg IPRED, 
150 µL reaction, 100 mg/mL Å3 sieves, Et₃N 5 µL, 24 h; | d  40% DMF, 10 mg IPRED, 100 µL reaction, 45 mg/mL 
Å3 sieves, Et₃N 5 µL, 24 h; |e  40% DMF, 10 mg IPRED, 100 µL reaction, 50 mg/mL Å3 sieves, Et₃N 5 µL,  96 h for 
TaqSbt and 24 h for DgSbt; | f  20 mM acyl donor, 30 mM nucleophile, 50% DMF, 10  mg IPRED, 100 µL reaction, 
20 mg/mL Å3 sieves, Et3N 5 µL, 24 h; | 
g  50% DMF, 110  mg IPRED, 500 µL reaction, 20 mg/mL Å3 sieves, Et₃N 
5 µL, 24 h; h 50% DMF, 10  mg IPRED, 100 µL reaction, 20 mg/mL Å3 sieves, Et₃N 5 µL, 24 h.
* Chemical hydrolysis observed (up to 4%). 10 mg of TaqSbt IPRED contained 0.2 mg of active subtilase and  10 
mg of DgSbt IPRED contained 0.5 mg of active subtilase determined by active site titration
TABLE  6 . 
Substrate scope of TaqSbt and DgSbt subtilase.Peptide coupling 
reactions were performed at 60°C in neat organic solvent with DMF 
as indicated below.  
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In most cases, hydrolysis was very low, like in the progress curves shown in Figure 
5. Water content was determined and indeed appeared low. For example, in the 
heptamer (Ac-Asp-Phe-Ser-Lys-Leu-Ala-Phe-NH₂) synthesis reactions, the 
blank reaction (no enzyme) contained 0.04% water and an incubation mixture 
with enzyme added had 0.12-0.13% water, regardless of the enzyme identity. No 
difference in water content was observed between reactions with fresh DgSbt 
IPRED or an IPRED preparation that had been stored for 1 month. The ternary 
solvent system is too complex for calculating water activity using the equations 
reported by Bell et al.54, but aw may be in the range of 0.01-0.03. However, even 
when carefully applying dry conditions, including water removal by molecular sieves, 
some hydrolysis of the Cam ester acyl donor was still observed in case of the more 
challenging substrates, especially with a D-amino acid in the nucleophile (Table 
6). This could be due to water strongly bound to the enzyme and not absorbed 
by the molecular sieves, which may be released and react during the incubation. 
In another set of experiments, we further explored the applicability of novel 
thermostable  subtilases in N→C peptide elongation reaction in combination with 
an amidase from Stenotrophomonas maltophilia (PAM). In neat organic solvent, 
the amidase can perform C-terminal deprotection-reactivation by catalyzing the 
conversion of a peptide amide to the methyl ester. The latter can be coupled to 
as nucleophilic peptide or amino acid in a kinetically controlled reaction step 
catalyzed by a protease (Figure 5).
For this two-enzyme reaction, PAM was used first for the conversion of the acyl 
donor Cbz-Gly-Tyr-NH₂ to the methyl ester. Next, the two new thermostable 
proteases DgSbt and TaqSbt described here were used for coupling the obtained 
Z-Gly-Tyr-OMe with Phe-NH₂ as the nucleophile (Figure 5). The peptide amidase 
was removed by centrifugation after the first step, after which the protease DgSbt 
was added directly to the reaction mixture. Although the reaction rate was low, the 
conversion reached a notable value of 76%. In another experiment, enzymatically 
obtained and purified Z-Gly-Tyr-OMe was used as a substrate in a subsequent 
TaqSbt protease-catalysed coupling reaction yielding 77% of Z-Gly-Tyr-Phe-NH₂ 
product over 6 days. After removal of the protease from the reaction mixture, the 
product could in principle be used in another elongation step. 






































FIGU RE  5 . 
Peptide elongation in N→C direction using a 
combination of peptide amidase-catalysed 
deprotection/activation and protease-
catalysed transacylation. The conditions 
for step 1: PAM (0.35 mg, lyophilised with 
5.85 mg sucrose), acetonitrile (88%, v/v), 
methanol (10%, v/v), DMF (2%, v/v), Z-Gly-
Tyr-NH2(5 mM), 3Å molecular sieves (7 mg), 
5Å molecular sieves (3.5 mg), total volume 
0.25 mL, 30°C, 16. Conditions for protease 
catalysed coupling are described under 
Material and Methods.
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Two novel thermostable subtilases (DgSbt and TaqSbt) were biochemically 
characterized and their applicability in chemo-enzymatic peptide 
segment condensation reactions in neat organic solvents, especially 
at high temperatures and with DMF as cosolvent, was demonstrated. 
Such conditions can improve substrate solubility, minimize the need for 
side chain group protection, and increase reaction rates. A simple and 
convenient enzyme preparation method was developed (IPREP/IPRED). 
It combines three steps: enzyme precipitation by alcohol (isopropanol); 
water removal by solvent washing; and precipitation in the presence 
of a high salt concentration that may increase activity of the enzyme 
preparation in anhydrous organic solvent. Drying of IPREP enzyme 
to a powder (IPRED) that can be stored at room temperature makes it 
convenient for use on laboratory scale. We observed only 30% reduction 
in activity after 1 month storage at room temperature. As shown, such 
IPRED preparations were efficient in 1+1 and 1+2 peptide coupling. At 
increased DMF levels, we could use higher substrate concentrations and 
also perform coupling reactions with substrates that are poorly soluble in 
other commonly used solvents. 
DgSbt and TaqSbt subtilases expand the scope of enzymatic peptide 
coupling reactions in neat organic solvents to high-temperature and high-
DMF reaction conditions. Proline is accepted at the P1 and P1’ position, 
and also a D-amino acid is accepted in the S2’ pocket. We also found that 
the use of thermostable subtilases at high-temperature and high-DMF 
concentration makes it possible to synthesize an octapeptide. Higher 
conversions can possibly be achieved by reaction optimization by means 
of more precise control of water activity, by addition of larger amounts of 
enzyme, or by applying prolonged incubation times.
In addition, the DgSbt and TaqSbt subtilases was applied in combination 
with an amidase in a peptide elongation reaction in the N→C direction on 
preparative scale in neat organic solvent.
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Enzymes with tolerance towards organic solvents could expand the 
applicability of biocatalysts in various industrial processes. Here, we 
report recombinant production in E. coli, purification and biochemical 
characterization of a novel serine protease from Pseudomonas 
mendocina. This protease, termed PmSbt, exhibited remarkable stability 
in aqueous solutions containing DMSO and DMF up to 50% v/v and was 
applied in the chemoenzymatic synthesis of a hexameric segment of the 
PHM27 bioactive peptide. 
Peptides receive increasing attention as pharmaceuticals for the 
treatment of infectious diseases, metabolic disorders and for use in 
cancer therapy¹. Other applications are in the food and cosmetics 
industries2–5. The development of such applications requires efficient 
synthetic methods, for which chemoenzymatic peptide synthesis is 
frequently considered. Here, a protease is used in the synthetic direction 
for coupling of peptide segments that are obtained by solution- or solid-
phase peptide synthesis (SPPS). With enzymes as catalysts of peptide 
bond formation, the use of organic solvents may offer advantages such 
as increased substrate solubility, shift of thermodynamic equilibrium to 
the synthetic product, suppression of water-dependent side reactions, 
alternation of substrate specificity and enantioselectivity, and elimination 
of microbial contamination⁶. 
Accordingly, engineering of a DMF-tolerant protease has been 
attempted7,8 for application under conditions that improve substrate 
solubility and suppress undesired hydrolytic reactions. In addition, 
proteases that possess tolerance to organic solvents are of interest 
for application in peptide synthesis. Such enzymes can be found in 
extremophiles, i.e. thermophiles and halophiles, and in organic-solvent 
tolerant microorganisms⁹. Soil, waste water and marine habitats are rich 
sources of organic-solvent tolerant microorganisms10. Many of these 
microorganisms belong to the Pseudomonas and Bacillus genera and 
are able to grow in the presence of organic solvents6,11. Several organic-
solvent tolerant metalloproteases were isolated from these organisms and 
were used in peptide synthesis under thermodynamic control, including 
pseudolysin,12 originating from Pseudomonas aeruginosa PST-01, as well 
as recently described metalloproteases from Pseudomonas aeruginosa 
PT121 and Bacillus cereus WQ9-213,14. Unlike metalloproteases, the 
serine or cysteine proteases can synthesize peptides under kinetic 
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control, which enables higher conversion and requires less enzyme15. Organic-
solvent compatible serine or cysteine proteases could expand the applicability 
of chemoenzymatic peptide synthesis.
During genome mining of DNA sequence databases for genes encoding novel 
subtilisin-like peptidases, we identified a putative serine protease gene in 
Pseudomonas mendocina strain ymp16. The recombinant enzyme PmSbt showed 
remarkable stability in aqueous solutions containing DMSO and DMF. In this 
Chapter we describe the biochemical characterization of PmSbt, a novel serine 
protease originating from P. mendocina strain ymp that is stable in organic 
cosolvents. In addition, we performed bioinformatic studies to elucidate PmSbt 
properties, and we tested the enzyme in peptide synthesis. 
Materials and methods 
Chemicals and reagents — Bacterial strain and plasmids are listed in Chapter 
3. Peptide amides were obtained from Sigma-Aldrich and Bachem (Bubendorf, 
CH). C-terminal carbamoylmethyl (Cam, glycolamide) esters of peptides were 
synthesized by SPPS as reported by de Beer et al.17. Sypro Orange dye was from 
Molecular Probes (Life Technologies, Carlsbad, CA, USA).
Cloning of the genes — The gene coding for the YP_001189588 protein 
was amplified from genomic DNA of Pseudomonas mendocina ymp with a 
modified start codon to incorporate an NdeI restriction site and with the 
stop codon omitted and an HindIII restriction site introduced downstream 
the structural gene. Cloning is described in Chapter 3. The gene coding for 
the truncated protein PmSbtdel (PMdel) was constructed using PCR with a 
suitable reverse primer with Arg420 as the last amino acid before the linker 
and a hexahistidine tag and cloned as mentioned before. The variants PmSbt 
CxA (x=154, 247, 370, 414, 479, 490) with the respective cysteine replaced by 
an alanine were constructed using QuikChange (Stratagene). The sequences 
of recombinant plasmids were confirmed by sequencing of both strands 
(GATC, Konstanz, Germany).
Enzyme production — Plasmids pBADMycHisA(NdeI)-PM (AmpR) and 
pBADMycHisA(NdeI)-PMdel (AmpR) constructed for the recombinant protease 
production were transformed to E. coli C43(DE3). The transformants grown on 
Luria Bertani (LB) agar plates containing 50 µg/mL ampicillin at 37ºC for 16 h 
were picked and inoculated into 5 mL of LB broth containing 0.1% glucose and 
antibiotic. After 16 h of incubation at 37ºC, 0.1 % (v/v) of the precultures were 
inoculated to 1 liter of Terrific broth (12 g/l tryptone, 24 g/l yeast extract, 4 mL 
glycerol supplemented with 10% solution of 0.17 M KH₂PO₄ and 0.72 M K₂HPO₄) 
containing 50 µg/mL ampicillin and cells were grown until late log-phase at 37ºC. 
Protein synthesis was induced at 17ºC by addition of 0.25% (w/v) L-(+) arabinose. 
The cells were grown for another 72 h at 17ºC with constant shaking at 200 rpm. 
Proteolytic activity was detected in the growth medium after 72 h.
 
For isolating cellular enzymes, the cells were harvested (Beckman, JLA 10.5 
rotor, 4°C, 15 min, 6,000 x g), washed and suspended in buffer A (25 mM Hepes/
NaOH pH 7.5, 1 mM CaCl₂, 20% glycerol) and disrupted by sonication. After 
centrifugation (Beckman, JA-17rotor, 4°C, 45 min, 30, 000 x g) the clear cell-free 
extract was loaded onto HisTrap (GE Healthcare). The protein was eluted using 
125 mM imidazole. Active protein fractions were collected and concentrated with 
an Amicon YM10 ultrafiltration membrane (Millipore, Billerica, MA, USA) followed 
by buffer exchange to buffer A. 
Protease in the culture medium was precipitated using ammonium sulfate (70% 
sat. at 4°C) and incubated for 1 h at 4°C, followed by a centrifugation step 
(8,000 rpm, 30 min, JLA 9.1000, 4°C). The protein pellet was resuspended in 
buffer A and desalted on HiPrep column (GE Healthcare). The desalted fraction 
was loaded onto HisTrap column and protein was purified as described above. 
Alternatively, the culture medium carrying proteolytic activity was concentrated 
with an Amicon YM10 ultrafiltration membrane (Millipore, Billerica, MA, USA), 
followed by subsequent buffer exchange to buffer A and purification on the 
HisTrap column (GE Healthcare). Protein concentrations were determined by 
measuring absorption at 280 nm using bovine serum albumin (BSA) as standard, 
and purity was determined by SDS-PAGE analysis. For further analysis, active site 
concentrations were determined by PMSF titration as reported previously18. The 
processed pure protein was stored at -20 °C.
Enzyme assays — General proteolytic activity of E. coli cells carrying 
gene for PmSbt and its variants was tested on agar plates containing 1% 
skim milk and appropriate antibiotic. The proteolytic activity was observed as 
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a clear halo surrounding the colonies. Amidolytic activity was quantified by 
following the release of p-nitroaniline from the standard proteolytic substrate 
N-succinyl-Ala-Ala-Pro-Phe p-nitroanilide (N-suc-AAPF-pNA) at 40°C in 
100 mM Hepes∙NaOH, pH 7.5, containing 1 mM CaCl₂, 10 % (v/v) DMSO and 
substrate (0.1-5 mM)19. The pH optimum was determined in triplicate using 
phosphate buffer (0.1 M, pH range 5.7-8.0), Tris buffer (0.1M, pH 6.8-9.4) 
and carbonate buffer (0.1 M, pH 9.0-10.8) in amidolytic assays. The pH was 
adjusted at the assay temperature (40°C). In addition, azocasein assays 
were used for temperature optimum determination as reported previously19.
Enzyme secretion — To compare the production and processing of PmSbt 
and PmSbtdel, 500 mL cultures were grown as described above. Time-samples 
of medium and cells were taken and analyzed for enzymatic activity using an 
amidolytic assay, as described above.
Enzyme identification — To confirm the identity of isolated recombinant 
protease, a protein band of 40 kDa was excised from a 12% SDS gel and tryptic 
digestion was performed according to the manual InGelBlue (GBiosciences, Saint 
Louis, MO, USA). The samples were analyzed by LC-MS/MS. Peptide identification 
was carried out using the program Scaffold (Proteome Software, Portland, OR, 
USA) searching against the E. coli protein database to which the sequences of 
PmSbt and trypsin were added. Matches were accepted if they could be assigned 
with a confidence of identification probability higher than 99%. 
Homology modeling — The generation of structural models was carried out 
using the YASARA20 homology model building protocol21,22. In order to increase 
the quality, the obtained models were submitted to 500 picoseconds molecular 
dynamic refinement simulation using the protocol describe by Krieger et al.23
Molecular dynamics (MD) simulations — The generated homology model 
of the mature sequence was used as starting point for MD simulations. All MD 
simulations were performed with GROMACS 4.6.724 using the Amber ff99SB-
ILDN25 force field. The LINCS algorithm26 was used for bond-length constraining. 
The non-bonded pair list was updated every 10 fs. All other titratable amino acids 
were assigned their canonical state at physiological pH. In order to generate a 
well-equilibrated starting structure, the previously generated homology model was 
placed in a dodecahedral box with walls set at least 12 Å from the protein surface. 
Explicit SPC27 water molecules were added, a total of 150 mM NaCl (including 
neutralizing counter-ions) was added to simulate physiological salinity. Following 
steepest descents minimization (50,000 steps, or maximum force lower than 100 
kJ mol-1 nm-2), the system was equilibrated in two steps, with position restraints 
applied to the protein heavy atoms throughout. The first phase involved simulating 
for 1000 ps under a constant volume (NVT) ensemble, thus allowing complete 
“soaking” of the protein. The complete system was coupled to temperature baths, 
and temperature was maintained at 310 K using the V-rescale coupling method28. 
After NVT equilibration, 1000 ps of constant pressure (NPT) equilibration were 
performed, also using weak coupling27 to maintain pressure isotropically at 1.0 bar. 
Production simulations were run 6 times with randomly generated initial velocities 
and a run time of at least for 25 ns, of which the first 5 ns were excluded from analysis 
and considered extra equilibration time. The simulations were then individually 
analyzed, and their averaged properties are reported. Programs included in the 
GROMACS package as well as some in-house scripts were used to perform the 
analysis of the trajectories. The solvent-accessible surface area (SASA) was 
calculated using the method reported by Eisenhaber et al.29. The secondary 
structure was monitored with the DSSP30 protocol. Conformational flexibility was 
assessed by the determination of root mean square fluctuation (RMSF) values. 
Molecular graphics images were produced using the UCSF Chimera package31. 
Aggregation tendency prediction — In order to identify protein regions with 
putative tendency to aggregation, we used the TANGO32–34 algorithms. A range of 
0.0 to 1.0, with increments of 0.1 units of ionic strength was simulated.  
Thermostability determination — For thermostability measurements, the 
thermofluor method35 was applied as follows. To the PMSF-inhibited subtilase (20 
min incubation with 10 mM PMSF) in Hepes buffer (100 mM Hepes∙NaOH, pH 7.5, 
with 1 mM CaCl₂) 5 μL of 100 x Sypro Orange dye was added in a thin-wall 96-
well PCR plate (total volume 25 µl). For measuring the effect of disulfide bonds on 
thermostability DTT-pretreated samples were also prepared (25 min incubation at 
room temperature with 10 mM 1,4-dithio-D-threitol (DTT)). The plates were sealed 
with Optical-Quality Sealing Tape (Bio-Rad) and were heated for 10 min in a CFX 
96 real-time PCR system (Bio-Rad) from 20 to 99°C with a heating rate of 0.5°C/
min. Fluorescence changes were monitored with a CCD camera. The wavelengths 
for excitation and emission were 490 nm and 575 nm, respectively. 
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Effect of salts, inhibitors and detergent on PmSbt activity — The 
protease inhibitor phenylmethylsulfonyl fluoride (PMSF), EDTA, and iodoacetate 
were tested at concentrations of 10 mM. Metal ions were used as chloride salts of 
calcium, magnesium, cobalt, zinc and nickel. The enzyme was preincubated with 
the respective reagents dissolved in 100 mM Hepes∙NaOH, pH 7.5, 1 mM CaCl₂, 
20% (v/v) glycerol for 1 h at 40°C, and the residual activity was determined with 
the amidolytic assay in duplo. The activity in the same buffer without potential 
inhibitor added was set at 100%.
Effect of organic solvents on the enzyme stability — To 200 µL of 
enzyme in buffer (100 mM Hepes•NaOH, 1 mM CaCl₂, 20% glycerol, pH 7.5) an 
equal volume of organic solvent was added. The reaction mixtures were incubated 
in glass HPLC vials at 30°C with 90 rpm shaking for up to 14 days. The residual 
amidolytic activity was determined as described above using 1 mM of the 
substrate N-succ-AAPF-pNA. In two-phase systems, carefully withdrawn water 
phase were used. Stability was expressed as the residual activity compared to 
the control (enzyme in the buffer). 
Enzymatic peptide synthesis — Enzymatic synthesis of the hexapeptide 
Ac-Asp-Phe-Ser-Lys-Leu-Leu-NH₂ was carried out as follows. Substrate stock 
solutions were prepared in DMSO, i.e. 40 mM stock of acyl donors (Ac-Asp-Phe-
Ser-Lys-Leu-OCam and Ac-Asp-Phe-Ser-Lys-Leu-OH) (OCam stands for the 
glycolamide ester) and 160 mM nucleophile (H-Leu-NH₂) stock. The substrates 
and if required an internal standard (p-toluenesulfonic acid, 40 mM in DMSO) 
were added to the 1M Hepes buffer. pH 8.0. Final concentrations were 20 mM 
acyl donor, 80 mM nucleophile, 1 mM DTT, 1 mM internal standard (optional) 
and 50% (v/v) DMSO in 1M Hepes∙NaOH buffer, pH 8.0. The presence of DMSO 
was necessary to solubilize the acyl donor. Reactions were started by addition 
of enzyme (11 nM) and the mixtures were shaken for 48 h at 150 rpm at 30°C. 
Samples (25 µL) were taken at different times, quenched (75 µL of acetonitrile-
water (3:1, v/v), 1% formic acid) and analyzed with HPLC and LC-MS. 
HPLC and LC-MS — Peptide coupling reactions were analyzed by HPLC as 
reported in Chapter 5 with one difference. Elution was done with a gradient as 
follows: 0-23 min linear gradient from 10%-30% eluent B in A, continued for 7 
min to 50% eluent B, then 10 min at 10% eluent B. Separation was carried out at 
25°C, with detection at 220 nm. The identity of synthetic products was confirmed 
by LC-MS as reported in Chapter 5.
A novel putative protease gene was discovered by searching the genome of 
Pseudomonas mendocina ymp for sequences related to subtilisin E19. This putative 
protease (YP_001189588) shows 38% sequence similarity to the query sequence 
and was termed PmSbt. The encoded protein belongs to the subtilisin subfamily19 
according to Siezen’s classification36. Comparison to other subtilases suggests 
the presence of an N-terminal domain (encompassing residues Met1-Met127, 
Figure 1) and a relatively long C-terminal region (Ala128-Glu520) including the 
catalytic core with a catalytic triad (Ser350, His193, Asp157) (Figure 1).
Results and Discussion
Proteinase K             ------MRLS--VLL--S--LLPLALGAPAVEQRSEAAPLI-------------EARGEM 35
Aqualysin                ------MRKT--YWLMAL--FAVLVLGGCQMASRSDPTPTLAEAFWPKEAPVYGLDDPEA 50
proN-Tk-SP               APQKPAVRNV-----SQQKNYGLLTPGLFKKVQRM----------------------SWD 33
Proteolysin              ------MKKI---LLTLV--IAVLLLSGFAGVKSAEL--LF--------VSNSTTTNQED 39
PmSbt                    ------MQGFQRT----T-VLLLLLSAGWTPVQADEK-PSF--------AAQAQIAVDDQ 40
Thermitase               ------MKNKIIVFLSVL---SFIIGGFFF----N----TN--------TSSAETSSTDY 35
Carlsberg                -----MMRKK-SFWLGMLTAFMLVFTMAF----------SD--------SASAAQ-PAKN 35
Subtilisin E             ------MRSK-KLWISLLFALTLIFTMAF----------SN--------M-SVQAAGKSS 34
BPN’                     ------MRGK-KVWISLLFALALIFTMAF----------GS--------TSSAQAAGKSN 35
                                         ::               : 
Proteinase K             VANKYIVKFKEGSALSALDAAME---------K--ISG-------KPDHVYKNVFSGFAA 77
Aqualysin                IPGRYIVVFKKGKGQSLLQGGIT---------T--LQARLAPQGVVVTQAYTGALQGFAA 99
proN-Tk-SP               QEVSTIIMFDNQA------------------DKEKAVEILDFLGAKIKYNY-HIIPALAV 74
Proteolysin              PENEIIVGYKENTDVAVLS---------KQVEK-TTGAKLSR---KGLKNF-AVFKLPQG 85
PmSbt                    QSPRYIIKYKELAPSPMNQANQPQPLSAGRFESRAAQRLLSQAQVQPLMHL-DSQAASVA 99
Thermitase               VPNQLIVKFKQNASLSN----------VQSFHKSVGATVLSK---DDKLGF-EVVQFSKG 81
Carlsberg                VEKDYIVGFKSGVKTA------------SV-----KKDIIKESGGKVDKQF-RIINAAKA 77
Subtilisin E             TEKKYIVGFKQTMSAMS----------SAK-----KKDVISEKGGKVQKQF-KYVNAAAA 78
BPN’                     GEKKYIVGFKQTMSTMS----------AAK-----KKDVISEKGGKVQKQF-KYVDAASA 79
                                        *: :.. 
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Proteinase K             TLDENMVR-----------VLRAHPDVEYIEQDAVVTINAAQT-----N----------- 110
Aqualysin                EMAPQALE-----------AFRQSPDVEFIEADKVVRAWATQS-----P----------- 132
proN-Tk-SP               KIKVKDLLIIAGLMDTGYFGNAQLSGVQFIQEDYVVKVAVETE----------------- 117
Proteolysin              KAADVVMN-----------QLKNDPNVEYVEPNYIAHAFDVPNDTFFNPYQWNFYDYGMT 134
PmSbt                    HLSPAQLK-----------QLQANPAIDYIELDPRRYLMAE------Q------------ 130
Thermitase               T-VKEKIK-----------SYKNNPDVEYAEPNYYVHSFWTPNDPYYK------------ 117
Carlsberg                KLDKEALK-----------EVKNDPDVAYVEEDHVAHALAQ------T------------ 108
Subtilisin E             TLDEKAVK-----------ELKKDPSVAYVEEDHIAHEYAQ------S------------ 109
BPN’                     TLNEKAVK-----------ELKKDPSVAYVEEDHVAHAYAQ------S------------ 110
                                         :                   : : : : 
Proteinase K             -----APWGLARISSTSPGTSTYYYDESAGQGSCVYVIDTGIEAS-------HPEFEGRA 158
Aqualysin                -----APWGLDRIDQRDLPLSNSYTYTATGRGVNVYVIDTGIRTT-------HREFGGRA 180
proN-Tk-SP               ----GLDESAAQVMATNM-----WNLGYDGSGITIGIIDTGIDAS-------HPDLQGKV 161
Proteolysin              SNGYVSNYGIQAVS---A-----WN-ITKGAGVKVAIIDTGVAYENYGAYTKAPDLANTL 185
PmSbt                    -----VPYGIPMVQADLL-----PDNA--ISNMKVCIVDSGYDLG-------HQDLPSAG 171
Thermitase               -----NQYGLQKIQAPLA-----WDSQRSDSSIKVAIIDTGVQGS-------HPDLSSKV 160
Carlsberg                -----VPYGIPLIKADKV-----QAQGFKGANVKVAVLDTGIQAS-------HPDLNV-- 149
Subtilisin E             -----VPYGISQIKAPAL-----HSQGYTGSNVKVAVIDSGIDSS-------HPDLNV-- 150
BPN’                     -----VPYGVSQIKAPAL-----HSQGYTGSNVKVAVIDSGIDSS-------HPDLKV-- 151
                                           .   :                     : ::*:*             :: 
Proteinase K             QMVKTY------YYSSRDGNGHGTHCAGTVGSR-------TYGVAKKTQL--FGVKVLDD 203
Aqualysin                RVGYDAL-----GGNGQDCNGHGTHVAGTIGGV-------TYGVAKAVNL--YAVRVLDC 226
proN-Tk-SP               IGWVDF---VNGKTTPYDDNGHGTHVASIAAGTGAASNGKYKGMAPGAKL--VGIKVLNG 216
Proteolysin              FDTANAYDFVNNDTHANDDNSHGTHVAGTIAQSTNNGMG-AAGIAYQATI--LPIKVLDS 242
PmSbt                    ITGNDGYGSVNSGNWYEDGDGHGTHVAGTIAALGGNNLG-VVGVSPSGNLGLHIVKVFNN 230
Thermitase               IYGHDYV--DN-DNVSDDGNGHGTHCAGITGALTNNSVG-IAGVAPQTSI--YAVRVLDN 214
Carlsberg                VGGASFV--AGEAY-NTDGNGHGTHVAGTVAAL-DNTTG-VLGVAPSVSL--YAVKVLNS 202
Subtilisin E             RGGASFV--PSETNPYQDGSSHGTHVAGTIAAL-NNSIG-VLGVSPSASL--YAVKVLDS 204
BPN’                     AGGASMV--PSETNPFQDNNSHGTHVAGTVAAL-NNSIG-VLGVAPSASL--YAVKVLGA 205
                                                    * ..**** *.  .           *::    :    ::*: 
Proteinase K             NGSGQYS-TIIAGMDFVASDKNNRNCPKGVVASLSLGGGY----SSSVNSAAARLQSSGV 258
Aqualysin                NGSGSTS-GVIAGVDWVTRNH-----RRPAVANMSLGGGV----STALDNAVKNSIAAGV 276
proN-Tk-SP               QGSGSIS-DIINGVDWAVQNKDKY---GIKVINLSLGSSQSSDGTDSLSQAVNNAWDAGL 272
Proteolysin              EGSGTYD-AIANGIIWAADK-------GARVINMSLGGSS---GSTTLQNAIQYAYNKGV 291
PmSbt                    SGNWAYGSDLVMAIQQCRAA-------GSTVINMSLGGGA---SSVTERNAMDAAYQNGV 280
Thermitase               QGSGTLD-AVAQGIREAADS-------GAKVISLSLGAPN---GGTALQQAVQYAWNKGS 263
Carlsberg                SGSGTYS-GIVSGIEWATTN-------GMDVINMSLGGPS---GSTAMKQAVDNAYARGV 251
Subtilisin               TGSGQYS-WIINGIEWAISN-------NMDVINMSLGGPT---GSTALKTVVDKAVSSGI 253
BPN’                     DGSGQYS-WIINGIEWAIAN-------NMDVINMSLGGPS---GSAALKAAVDKAVASGV 254
                                    *.      :  .:                * .:***.        :   .       * 
Proteinase K             MVAVAAGNNNADARN---YSPASEPSVCTVGASDRYDRRSSFSNYGSVL------DIFGP 309
Aqualysin                VYAVAAGNDNANACN---YSPARVAEALTVGATTSSDARASFSNYGSCV------DLFAP 327
proN-Tk-SP               VVVVAAGNSGPN--KYTVGSPAAASKVITVGAVDKYDVITDFSSRGPTADNRLKPEVVAP 330
Proteolysin              VIVCASGNDRRS----TVSYPAAYTQCIAVGSTRFDGTRARYSNYGSAL------DIVAP 341
PmSbt                    LVVAAAGNSGTS----NLSYPASYDSVVSVAAVDSSGNHASFSQYNSQV------EVAAP 330
Thermitase               VIVAAAGNAGNT----KANYPAYYSEVIAVASTDQSDRKSSFSTYGSWV------DVAAP 313
Carlsberg                VVVAAAGNSGSSGNTNTIGYPAKYDSVIAVGAVDSNSNRASFSSVGAEL------EVMAP 305
Subtilisin E             VVAAAAGNEGSSGSTSTVGYPAKYPSTIAVGAVNSSNQRASFSSAGSEL------DVMAP 307
BPN’                     VVVAAAGNEGTSGSSSTVGYPGKYPSVIAVGAVDSSNQRASFSSVGPEL------DVMAP 308
                                   : . *:**            *.   .  :*.:       : :*            :: .*
Proteinase K             GTSILSTWIGG-----------------S--TRSISGTSMATPHVAGLAAYLMTLGKT-T 349
Aqualysin                GASIPSAWYTS-----------------DTATQTLNGTSMATPHVAGVAALYLEQNPSAT 370
proN-Tk-SP               GNWIIAARA----------SGTSMGQPINDYYTAAPGTAMATPHVAGIAALLLQAHPSWT 380
Proteolysin              GGDTSVDQNHDGYGDGILQQTFAEGSPTDFAYYFFQGTSMASPHVAGVAALVLSAHPTYT 401
PmSbt                   GVGVRSTLP-------------------GNRYASYNGTSMATPHVSALYALVWSQHRQCT 371
Thermitase              GSNIYSTYK-------------------GSTYQSLSGTSMATPHVAGVAALLAN--QGYS 352
Carlsberg               GAGVYSTYP-------------------TSTYATLNGTSMASPHVAGAAALILSKHPNLS 346
Subtilisin E            GVSIQSTLP-------------------GGTYGAYNGTSMATPHVAGAAALILSKHPTWT 348
BPN’                    GVSIQSTLP-------------------GNKYGAYNGTSMASPHVAGAAALILSKHPNWT 349
                                   *                                   **:**:***:.  *         :
Proteinase K             AASACRYIADTANKGD-----LSNIPFGTVNLLAYNNYQA-------------------- 384
Aqualysin                PASVASAILNGATTGR-----LSGIGSGSPNRLLYSLLSSGSGSTAPCTSCSYYTGSLSG 425
proN-Tk-SP               PDKVKTALIETADIVKPDEIADIAYGAGRVNAYKAAYYDNYAK----LTFTGYVS----N 432
Proteolysin              NEQVRTALQSTAKDLGT-AGWDKYYGYGLVNAYAAVNWTP-------------------- 440
PmSbt                    PAQIRRVVNITAEDRGT-PGRDPYYGYGIVKAKRASDLIAQRG----CDASD--G----R 420
Thermitase               NTQIRQIIESTTDK--I-SGTGTYWKNGRVNAYKAVQYAKQLQ----EKKAS-------- 397
Carlsberg                ASQVRNRLSSTATY--L--GSSFYYGKGLINVEAAAQ----------------------- 379
Subtilisin E             NAQVRDRLESTATY--L--GNSFYYGKGLINVQAAAQ----------------------- 381
BPN’                     NTQVRSSLENTTTK--L--GDSFYYGKGLINVQAAAQ----------------------- 382
                                     .    :   :               *  : 
Aqualysin                PGDYNFQPNGTYYYSPAGTHRAWLR----------------GPAGTDFDLYLWRWDGSRW 469
proN-Tk-SP               KGSQ------SHQFTISGA--GFV-----------TATLYWDNSGSDLDLYLYDPNGNQV 473
Proteolysin              ------------------------------------------------------------ 440
PmSbt                    NGEE------QTYPNLSGARGAWVRHSVAVPSGARRLTVRISGGSGDADL--YTHLGSQP 472
                                                                                               
Aqualysin                LTVGSSTGP----TSEESLSYSGTAGYYLWRIYAYSGSGMYEFWLQRP------------ 513
proN-Tk-SP               ---DYSYTAYY--GFEKVGYYNPTAGTWTIKVVSYSGSANYQVDVVSDGSLGQPSGGGSE 528
PmSbt                    TTSQWTCRPYLEGNQETCIQENPAAGTWHIGVRGYSSFSGVTLYWRYE------------ 520
                                                                                               
proN-Tk-SP               PSPSPSPEPTV 539
FIGU RE  1 . 
Sequence alignment of PmSbt and other subtilases made by ClustalO software. Subtilisin E (P01489), subtilisin 
BPN' (P00782), subtilisin Carlsberg (P00780), thermitase (P04072), proteolysin (YP_002247839), pro-N-Tk-SP 
(3AFG), aqualysin I (P08594), proteinase K (P06873).  The first amino acid of the mature domain is indicated in 
yellow and the C-terminal Arg420 of truncated PmSbtdel in cyan. If present, the first amino acid of the C-terminal 
prodomain is indicated in red. The active site residues are marked in grey (Ser350, His193, Asp157 in PmSbt).
In order to obtain structural information for this novel protease, a series of 
homology models were created using the YASARA suite and subsequently refined 
by MD simulations, as described in Materials and Methods (Table 1). Model 0 
was generated using only proN-Tk-SP as template (3AFG), while models 1 and 
2 correspond to the precursors of PmSbt and PmSbtdel, respectively, and were 
created using several templates. Structure of subtilisin E (PDB:1SCJ) contributed 
the most to the final hybrid model. Models 3 and 4 were made using predicted 
mature sequences of PmSbt (residues 128-520) and PmSbtdel (residues 128-
420) and several templates. Here, the structure of subtilisin Carlsberg complexed 
with the inhibitor greglin (PDB: 4GI3) was the main contributor to the final hybrid 
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model. The homology models provided reliable structural information for residues 
Ala33 to Arg420 of the full sequence of PmSbt (model 3), confirming the presence 
of signal sequence followed by a central domain with a typical subtilase fold 
structure. However, there were no suitable templates to generate a high quality 
model of the C-terminal domain which was predicted in model 0 to have a β-jelly 
roll structure, similar to what is observed in Tk-SP from T. kodakaraensis (PDB: 
3AFG)37. This C-terminal domain also shares some structural similarities to that of 
an unpublished domain that is part of a metalloprotease (PDB: 2LUW). A homology 
model obtained with the crystal structure 3AFG as template was of low quality 
(model 0) but still illustrates the domain organization of PmSbt (Figure 2). 
The N-terminal prodomain (residues 33-120), that is removed upon maturation 
showed a typical α/β organization with connections by short loop regions. 
Interestingly section 121-131 showed a rather extended loop that passes across 
the active site of the enzyme, thus allocating residues Ala128 and Met127 within 
reach of the catalytic triad (Figure 3, panel A). These structural observations 
indicate that autocatalytic cleavage of the N-terminal is most probable to happen 
at the peptide bond between residue Met127 and Ala128, thus leaving residue 
128 as the first residue of the mature sequence. After MD relaxation the catalytic 
Ser350 got into close proximity to the carboxylic group of Met127 (about 3.8 
Å, distance between Ser Oγ and Met127 carbonyl carbon), thus suggesting the 
possibility of a nucleophilic attack at this position, suggesting cleavage of the 
Met127-Ala128 peptide bond. 
The rest of the model (residues 131-420) shows the characteristic structural 




































FIGU RE  2 . 
Domain organization of the PmSbt. This 3D 
model was generated based on a single 
structural template (3AFG). The N-terminal 
domain (blue) is removed by autocatalytic 
processing. The C-terminal domain has 




































































TABLE  1 . 
Homology models of the P. mendocina proteases. The amino acid sequence range of the target subtilase 
variants, the selected highest contributing templates, the amino acid range with trustable structural information, 
and the number of models generated per run is shown. The best model was used for further structural analyses 
and is marked in red. Moreover, the accuracy of the generated models is reported by the use of Z-scores. The 
models were subjected to MD-simulations and improved Z-scores are reported. 
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Figure 3, panel B) interlaced by series of loops and turns with a total of 9 α-helix 
elements, and 2 antiparallel β-sheets towards the C-terminus. The acid member 
of the triad (Asp157) is located at the extreme of the β1 element, while the base 
(His193) and the nucleophile (Ser350) are located at the beginning of the α4 
and α7 elements, respectively (Figure 3, panels B and C). The active site triad 
resides are in a classical configuration, in which Asp157 makes a hydrogen 
bond with His193, and His193 forms a hydrogen bond with Ser350. Three loops 
seem to encompass the bedding of the substrate binding site; β3-α5 (Phe228-
Tyr236), β4-α6 (Leu259-Ser265), and β5-β6 (Ala286-Ser302) are depicted in 
Figure 3 (panel B and C, in green). These three loops showed high conformational 
flexibility; especially high RMSF values were observed for the loop connecting 
the structural elements β3-α5 (with RMSF values of around 2 Å), thus suggesting 
a great plasticity in the substrate-binding site (Figure 3). Although significant 
conformational flexibility is observed, the overall secondary structure of this 











































FIGU RE  3 . 
Structural organization of the Pseudomonas mendocina protease (PmSbt). Panel A shows the 
homology model generated for the full-sequence of PmSbt. The N-terminal domain is depicted in 
yellow. Segment 121-131 which passes across the active site is in green, while the predicted cleavage 
point (Met127) is shown as a green sphere. The catalytic triad residues are depicted with red spheres. 
The mature catalytic domain is depicted in grey, while the N-terminal domain is shown in yellow. 
Panel B shows a schematic representation of the secondary structure topology of the mature PmSbt, 
with α-helices shown as cylinders, β- strands as block-arrows, and loops and turns as lines. This 
organization was found in all the homology models generated. The approximate residue numbers of 
the structural elements, the location of the catalytic triad residues (in red font), and the location of the 
loops encompassing the substrate binding site (green lines) are indicated. Panel C shows a close-up 
of the active site of PmSbt. The catalytic triad residues are depicted in red and the loops surrounding 
the substrate-binding site are shown in green.
The model structure was inspected for potentially stabilizing features. Three 
disulfide bonds were predicted (Cys154-Cys247, Cys370-Cys414, Cys479-
Cys490). The first is in the catalytic core, the second, if present, may connect 
the catalytic domain and the C-terminal domain, whereas the third is predicted to 
be within the C-terminal domain (predicted β-jellyroll). The cysteines are missing 
in the C-terminal jellyroll domain of T. kodakaraensis subtilase Tk-SP, but on the 
other hand two calcium binding sites important for the Tk-SP thermostability were 
identified37. Sequence comparison reveals that four out of five residues forming 
calcium site 1 in Tk-SP are conserved in the PmSbt sequence (Asp461, Asp463, 
Leu461 and Glu488 (PmSbt numbering),  but the calcium site 2 of Tk-SP37 is not 
clearly conserved in PmSbt. On the other hand, two calcium binding sites with 
subtilisin E topology (Ca-site 1: Glu129, Asp166, Leu194, Asn197, Leu199, Val201; 
and Ca-site 2: Ala298, Tyr300, Val303 (PmSbt numbering) are conserved in the 
sequence of PmSbt.
The gene coding for PmSbt was PCR amplified and recombinantly expressed in 
E. coli with a hexahistidine tag fused to the C-terminus. In order to investigate the 
role of the extended C-terminal region, a truncated variant called PmSbtdel in 
which the C-terminal Arg420 just before the proposed jellyroll domain is fused to 
the hexahistidine tag was also constructed. The majority of the enzyme (85%) was 
found in the medium of E. coli cells expressing PmSbt, and only a small fraction 
could be isolated from the cell-free extract (15%). In contrast, the proteolytic 
activity of the truncated variant PmSbtdel was more equally distributed over 
cell-free extract and medium (59% and 41%, respectively), suggesting that the 
C-terminal domain also facilitates enzyme secretion in the E. coli host. Apparently, 
the C-terminal domain did not block processing of the protease precursor in E. 
coli since also the truncated variants showed proteolytic activity. 
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The C-terminal hexahistidine tag allowed purification of both PmSbt and PmSbtdel 
using IMAC chromatography. When isolated from the medium, the enzyme was 
precipitated with ammonium sulfate, resuspended in buffer, desalted and then 
applied onto His Trap column. Glycerol had to be added to the buffers (20% v/v) in 
order to solubilize the protein pellet after ammonium sulfate precipitation. Without 
that, the PmSbt and PmSbtdel enzymes showed a tendency to aggregate. Using 
the protocol described under Materials and Methods, 10 mg of purified PmSbt 
and 11 mg of PmSbtdel protein were isolated from 1 L of recombinant culture. MS 
performed on tryptic digests of the excised 40 kDa band of pure PmSbt and the 
33 kDa protein band of PmSbtdel subtilase confirmed their identity and suggested 
Ala128 as the first residue of the mature domain (Figure 4).
M Q G F Q R T T V L
S Q A Q V Q P L M H
D L G H Q D L P S A
V M A I Q Q C R A A
Y N S Q V E V A A P
K A K R A S D L I A
P Y L E G N Q E T C
L L L L S A G W T P
L D S Q A A S V A H
G I T G N D G Y G S
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G V G V R S T L P G
Q R G C D A S D G R
I Q E N P A A G T W
V Q A D E K P S F A
L S P A Q L K Q L Q
V N S G N W Y E D G
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N R Y A S Y N G T S
N G E E Q T Y P N L
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D P R R Y L M A E Q
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A L V W S Q H R Q C
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S G N W A Y G S D L
S S G N H A S F S Q
R D P Y Y G Y G I V
Q P T T S Q W T C R
PmSbt
12 exclusive unique peptides, 16 exclusive unique spectra, 21 total spectra, 162/520 amino acids (31% coverage)
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9 exclusive unique peptides, 10 exclusive unique spectra, 28 total spectra, 77/520 amino acids (15% coverage)






FIGU RE  4 . 
SDS-PAGE of purified PmSbtdel and PmSbt subtilases. M, marker; PageRuler Prestained 
Protein Ladder (ThermoFischer). The excised bands are indicated with a red arrow. Results 
of tryptic digestion of PmSbt 40 kDa (PM40B) excised band and PmSbtdel 35kDa 9(R35) 
excised band. Identification is performed by Scaffold software. Bottom: position of identified 
peptide segments after trypsin digestion in the prosequences of PmSbtand PmSbtdel 
proteases (in yellow). Residues in green indicate amino acids for which modifications were 
allowed by the software. 
To explore the aggregation behavior, we analyzed the sequence of 
PmSbt with the statistical mechanics algorithm TANGO32, which predicts 
aggregation-prone segments from sequence information. For PmSbt 10 
sequence segments with potential aggregation properties were detected. 
Three segments with low aggregation tendency (lower than 5%) were 
found: 197-205 (L1), 209-214 (L2), and 394-400 (L3). Four segments 
with medium aggregation tendency (aggregation between 5% - 50%) 
were identified: 240-245 (M1), 302-309 (M2), 378-383 (M3), and 507-517 
(M4). Three segments with high aggregation tendency (>50%) were found: 
7-20 (H0), 276-288 (H1), and 355-366 (H2). Segments H1 and H2 showed 
aggregation tendency values of above 90% (predicted percentage of 
aggregation for a fully solvent-exposed unfolded peptide) (Figure 
5a). Since these segments are likely responsible for the aggregation 
propensity we investigated their position in the structural model (Figure 
5b). Interestingly, H1 encompasses the end section of α5 and the complete 
β5, showing a very low solvent exposure and very low RMSF values for 
the residues with the highest aggregation tendency. However, the flanking 
reside Gly279, which shows an aggregation tendency of 10.3±0.16%, an 
RMSF value of 0.67±0.03 Å, and a solvent exposure value of 15.9±2.1%, 
could work as a trigger towards aggregation under specific conditions 
due to its partial solvent exposure and moderate flexibility (Figure 5C). On 
the other hand, aggregation prone segment H2 encompasses the majority 
of helix α7 and shows a higher flexibility than H1. This suggests a more 
important role of H2 in the aggregation. Residue Leu362, which shows an 
aggregation tendency of 93.4±0.18%, with an RMSF value of 1.04±0.15 
Å and a solvent exposure value of 12.0±3.72%, could be the main trigger 
for the formation of aggregates (Figure 5D).
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FIGU RE  5 . 
Aggregation tendency prediction for the P. mendocina protease (PmSbt). Panel A shows the results 
obtained from the TANGO algorithm. The catalytic domain of PmSbt (residue 128-420) is depicted 
in a grey box. Panel B shows the 3D location of the segments with potential aggregation tendencies. 
Segments with low aggregation tendency are depicted in yellow, medium tendency in orange and high 
tendency in red. Also, the location of the catalytic triad residues is shown. Moreover, the conformational 
flexibility of the system as observed in MD simulations is depicted in “worm” tube representation, 
where large diameter tubes indicate high flexibility and vice versa. The conformational flexibility was 
estimated based on the RMSF calculation of each residue. Panels C and D show the aggregation 
tendency [%], solvent exposure [%] and RMSF [Å] for the segments H1 and H2, respectively. The error 
lines indicate the standard deviation upon 6 independent MD simulations.
Further biochemical characterization of the isolated enzymes indicates 46°C 
as optimal temperature of PmSbt with azocasein as the substrate (Figure 6). 
The apparent melting temperatures (Tm,app) as determined by the thermofluor 
method were 54.5 ºC and 53.3 ºC for PmSbt and PmSbtdel, respectively, implying 
that deletion of the C-terminal domain only slightly decreased thermostability. The 
optimum pH in the amidolytic assay was 8.0 for PmSbt subtilase. 
FIGU RE  6 . 
Temperature and pH profile of PmSbt. Panel A: 
temperature profile determined in triplicate using 
the azocasein assay. Panel B: pH curve determined 
in triplicate using phosphate buffer (0.1 M, pH range 
5.7-8.0), Tris buffer (0.1M, pH 6.8-9.4) and carbonate 
buffer (0.1 M, pH 9.0-10.8) in the amidolytic assay. 
As mentioned earlier, many organic-solvent tolerant enzymes (lipases, esterases) and 
metalloproteases originate from Pseudomonas genera⁶. To examine the tolerance of 
the PmSbt protease to organic cosolvents, a set of 20 cosolvents with varying logP 
values was used in 50% (v/v) concentration (Table 2). As expected, hydrophobic 
solvents in a two-phase system (logP>2) did not inhibit the protease as determined 
in amidolytic assays. Hydrophilic solvents (logP<2) caused inactivation within 5 days 
(acetonitrile, THF, chloroform, alcohols). Exposure to acetone, isopropanol and dioxane 
caused 70% loss of activity in 5 days. Longer incubation resulted in complete loss of 
activity. Surprisingly, PmSbt exhibited remarkable stability in the presence of DMSO 
and DMF as cosolvents (50% v/v) for up to 14 days. Also dichloromethane appeared 
well tolerated. A similar behavior was observed with PmSbt and the truncated enzyme 
PmSbtdel when activity was assayed using azocasein as the substrate (data not shown). 
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logP Solvent Solvent type Solvent system
Residual activity
day 5 day 14
-1.412 dimethylsulfoxide polar aprotic cosolvent 0.81 0.92
-1.362 ethane-1,2-diol polar protic two-phase ND 0.55
-0.829 N.N-dimethyl formamide polar aprotic cosolvent 0.52 0.47
-0.69 methanol polar protic cosolvent 0.07 0.01
-0.334 acetonitrile polar aprotic cosolvent 0.00 0.00
-0.255 1,4-dioxane nonpolar cosolvent 0.25 0.06
-0.18 ethanol polar protic cosolvent 0.08 0.00
-0.042 acetone polar aprotic cosolvent 0.24 0.05
0.173 propan-2-ol polar protic cosolvent 0.27 0.05
0.329 propanol polar protic cosolvent 0.00 0.00
0.473 tetrahydrofuran polar aprotic cosolvent 0.00 0.00
1.405 dichloromethane slightly polar two-phase 0.43 0.39
1.935 chloroform slightly polar two-phase 0.01 0.00
2.177 benzene nonpolar two-phase 0.67 0.54
2.72 toluene nonpolar two-phase 0.70 0.62
3.163 cyclohexane nonpolar two-phase 0.68 0.62
3.764 hexane nonpolar two-phase 0.64 0.62
4.783 octane nonpolar two-phase 0.71 0.62
5.802 decane nonpolar two-phase 0.68 0.22
6.821 dodecane nonpolar two-phase 0.78 0.62
buffer none none 0.91 0.81
TABLE  2 . 
Effect of organic solvents on PmSbt stability. The enzyme was incubated with 50% (v/v) 
cosolvent and 10% (v/v) glycerol. The stability was determined as the remaining activity 
relative to the control (enzyme in buffer) using the amidolytic assay as described in Materials 






-1] Km [mM] kcat/Km [mM
-1 s-1] kcat [s
-1] Km [mM] kcat/Km [mM
-1 s-1]
PmSbt 10.5±1.4 2.98±0.73 3.5 19.8±4.3 7.4±2.2 2.7 this work
PmSbtdel 8.4±3 0.99±0.24 8.5 ND ND ND this work
Subtilisin A 551±62 1.1±0.3 489 40±3 1.57±0.25 23 19
TABLE  3 . 
Kinetic parameters of proteases. All reactions were 
performed in 100 mM Hepes∙NaOH buffer, pH 7.5, 
containing 1 mM CaCl₂ and 10% DMSO (v/v) at 40°C 
using N-suc-AAPF-pNA as the substrate. Where 
indicated the reaction was supplemented with 10 mM 
DTT.
Next, the effects of various metal ions, protease inhibitors and detergents 
on PmSbt activity were determined by measuring residual amidolytic 
activity after 1 h preincubation under appropriate conditions (Table 4). 
The serine protease inhibitor PMSF abolished the activity of protease, 
confirming that PmSbt belongs to the serine protease class. In addition, 
The organic solvent tolerance could make the PmSbt enzyme a valuable 
protease when substrate solubility needs to be increased by cosolvent 
addition. In order to compare the PmSbt enzyme with other subtilases, 
the steady-state kinetic parameters of PmSbt and PmSbtdel were 
determined (Table 3) using the standard amidolytic substrate. The Km 
for this substrate is high. With addition of thiol-reducing agent DTT (10 
mM), both the Km and the kcat of PmSbt for N-suc-AAPF-pNA increased, 
resulting in lower overall enzyme efficiency as compared to the reaction 
without DTT addition. In case of PmSbtdel with the truncated C-terminus, 
the enzyme is saturated with substrate at lower concentrations. Under 
these conditions subtilases PmSbt and PmSbtdel catalyzed hydrolysis of 
N-suc-AAPF-pNA with far lower efficiency than subtilisin A.
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the metal chelator EDTA strongly reduced PmSbt activity suggesting 
a crucial role of the predicted metal ion binding site (see text above) 
for enzyme integrity or activity. However, not every bivalent cation was 
accepted; by addition of Ca2+ ions the activity was doubled, as observed 
for proteolysin (Chapter 4). On contrary, the addition of Ni2+ and Co2+ 
proved to be deleterious for the enzymatic activity. 
TABLE  4 . 
Effect of different agents on PmSbt activity.  Enzymes were incubated for 1 h at 40°C in 
100 mM Hepes∙NaOH buffer, pH 7.5, supplemented with the agent indicated. Remaining 
activities were measured in triplicate with N-suc-AAPF-pNA as the substrate..




Ca2+ 10 mM 218±6
Ni2+ 10 mM 1.6±2.1
Co2+ 10 mM 1.4±1.0
SDS (sodium dodecyl sulfate) 10% (w/v) 0.1±0.1
cetyl trimethylammonium chloride 12.5% (w/v) 0.4±0.2
Tween 20 10% (w/v) 281±11
PMSF 10 mM 0.1±0.1
EDTA 10 mM 1.5±0.2
iodoacetamide 10 mM 170±2
DTT 10 mM 137±5
urea 6 M 0.2±0.3
guanidinium chloride 6 M 0.5±0.6
Mutation
Disrupted disulfide bond 
suggested by the model
Proteolytic activity 
on 1% skim milk plate
Proteolytic activity in liquid culture, U/mL
medium CFE extract
Cys154Ala Cys154-Cys247 - NA NA
Cys247Ala - NA NA
Cys370Ala Cys370-Cys414 - NA NA
Cys414Ala - NA NA
Cys479Ala Cys479-Cys490 + 1.2 0.4
Cys490Ala + 0.5 0.3
TABLE  5 . 
Alanine scan of putative disulfide bond forming 
cysteines. Proteolytic activities of the mutants was 
tested by plating on a skim-milk plates, and in liquid 
culture using the amidolytic assay described in 
Materials and Methods.
Another activator was the nonionic detergent Tween 20 (2.8-fold increase 
in activity). The ionic detergents and high concentrations of urea or 
guanidinium chloride (6M) were not tolerated by the PmSbt subtilase. 
Iodoacetamide, an irreversible inhibitor of cysteine peptidases, did not 
have an inhibitory role; in contrast, it exhibited a positive effect on activity 
as did DTT (dithiothreithol) which disrupts disulfide bonds. The effect of 
DTT and iodoacetamide on the activity was higher for PmSbt than for the 
other subtilases reported in this thesis which prompted us to examine 
sulfhydryl groups and potential disulfide bonds.
As described above, inspection of the sequence and the structural model 
identified six cysteines that may form disulfide bonds in PmSbt subtilase. 
PmSbt CysxAla variants (x=154,247,370,414,479,490) were tested for 
functional expression using a skim milk plate assay. The activity of the 
variants was further quantified in a culture medium using amidolytic 
substrate N-succ-AAPF-pNA (Table 5). 
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By disrupting the Cys154-Cys247 and Cys370-Cys414 bonds in the catalytic 
domain, the functional expression of the PmSbt subtilase was impaired. On the 
other hand, the Cys479-Cys490 bond predicted in the C-terminal β-jellyroll domain 
could be disrupted without deleterious effect on enzyme expression and activity.
One of the applications of subtilases is chemoenzymatic peptide synthesis. The 
subtilase PmSbt was tested in the synthesis of the hexameric segment of the 
bioactive human peptide PHM27(9-14), a potent agonist of the human calcitonin 
receptor38. Enzymatic synthesis of the hexapeptide Ac-Asp-Phe-Ser-Lys-Leu-
Leu-NH₂ was attempted out by mixing activated acyl donor Ac-Asp-Phe-Ser-
Lys-Leu-OCam and nucleophile H-Leu-NH2, both dissolved in 50% (v/v) DMSO 
in buffer of pH 8. Samples were analyzed by LC-MS, which revealed formation of 
hydrolytic product Ac-Asp-Phe-Ser-Lys-Leu-OH (retention time 16.3 min, m/z 
(ESI+)=651.7, [M+H]+ calcd. for C30H47N6O10+ = 651.72). Surprisingly, this hydrolysis 
was was followed by peptide synthesis as shown by the formation of synthetic 
product, which was identified by LC-MS as the expected Ac-Asp-Phe-Ser-
Lys-Leu-Leu-NH₂ (retention time 18.8 min, m/z (ESI+)=763.9, [M+H]+ calcd. for 
C36H59N8O10+ = 763.89). This indicates that thermodynamically controlled peptide 
coupling occurred after the initial hydrolysis reaction, which was kinetically 
preferred: ester hydrolysis occurred fast and initially within 20 min all ester was 
hydrolyzed to acid (Figure 7). After 48 h, in the presence of 50% DMSO, 60% of 
the acyl donor was converted to synthetic product. Thus, under these conditions 
the overall equilibrium favored coupling product over free peptide segments, and 
PmSbt efficiently catalyzed the coupling reaction.
FIGU RE  7. 
Chemoenzymatic synthesis of the bioactive 
human peptide PHM27 (9-14) segment 
by PmSbt subtilase. The reaction was 
performed in a 50% (v/v) DMSO-buffer 
mixture at 30°C using a Cam ester as 
activated acyl donor (Ac-Asp-Phe-Ser-
Lys-Leu-OCam, 20 mM) and H-Leu-NH₂ 
(80 mM) as the nucleophile. Starting OCam 
ester (x), hydrolytic byproduct (Ac-Asp-Phe-
Ser-Lys-Leu-OH, squares), product (Ac-
Asp-Phe-Ser-Lys-Leu-Leu-NH₂, triangles) 
and conversion (diamonds) were followed 
by HPLC analysis of time course samples.
Peptide synthesis under thermodynamic control was further tested using Ac-Asp-
Phe-Ser-Lys-Leu-OH as acyl donor and leucine amide as the nucleophile. The 
synthesis was performed both in the presence of 50% (v/v) DMSO and with 50% 
DMF as the cosolvents and samples were analyzed by LC-MS After 48 h 67% 
conversion to the coupling product mentioned above was achieved by PmSbt in 
both cases.  Peptide-coupling under thermodynamic control was reported also 
for the serine protease trypsin in reactions containing 50% DMF (v/v), producing 
α-melanocyte stimulating hormone in an 8+5 coupling in 28% yield after 48 h39. 
Often, in thermodynamically controlled enzymatic peptide couplings with 
metalloproteases (i.e. thermolysin) the product is precipitated in order to shift the 
equilibrium towards synthesis. Here, we could shift the equilibrium to the synthetic 
product (67% conversion) by adding cosolvent in 50% (v/v) ratio, without the 
need for product precipitation. However, in reactions with prolonged reaction 
times (> 24 h) a byproduct was observed close to the synthetic product in the 
HPLC elution profile. Mass spectrometry analysis suggested both correspond to 
the expected synthetic product; one component may be C-terminally deamidated 
coupled peptide. 
Although chemoenzymatic peptide synthesis under kinetic control is faster 
and gives higher yields than thermodynamically controlled peptide synthesis, it 
requires activated acyl donors that need to be synthesized solid- or solution-phase 
chemical synthesis to attach the activating and protecting groups. In contrast, 
peptides used in thermodynamic coupling do not require an activating C-terminal 
group and can be produced otherwise (e.g. by fermentation). In that case, the 
N-terminal protective group can be enzymatically incorporated (acylase, peptide 
deformylase). As shown here, by using enzyme that tolerate high amounts of 
cosolvents, the reaction equilibrium can be shifted toward the synthetic product side.
In conclusion, we report the biochemical characterization of a subtilisin E 
homologue from Pseudomonas mendocina strain ymp. The enzyme was produced 
in E. coli and isolated from the culture medium by His-tag affinity chromatography. 
The purified subtilase was remarkably stable in the presence of cosolvents such 
as DMF and DMSO present at levels of up to 50% (v/v). Compared to subtilisin 
E, PmSbt, carries an additional C-terminal domain (predicted β-jellyroll), which 
appeared of minor importance for stability, unlike in the case of the protease 
from T. kodakaraensis37. Deletion of the C-terminal domain impaired secretion 
to the medium, but did not significantly affect activity. Homology modeling 
suggested the presence of 3 disulfide bonds (Cys154-Cys247, Cys370-Cys414, 
Cys479-Cys490), of which only Cys479-Cys490 in the C-terminal domain could 
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be removed by Cys→Ala mutagenesis without disturbing enzyme production. The 
enzyme exhibited a tendency to aggregate. The predicted aggregation tendency 
of regions H1 (276-288) and H2 (355-366) may contributed to this and can 
therefore serve as a target for mutagenesis aimed at reducing PmSbt aggregation.
In chemoenzymatic peptide synthesis the addition of cosolvents such as DMSO 
or DMF can increase substrate solubility and shift the reaction equilibrium towards 
peptide synthesis, allowing thermodynamically-controlled synthesis if the coupling 
enzymes remain sufficiently active40. The robustness of PmSbt made it possible to 
use this enzyme for peptide synthesis in the presence of 50% cosolvent. When 
the activated pentapeptide (Ac-Asp-Phe-Ser-Lys-Leu-OCam, 20 mM) was used 
as the acyl donor and Leu NH₂ (80 mM) as the nucleophile in the presence of 
50% DMSO or DMF, the enzyme showed a strong kinetic preference for water as 
nucleophile, resulting in swift hydrolysis of the activated acyl donor. However, due 
to the equilibrium of the overall reaction, prolonged incubation led to formation of 
coupled product. The same coupling product was indeed obtained in reactions of 
the unactivated pentameric acyl donor and Leu NH₂ as the nucleophile reaching 
conversion of 67% after 48 h. These initial results suggest that the P. mendocina 
protease may be useful for coupling non-activated peptides by thermodynamic 
control. The industrial applicability will depend on substrate scope and possibilities 
to optimize enzyme production. 
Acknowledgments 
This project is part of the Integration of Biosynthesis and Organic Synthesis program (IBOS-2; project 
053.63.014), funded by The Netherlands Organization for Scientific Research (NWO) and Advanced 
Chemical Technologies for Sustainability (ACTS). 
Author contribution 
AT performed experimental work, MFM performed bioinformatic and molecular modeling studies, MO 
performed MS analysis, TN synthesized the substrates, PJLMQ and DBJ supervised the work. AT, MFM 
and DBJ wrote the paper.
References 
01 — Thundimadathil, J. Cancer treatment using peptides: current therapies 
and future prospects. J. Amino Acids 2012, 967347 (2012).
02 — Thayer, A. Improving peptides. Chem. Eng. News 89, 13–20 (2011).
03 — Thayer, A. M. Making peptides at large scale. 
Chem. Eng. News 89, 9–12 (2011).
04 — Lax, R. The future of peptide development in the pharmaceutical 
industry. PharManufacturing Int. Pept. Rev. 10–15 (2010).
05 — Mine, Y., Li-Chan, E. & Jiang, B. Bioactive proteins and peptides 
as functional foods and nutraceuticals. (eds. Mine,Y., Li-
Chan,E. & Jiang, B.),Wiley-Blackwell, Oxford, UK, (2010).
06 — Doukyu, N. & Ogino, H. Organic solvent-tolerant 
enzymes. Biochem. Eng. J. 48, 270–282 (2010).
07 — Wong, C.-H., Chen, S., Hennen, W. J., Bibbs, J. A., Wang, Y., Liu, J. L., 
Pantoliano, M. W., Whitlow, M. & Bryan, P. N. Enzymes in Organic Synthesis : 
Use of subtilisin and a highly stable mutant derived from multiple 
site-specific mutations. J. Am. Chem. Soc. 112, 945–953 (1990).
08 — Economou, C., Chen, K. & Arnold, F. H. Random mutagenesis to 
enhance the activity of subtilisin in organic solvents: Characterization 
of Q103R subtilisin E. Biotechnol. Bioeng. 39, 658–662 (1992).
09 — Ogino, H. & Ishikawa, H. Enzymes which are stable in the presence 
of organic solvents. J. Biosci. Bioeng. 91, 109–16 (2001).
10 — Sardessai, Y. N. & Bhosle, S. Industrial potential of organic solvent 
tolerant bacteria. Biotechnol. Prog. 20, 655–660 (2004).
11 — Gupta, A. & Khare, S. K. Enzymes from solvent-tolerant 
microbes: useful biocatalysts for non-aqueous enzymology. 
Crit. Rev. Biotechnol. 29, 44–54 (2009).
12 — Ogino, H., Yasui, K., Shiotani, T., Ishihara, T. & Ishikawa, H. Organic 
solvent-tolerant bacterium which secretes an organic solvent-stable 
proteolytic enzyme. Appl. Environ. Microbiol. 61, 4258–62 (1995).
13 — Xu, J., Jiang, M., Sun, H. & He, B. An organic solvent-stable 
protease from organic solvent-tolerant Bacillus cereus WQ9-2: 
Purification, biochemical properties, and potential application in 
peptide synthesis. Bioresour. Technol. 101, 7991–7994 (2010).
CHAPTER — 0 6 CHAPTER — 0 6 — REFERENCES 
175174
14 — Tang, X. Y., Pan, Y., Li, S. & He, B. F. Screening and isolation of an 
organic solvent-tolerant bacterium for high-yield production of organic 
solvent-stable protease. Bioresour. Technol. 99, 7388–7392 (2008).
15 — Schellenberger, V. & Jakubke, H.-D. Protease-catalyzed kinetically controlled 
peptide synthesis. Angew. Chemie Int. Ed. English 30, 1437–1449 (1991).
16 — Awaya, J. D. & Dubois, J. L. Identification, isolation, and analysis 
of a gene cluster involved in iron acquisition by Pseudomonas 
mendocina ymp. Biometals 21, 353–66 (2008).
17 — de Beer, R. J. A. C., Nuijens, T., Wiermans, L., Quaedflieg, P. J. L. M. & 
Rutjes, F. P. J. T. Improving the carboxyamidomethyl ester for subtilisin 
A-catalysed peptide synthesis. Org. Biomol. Chem. 10, 6767–75 (2012).
18 — Toplak, A., Nuijens, T., Quaedflieg, P. J. L. M., Wu, B. & Janssen, D. B. 
Peptide synthesis in neat organic solvents with novel thermostable 
proteases. Enzyme Microb. Technol. 73-74, 20–28 (2015).
19 — Toplak, A., Wu, B., Fusetti, F., Quaedflieg, P. J. L. M. & Janssen, D. B. 
Proteolysin, a novel highly thermostable and cosolvent-compatible 
protease from the thermophilic bacterium Coprothermobacter 
proteolyticus. Appl. Environ. Microbiol. 79, 5625–32 (2013).
20 — Krieger, E., Koraimann, G. & Vriend, G. Increasing the precision of 
comparative models with YASARA NOVA - A self-parameterizing 
force field. Proteins Struct. Funct. Genet. 47, 393–402 (2002).
21 — Krieger, E., Nabuurs, S. B. & Vriend, G. in Structural Bioinformatics, 
Vol 44 (eds. Bourne, P. E. & and Weissig, H.) 509–523 (John 
Wiley & Sons, Inc., Hoboken, New Jersey, USA, 2005). 
22 — Venselaar, H., Joosten, R. P., Vroling, B., Baakman, C. A. B., Hekkelman, 
M. L., Krieger, E. & Vriend, G. Homology modelling and spectroscopy, 
a never-ending love story. Eur. Biophys. J. 39, 551–563 (2010).
23 — Krieger, E., Darden, T., Nabuurs, S. B., Finkelstein, A. & Vriend, G. 
Making optimal use of empirical energy functions: force-field 
parameterization in crystal space. Proteins 57, 678–83 (2004).
24 — Hess, B., Kutzner, C., van der Spoel, D. & Lindahl, E. GROMACS 4: 
Algorithms for highly efficient, load-balanced, and scalable molecular 
simulation. J. Chem. Theory Comput. 4, 435–447 (2008).
25 — Lindorff-Larsen, K., Piana, S., Palmo, K., Maragakis, P.,  Klepeis, J. L., 
Dror, R. O. & Shaw, D. E. Improved side-chain torsion potentials for the 
Amber ff99SB protein force field. Proteins. 78, 1950–1958 (2010).
26 — Hess, B., Bekker, H., Berendsen, H. J. C. & Fraaije, J. G. 
E. M. LINCS: A linear constraint solver for molecular 
simulations. J. Comput. Chem. 18, 1463–1472 (1997).
27 — Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., 
DiNola, A. & Haak, J. R. Molecular dynamics with coupling to 
an external bath. J. Chem. Phys. 81, 3684–3690 (1984).
28 — Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling 
through velocity rescaling. J. Chem. Phys. 126, 1–7 (2007).
29 — Eisenhaber, F., Lijnzaad, P., Argos, P., Sander, C. & Scharf, M. The 
double cubic lattice method: Efficient approaches to numerical 
integration of surface area and volume and to dot surface contouring 
of molecular assemblies. J. Comput. Chem. 16, 273–284 (1995).
30 — Joosten, R. P., te Beek, T. A. H., Krieger, E., Hekkelman, M. L., Hooft, R. 
W. W., Schneider, R., Sander, C. & Vriend, G. A series of PDB related 
databases for everyday needs. Nucleic Acids Res. 39, D411–9 (2011).
31 — Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. 
M., Meng, E. C. & Ferrin, T. E. UCSF Chimera—A visualization system for 
exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
32 — Fernandez-Escamilla, A.-M., Rousseau, F., Schymkowitz, 
J. & Serrano, L. Prediction of sequence-dependent and 
mutational effects on the aggregation of peptides and 
proteins. Nat. Biotechnol. 22, 1302–1306 (2004).
33 — Linding, R., Schymkowitz, J., Rousseau, F., Diella, F. & Serrano, 
L. A comparative study of the relationship between protein 
structure and beta-aggregation in globular and intrinsically 
disordered proteins. J. Mol. Biol. 342, 345–53 (2004).
34 — Rousseau, F., Schymkowitz, J. W. H. & Serrano, L. Protein 
aggregation and amyloidosis: confusion of the kinds? 
Curr. Opin. Struct. Biol. 16, 118–126 (2006).
35 — Ericsson, U. B., Hallberg, B. M., Detitta, G. T., Dekker, N. & Nordlund, 
P. Thermofluor-based high-throughput stability optimization of 
proteins for structural studies. Anal. Biochem. 357, 289–98 (2006).
36 — Siezen, R. J. & Leunissen, J. A. Subtilases: the superfamily of 
subtilisin-like serine proteases. Protein Sci. 6, 501–23 (1997).
37 — Foophow, T. Tanaka, S. I., Angkawidjaja, C., Koga, Y., Takano, K. & 
Kanaya, S.  Crystal structure of a subtilisin homologue , Tk-SP, from 
Thermococcus kodakaraensis: Requirement of a C-terminal β-Jelly 
roll domain for hyperstability. J. Mol. Biol. 400, 865–877 (2010).
38 — Ma, J.-N., Currier, E. A., Essex, A., Feddock, M., Spalding, T. A., Nash, N. 
R., Brann, M. R. & Burstein, E. S. Discovery of novel peptide/receptor 
interactions: identification of PHM-27 as a potent agonist of the human 
calcitonin receptor. Biochem. Pharmacol. 67, 1279–84 (2004).
39 — Nishino, N., Xu, M., Mihara, H. & Fujimoto, T. Use of 
hexafluoroisopropyl alcohol in tryptic condensation for 
partially protected precursor of α-melanocyte stimulating 
hormone. Tetrahedron Lett. 33, 3137–3140 (1992).
40 — Guzman, F., Barberis, S. & Illanes, A. Peptide synthesis: chemical 
or enzymatic. Electron. J. Biotechnol. 10, 279–314 (2007).
CHAPTER — 0 6 — REFERENCES CHAPTER — 0 6 — REFERENCES 
Peptiligase, an enzyme for efficient 
chemoenzymatic peptide synthesis 
and cyclization in water
Ana Toplaka,b, Timo Nuijensb, 
Peter J. L. M. Quaedfliegc, Bian Wua 
and Dick B. Janssena
Biochemical Laboratory, Groningen Biomolecular 
Sciences and Biotechnology Institute, University of 
Groningen, 9747 AG Groningen, the Netherlands
EnzyPep B.V., Urmonderbaan 22,6167 
RD Geleen, the Netherlands
DSM Innovative Synthesis, 6167 RD 
Geleen, the Netherlands
CHAPTER — 07
Part of this chapter has been published in:
Toplak A, Nuijens T, Quaedflieg PJML, Wu 
B, Janssen DB. Peptiligase, an enzyme for 
efficient chemoenzymatic peptide synthesis and 
cyclization in water. Adv Synth Catal (2016) 
doi: 10.1002/adsc.201600017
Patent filed under: PCT/






We describe a novel, organic cosolvent-stable and cation-independent 
engineered enzyme for peptide coupling reactions. The enzyme is a 
variant of a stable calcium-independent mutant of subtilisin BPN’, with 
the catalytic Ser212 mutated to Cys and Pro216 converted to Ala. The 
enzyme, called peptiligase, catalyzes exceptionally efficient peptide 
coupling in water with a surprisingly high synthesis over hydrolysis (S/H) 
ratio. The S/H ratio of the peptide ligation reaction is correlated to the 
length of the peptide substrate and proved to be >100 for the synthesis 
of a 13-mer peptide, which corresponds to >99% conversion to the 
ligated peptide product and <1% hydrolytic side-reactions. Furthermore, 
peptiligase does not require a particular recognition motif resulting 
in a broadly applicable and traceless peptide ligation technology.
Despite the high demand for peptides, the large scale manufacturing of 
peptides remains a challenging target. Chemoenzymatic peptide synthesis 
(CEPS), wherein chemically synthesized peptide segments are coupled 
together, is potentially one of the most cost-efficient technologies for 
the synthesis of medium-sized and long peptides (20-50 amino acids)¹. 
The peptide segments can be made in high purity via conventional (solid 
phase) methods and condensed by enzymatic coupling to obtain the final 
product of interest. 
Complete solid phase synthesis of long peptides leads to accumulation 
of by-products and cumbersome purification. Furthermore, chemical 
segment condensation leads to racemization and requires fully protected 
peptides, which are difficult to handle due to their hydrophobicity. As 
compared to chemical coupling, CEPS owns several notable advantages, 
i.e., the protection of the side-chain functionalities is not necessary, 
racemization is absent, and it is more environment friendly. Nevertheless, 
CEPS is rarely applied in academia and industry since it is not broadly 
applicable and suffers from severe hydrolytic side-reactions. A more 
commonly used strategy is native chemical ligation², which however relies 
on certain amino acids, e.g. an N-terminal Cys, and is not scalable due to 
the instability of the peptide thioesters.
CEPS is usually carried out by using (hydrolytic) proteases in the 
reversed direction3,4. Since peptide bond synthesis is thermodynamically 
unfavourable in the presence of water, the use of neat organic solvents 
with very low water activity can be beneficial for peptide coupling. 
For instance, the industrial serine protease Alcalase has been applied 
for peptide synthesis under nearly anhydrous conditions5–8. However, 
proteases exhibit very low activity in neat organic solvent⁸ and the peptide 




(partially) unprotected. An alternative approach would be performing reactions 
in water. Here, a peptide C-terminal ester (acyl donor) is coupled to a peptide 
N-terminal amine (acyl acceptor), and the enzyme or reaction system is designed 
to kinetically favour the ligation product.  There are some effective ligating 
enzymes known from nature, such as sortase⁹ and butelase10, but they require 
specific recognition sequence motifs. 
Protein engineering has been applied to tailor more broadly applicable proteases 
for peptide coupling in water. Wells and co-workers constructed subtiligase, a 
double mutant derived from the Bacillus amyloliquefaciens subtilisin BPN’11,12. The 
catalytic serine residue was mutated to a cysteine, and a proline near the active 
site was converted to an alanine to reduce steric crowding. The hydrolytic activity 
of this mutant is significantly reduced compared to wild-type, since the introduced 
cysteine forms a thioester intermediate with the acyl donor, which is more prone 
to the amine nucleophilic attack leading to the ligation product. Unfortunately, 
the average ligation yield is 66%11, even when using at least a ten-fold excess of 
the acyl acceptor12, making this technology economically non-viable. Elliott et al. 
reported another approach by using a mutant of Streptomyces griseus protease B 
(SGPB) for peptide coupling13. Here, the active site catalytic serine is mutated to 
an alanine and the reaction proceeds through a proposed histidine-involved acyl-
enzyme intermediate. The stability of both enzymes was improved by introducing 
additional mutations, yielding stabiligase and streptoligase respectively14,15. 
However, in both cases, an enzyme bound cation, is crucial for the stability, which 
restricts their application. Alternative broadly applicable, robust and cation-
free enzymes that catalyze peptide coupling reactions without (hydrolytic) side 
reactions are highly desired. Since such enzymes have not been discovered, a 
stable and cation (calcium) independent variant of subtilisin BPN’ (Sbt149)16 was 
chosen in our study as the starting point for protein engineering. This variant has a 
deleted calcium binding domain (deletion of 9 amino acids, number 75 to 83) and 
an additional 18 stabilizing mutations, including one disulphide bridge. We herein 
report that by introducing the Ser212Cys and the Pro216Ala mutation into this 
robust enzyme scaffold, a new subtilisin variant is obtained, termed peptiligase, 
that catalyzes efficient peptide ligation in water. 
Materials and methods 
Chemicals and reagents — Chemicals and reagents are listed in Chapter 3
Construction of peptiligase plasmid — The Sbt149 encoding gene with its 
natural promoter sequence (a kind gift from prof. P.N. Bryan, University of Maryland, 
USA) was used as the template to generate the Ser212Cys/Pro216Ala mutant by 
the megaprimer method. The final PCR product was purified, digested with EcoRI 
and BamHI, and ligated into the EcoRI/BamHI treated pBS-42 vector (DSM8748, 
DSMZ, Braunschweig, Germany). The ligation mixtures were transformed to 
competent E. coli ER 1821 cells (NEB, Ipswich, MA, USA) and transformants were 
plated on LB plates containing 34 µg/mL chloramphenicol. The mutant gene was 
confirmed by DNA sequencing.
Expression and purification of peptiligase — Plasmid pBS42-peptiligase 
was transformed into B. subtilis DB104, which is a double mutant (his nprR2 
nprE18 aprΔ3) strain deficient in extracellular neutral and serine proteases17 and 
was a kind gift from prof. O. Kuipers (Molgen). Transformants grown on an LB 
plate containing 10 µg/mL chloramphenicol at 37°C for 16h were picked and 
inoculated into 10 mL of LB broth containing 10 µg/mL chloramphenicol. After 
16h of incubation at  37°C, 1 % (v/v) of the cultures were inoculated to 1 L rich 
broth (20 g/L yeast extract, 5 g/L trypton, 6.4 g NaCl, 30 mM phosphates pH 7.6, 
10 g/L glucose, 50 mg/L Trp, 50 mg/L Lys, 50 mg/L Met, 0.06 mM MnCl₂). Cultures 
were grown at 37°C with shaking and incubation was continued for 48 h. Next, 
medium was harvested by centrifugation at 6,000 g for 20 min, 4°C. Subsequently, 
5 g of CaCl₂ were added to the medium to precipitate phosphate salts and the 
pH was adjusted to 7.5. The precipitate was removed by centrifugation at 6,000 
g for 20 min, 4°C. Ammonium sulfate was added to the supernatant to a final 
concentration of 45wt%. The mixture was stirred for 1 h at 4°C to precipitate 
peptiligase. Precipitated peptiligase was harvested by centrifugation at 8,000 g 
for 30 min, 4°C. The pellet was washed 4 times with 100 mL 80% acetone, and 
resuspended in 15 mL water. Resuspended material was centrifuged at 15,000 
g for 10 min, 4°C, to remove insoluble material. The supernatant was desalted 
using a HiPrep 26/10 desalting column in buffer (20 mM Tricine, pH 7.5).  The 
desalted proteins were loaded on a 5 mL HiTrap Q HP column. Flow through, which 
contains peptiligase, was collected and concentrated. The purity of the protein 
was analyzed by SDS-PAGE and estimated to be 70%. The purified enzyme was 
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flash-frozen in liquid nitrogen and stored at -80°C until further use. Enzyme 
concentration was determined by measuring absorption at 280 nm.
Expression and purification of subtiligase — A gene encoding of 
subtiligase⁸ was provided by DNA2.0 and recloned into EcoRI-BamHI digested 
E. coli- B. subtilis shuttle vector pBS42.The plasmid pBS42-S5 was propagated 
in E. coli strain MM294 (DSM5208, DSMZ, Braunschweig, Germany) isolated and 
validated by sequencing. The validated plasmid was used for transformation of 
B. subtilis DB104. The production and purification protocol was similar to that 
for peptiligase, but with the buffers supplemented with 1 mM CaCl₂. The yield of 
purified subtiligase was 2-5 mg/L culture.
Thermostability assays — The fluorescence based thermal stability assay18 
was used to determine apparent melting temperatures of the proteins. For this, 20 
µl of protein solution in buffer (20 mM Tricine, pH 7.5) was mixed with 5 µl of 100 x 
Sypro Orange (Molecular Probes, Life Technologies, San Diego, CA) dye in a thin 
wall 96-well PCR plate. The plate was sealed with Optical-Quality Sealing Tape 
and heated in CFX 96 Real Time PCR System (BioRad, Hercules, CA, USA) from 
20 to 99°C at a heating rate of 1.75°C/min. Fluorescence changes were monitored 
with a charge-coupled device (CCD) camera. The wavelengths for excitation and 
emission were 490 and 575 nm, respectively.
Peptide ligation reactions — Typical ligation reactions were performed at 
25°C in 100 mM Tricine (pH 8.0), containing 15 µM peptiligase and different acyl 
donors and acyl acceptors. The efficiency of the ligation reactions was analyzed 
by an LC/MS ion-trapping system (Thermo Scientific) using methods described 
in the Chapter 5. For reactions using tryptophan containing acyl donor, the UV 
detection was set at 280 nm, and concentration of the compounds were calculated 
based on their corresponding peak area. For reactions using tryptophan-free acyl 
donor, the UV detection was set at 220 nm and the conversion was calculated 
based on the consumption of the acyl donor substrate. Chemical hydrolysis of 
the acyl donor was calculated from control experiments.
pH-ligation profile — The reaction mixture containing 1 mM Ac-Phe-Ile-Glu-
Trp-Leu-OCam, 3 mM Ala-Phe-amide, and 15 µM peptiligase were incubated at 
25°C for 1 h. To determine the effect of pH on the ligation efficiency, experiments 
were carried out over a pH range of 6.0 – 8.85. The buffers used were MES (100 
mM, pH range 6.0-7.0) and Tricine (100 mM, pH range 7.5-8.85). The chemical 
hydrolysis of the acyl donor was assayed in the absence of the enzyme.
Effect of organic solvent and additives on peptiligase activity — The 
standard reaction mixtures consisted of 1 mM Ac-Phe-Ile-Glu-Trp-Leu-OCam, 
3 mM Ala-Phe-amide, 15 µM enzyme and different concentrations of organic 
solvent, metal ions, chelating agent or denaturing agent in 100 mM Tricine buffer 
(pH 8.0). The assays were performed at 25°C.
Synthesis of a 19-mer peptide — The coupling reaction was performed using 
4 mM acyl donor (Ac-Lys-Lys-Lys-Lys-Lys-Lys-Asp-Phe-Ser-Lys-Leu-OCam-
Leu-OH) and 6 mM acyl acceptor (H-Ala-Ala-Pro-Arg-Ala-Ala-Arg-Glu-OH) in 
phosphate buffer (1 M, pH 8.0). To this reaction mixture, 5 µg of enzyme was 
added and the mixture (1 mL) was analyzed by LC-MS after 30 min. The Cam-
ester starting material was fully consumed and the ratio between the product and 
hydrolysis peak was 97/3. See Supporting Information for further details.
Cyclization of linear microcin J25 Cam-Leu-ester — The cyclization 
reaction was performed with 1 mg linear peptide Cam-ester (H-Gly-Thr-Pro-
Ile-Ser-Phe-Tyr-Gly-Gly-Gly-Ala-Gly-His-Val-Pro-Glu-Tyr-Phe-Val-Gly-Ile-
OCam-Leu-OH) in 1 mL phosphate buffer (100 mM, pH 8.0) supplemented with 
DMSO (20 vol%). To this reaction mixture, 10 µg of peptiligase was added and 
the solution was analyzed by LC-MS after 30 min. Conversion to product was 
measured by integrating the starting material, product and hydrolyzed Cam-
ester peaks. The amount of product after 30 min was 82% and the amount of 
hydrolysis 18%. The Cam-ester starting material was completely consumed. See 
Supporting Information for further details. In a second reaction, concentrated 
substrate solution in DMSO (100 mg/mL) was prepared and dosed in time (20 
µl every 15 min) to the enzyme solution (10 µg peptiligase) in 200 µL phosphate 
buffer (100 mM, pH 8.0). The pH was continuously kept at 8.0 using 5 N aqueous 
NaOH. The reaction mixture was analyzed by LC-MS after 150 min as described 
above. The starting material was fully consumed and the amount of product was 
81% and hydrolysis 19%.
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The gene encoding peptiligase was constructed by site-directed mutagenesis 
and cloned into E. coli/B. subtilis shuttle vector pBS42. Production of the enzyme 
was performed in B. subtilis DB104 strain which lacks native extracellular neutral 
and serine proteases expression12. Peptiligase is translated as a precursor and 
needs to be processed to obtain the mature protein. It was reported that a 
‘helper’ protease, i.c. native subtilisin, is required for the processing of the mutant, 
which has reduced protease activity⁸. In the present study, we observed that 
peptiligase can perform the autoproteolytic removal of the pro-sequence without 
any additional subtilisin, which suggests the retained proteolytic activity of this 
enzyme is sufficient for its maturation. Secreted peptiligase was purified from the 
culture medium after ammonia precipitation and ion-exchange chromato¬graphy. 
The yield from 1 liter of cell culture was approximately 20 mg (70% pure on 
SDS-PAGE gel). The thermostability of the purified peptiligase was determined 
using the Thermofluor assay. An apparent transition temperature (Tm, app) of 
66°C indicates that the enzyme well preserves the thermostability of its parent. 
As anticipated, peptiligase is cation-independent. In a standard peptide ligation 
reaction consisting of activated acyl donor as carboxamidomethyl (Cam) 
ester (Ac-Phe-Ile-Glu-Trp-Leu-OCam) and amidated acyl acceptor (H-Ala-
Phe-NH₂) none of the metal cations tested (Ca2+, Mg2+, Mn2+, Ni2+) displayed a 
remarkably stimulatory or inhibitory effect on the activity of peptiligase at 10 mM 
concentration. The influence of metal ion chelating reagent EDTA (10 mM) on the 
enzymatic activity was also negligible, in contrast to enzymes without a deleted 
calcium domain. In addition, the thermostability of peptiligase also remained 
unaffected (Table 1). The optimal pH value (highest synthetic/hydrolytic ratio) 
was achieved at pH 8.0. When a higher pH was used, chemical hydrolysis of the 
peptide ester was more profound. At lower pH the amine acyl donor is protonated 
and unreactive.
Results
TABLE  1 . 
Effect of metal ions and chelating agent EDTA on the (Ac-Phe-
Ile-Glu-Trp-Leu-OCam + H-Ala-Phe-NH₂) coupling activity and 
thermostability of peptiligase. Details are given in the Experimental 
section
Activity (mU/mg) Tm, app (°C)
Control 26 66.0
Ca2+ (10 mM) 20 65.5
Mg2+(10 mM) 26 65.0
Mn2+(10 mM) 30 64.5
Ni2+(10 mM) 22 62.0
EDTA(10 mM) 26 66.5
To test whether peptiligase tolerates high concentrations of organic solvents, 
peptide ligation reactions were performed in the presence of various 
amounts of water-miscible cosolvents, including tetrahydrofuran (THF), N,N-
dimethylformamide (DMF) and dimethylsulfoxide (DMSO). Reaction mixtures again 
contained the Ac-Phe-Ile-Glu-Trp-Leu-OCam acyl donor and H-Ala-Phe-NH₂ as 
acceptor. Conversion of substrate and product formation were estimated by HPLC.
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FIGU RE  1 . 
Effect of organic solvents and denaturing agent on the peptiligase catalyzed peptide ligation. Black 
bars: relative total activity; grey bars: relative synthetic activity; grey triangles: log value of synthesis/
hydrolysis ratio.
As shown in Figure 1, the enzyme exhibited moderate tolerance towards THF, 
and a reasonable residual total activity (of 30%) was observed in the presence 
of 20 vol% THF. However, THF strongly repressed the nucleophilicity of the acyl 
acceptor and hydrolysis of the acyl donor became the dominate reaction. Only 
hydrolysis of the acyl donor Cam ester to free acid was observed.  In contrast, the 
S/H ratio was not significantly affected by the addition of either DMF or DMSO. 
The enzyme also showed good stability in these two cosolvent systems. Notably, 
the enzyme retained 36% of its activity in the presence of 50 vol% DMSO in 
water, which is a very good mixture for dissolving hydrophobic peptides. Therefore, 
if substrate solubility requires, DMSO should be considered as the preferred 
organic cosolvent for the coupling reaction. 
A possible issue for peptide ligation, as described by Chang et al.14,  that substrates 
could adopt a secondary structure, which could reduce the accessibility to the 
binding pockets of the coupling enzyme. In such cases, denaturing agents, 
such as guanidine hydrochloride (GndCl) or urea, can be added to weaken the 
secondary structure and expose the ligation junction of the substrates. Under 
extreme denaturing conditions, peptiligase retained significant activity; up to 4 
M GndCl could be used. Moreover, the S/H ratio was only marginally influenced 
by the addition of GndCl. Next, peptiligase was investigated with relation to its 
peptide ligation efficiency. The parent enzyme Sbt149 binds the substrate in an 
extended antiparallel β-sheet conformation, while substrate residues flanking the 
scissile bond (peptide groups P4-P3’) are in close contact with the respective 
binding pockets (subsites S4-S3’)16. To test whether ligation reactions catalyzed 
by peptiligase also require both the acyl donor and the acyl acceptor substantially 
occupying the binding pockets of the enzyme, we used substrates of varying 
lengths in peptiligase catalyzed couplings (Tables 2-4). First, single amino acid 
and dipeptide substrates were coupled via the kinetically controlled conversion. 
Cam-esters are optimal substrates for proteases/ligases as they mimic a glycine 
residue11,12. The Cam-ester substrates are easily produced via standard solid 
phase peptide synthesis using conventional resins in high yield and good purity19. 
However, when such amino acids and dipeptides were tested in coupling reactions, 
the efficiency by peptiligase was poor (Table 2).
Acyl donor Acyl acceptor Conversion (%) Synthesis (%) Hydrolysis (%) S/H ratio
Cbz-F-OCam H-A-NH₂ 26 3 23 0.13
Cbz-F-OCam H-AF-NH₂ 50 6 44 0.13
Cbz-AF-OCam H-A-NH₂ 53 2 51 0.04
Cbz-AF-OCam H-AF-NH₂ 53 6 47 0.13
TABLE  2 . 
Peptiligase catalyzed coupling reactions with short peptide substrates. Reactions were 
performed with 1 mM acyl donor and 3 mM acyl acceptor in 100 µl Tricine buffer (100 mM, 
pH 8.0).  Reaction time =3 h
Subsequently, a series of longer (5-11 amino acids) acyl donor Cam-esters with the 
same ligation junctions were tested. The results (Table 3) indicate that peptiligase 
catalyzes the coupling reaction of longer acyl donors with high efficiency, and that 
there is a clear correlation between the length of the acyl donor and the S/H ratio 
of the reaction. Virtually no hydrolytic side-reactions were observed at all when an 
11-mer Cam-ester was used, i.e. an S/H ratio of more than 100. This corresponds 
to a conversion of >99% to product and less than 1% of hydrolysis. Notably, this 
high yield was obtained using only 1.5 equivalent of acyl acceptor, making this an 
economically very attractive ligation technology.
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Acyl donor Conversion (%) Synthesis (%) Hydrolysis (%) S/H ratio
Ac-DLSKQ-OCam 93 81 12 6
Ac-TSDLSKQ-OCam 85 83 2 41.5
Ac-TFTSDLSKQ-OCam 66 64 2 32
Ac-EGTFTSDLSKQ-OCam 60 60 <1 >100
TABLE  3 . 
Peptiligase-catalyzed coupling reactions using acyl donors with 
varying lengths and H-AF-NH₂ as the amine nucleophile. Reactions 
were performed with 10 mM acyl donor and 15 mM acyl acceptor in 
100 µl Tricine buffer (100 mM, pH 8.0). Reaction time =3 h.
Next, we investigated whether the length of the acyl acceptor has a similar effect 
(Table 4). The efficiency of peptide ligation was analyzed using a series of acyl 
acceptors, with the same amino-terminal residue and subsequent length extension 
(1-4 amino acids). While a coupling reaction with alanine amide as nucleophile 
appeared to be accompanied by overwhelming hydrolysis, longer peptide amides 
served as better acyl acceptors.
Acyl acceptor Conversion (%) Synthesis (%) Hydrolysis (%) S/H ratio
H-A-NH₂ 35 <1 35 <0.01
H-AF-NH₂ 59 32 27 1.2
H-AFA-NH₂ 25 13 11 1.2
H-AFAY-NH₂ 23 14 9 1.5
TABLE  4 . 
Peptiligase-catalyzed coupling reactions using amine nucleophiles 
with varying length and Ac-FIEWL-OCam as acyl donor. Reactions 
were performed with 1 mM acyl donor and 3 mM acyl acceptor in 
Tricine buffer (100 mM, pH 8.0). Reaction time =1 h.
These results suggest that occupation of both the S1’ and the S2’ subsites 
as well as the S1-S4 subsites is a prerequisite for efficient ligation. Thus, 
the minimal peptide length for an efficient coupling reaction is 4 + 2, with 
longer segments giving more efficient ligation, as desired. From the results 
of an 11 + 8 coupling reaction, i.e. Ac-Lys-Lys-Lys-Lys-Lys-Lys-Asp-
Phe-Ser-Lys-Leu-OCam-Leu-OH + H-Ala-Ala-Pro-Arg-Ala-Ala-Arg-
Glu-OH, it became clear that by far we have not reached the limitations 
of this technology since the reaction reached 97% conversion to 19-
mer product with only 3% of Cam-ester hydrolysis (details in supporting 
information). Clearly, this enzymatic ligation technology can be used for 
the synthesis of medium-sized and long peptides.
To determine whether the synthetic properties of peptiligase are better 
than those of subtiligase, the S/H ratio was determined using various acyl 
acceptors. Sub-optimal (diluted) reaction conditions were used to clearly 
quantify the amounts of synthetic product and product of the hydrolytic 
side reaction. 
Under the same reaction conditions, the S/H ratio of peptiligase is 
surprisingly higher than that of subtiligase; in most cases the S/H ratio 
of peptiligase was twofold higher. The improved S/H ratio together with 
the excellent stability render peptiligase as a highly promising enzyme 
for further development of a generally applicable CEPS technology. We 
are currently investigating the peptiligase-catalyzed synthesis of various 
pharmaceutical products on gram scale to determine purified product 
yield and compare the results to conventional synthetic methods.
CHAPTER — 07 Peptiligase
191190
Peptiligase Subtiligase
Acyl acceptor  H-Xxx-Leu-Arg-NH₂ Synthesis (%) S/H ratio Synthesis (%) S/H ratio
Ser 58 1.38 40 0.67
Gly 48 0.92 25 0.33
Ala 47 0.89 20 0.25
Asp 21 0.27 6.8 0.07
Acyl acceptor  H-Ala-Xxx-Arg-NH₂ Synthesis (%) S/H ratio Synthesis (%) S/H ratio
Ile 46 0.83 26 0.35
Val 46 0.86 29 0.41
Leu 32 0.46 26 0.34
Met 31 0.38 24 0.28
a) Reactions were performed with 0.75 mM acyl donor and 1.5 mM acyl acceptor in Tricine buffer (100 mM, pH 
8.0) and 5 µg of enzyme. Full conversion was reached after 30 min. b) Products yields derived from HPLC analysis 
of reaction mixtures. 
TABLE  5 . 
P1’and P2’ substrate scope of peptiligase and subtiligase 
using Ac-DFSKL-OCam as acyl donor and various acyl 
acceptors, where Xxx = the proteinogenic amino acid 
indicated. Best eight results shown.
Besides peptide segmentt condensation, subtiligase has been used to cyclize 
linear peptides longer than 13 amino acids in reasonable yield (average of 64%)20. 
Macrocylic peptides are a very promising class of pharma¬ceuticals, mainly due 
to their high stability in blood serum20. We embarked on the cyclization (Figure 2) 
of linear Microcin J25, a 21 amino acid long lasso-peptide naturally produced by 
a strain of E. coli isolated from human feces with antibiotic properties21. Chemical 
head-to-tail cyclization of such a long peptide is very challenging and the reaction 
has to be performed with extremely diluted substrate to prevent polymerization, 
making it difficult for scale-up22. Microcin J25 is hydrophobic and cosolvents 
such as DMSO are needed in high amounts to solubilize the peptide in aqueous 
environment, which is well tolerated by peptiligase.
FIGU RE  2 . 
Head-to-tail cyclization of linear Microcin J25 (21-mer) 
by peptiligase in 20% (v/v) DMSO (details in Supporting 
Information). 
When activated linear Microcin J25 (1 mg/mL) was cyclized with peptiligase using 
20% (v/v) DMSO in phosphate buffer, a very good conversion to cyclic product 
was observed, i.e. 82% of synthetic product and only 18% of hydrolysis of the 
linear Microcin J25Cam ester to free acid. No dimerization or polymerization was 
detected. Moreover, a similar conversion to cyclic peptide (81%) was obtained 
in a reaction with concentrated substrate (100 mg/mL in DMSO) dosed to 
peptiligase in phosphate buffer, thus obtaining a concentrated product solution 
(50 mg/mL). Clearly, besides peptide segment condensation, peptiligase can 
be used to synthesize head-to-tail macrocyclic peptides in an efficient manner.
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We have successfully constructed a stable peptide ligase that is able to 
ligate peptides in water with very high S/H ratios. When longer peptides 
are coupled, the hydrolytic side-reaction is almost completely suppressed. 
To the best of our knowledge, this is the first reported broadly applicable 
and traceless peptide ligating enzyme that is independent of cations 
and is very robust. The enzyme can be expressed in B. subtilis and can 
be directly isolated from the culture medium since it is secreted and no 
additional protease is required for maturation. Furthermore, peptiligase 
is compatible with a variety of additives and cosolvents, has a relaxed 
specificity in coupling reactions, and does not hydrolyze amide bonds 
in the main chain of precursor or product peptides. These features 
endow the enzyme with catalytic properties required for the synthesis 
of a variety of medium-sized and long (pharmaceutical) peptides. 
Moreover, we have shown that peptiligase can be used for the synthesis 
of a peptide macrocycle, which represents an important upcoming class 
of pharmaceutical peptides for future medicines. Based on the robust 
framework of peptiligase, further protein engineering for even higher 
synthetic performance or broader substrate acceptance is ongoing. 
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The focus of this thesis is discovery and engineering of proteases for peptide 
synthesis. Using genome mining and heterologous expression, novel thermostable 
subtilisin-like proteases originating from extremophiles were produced and 
their properties are described, including their activity in peptide synthesis. The 
novel biocatalysts could be applied under harsh reaction conditions, i.e. at high 
temperature, in the presence of organic cosolvents or in anhydrous organic 
solvents, and in the presence of denaturants. In addition, engineering of a stable, 
cation-independent thiol-subtilisin for efficient peptide synthesis in water is 
reported. Finally, we discuss the future perspectives of chemoenzymatic peptide 
synthesis technology.
A generic technology for the production of peptides does not exist. Current 
methods for peptide production are chemical synthesis, production in recombinant 
systems, and chemo-enzymatic synthesis (CEPS), and the preferred synthetic 
route depends on sequence, length and properties of the target peptide¹. A short 
description of the methods is given in Chapter 1. At this moment, chemical peptide 
synthesis is still the preferred method for the production of therapeutic peptides, 
since it allows the synthesis of almost any desired peptide sequence, including 
peptides with non-proteinogenic amino acids. Usually, in the early peptide 
drug development phase the synthesis is performed on a solid-phase, where a 
large excess of reagents is required to reach high yields and large amounts of 
solvent are used in washing steps. As the complexity and length of the target 
peptide grow, tedious and expensive preparative HPLC purification is needed to 
remove impurities, which further increases production costs. In addition, longer 
peptides (>10 amino acids) tend to form tertiary structures due to a process 
called hydrophobic collapse, making further synthetic steps difficult. Therefore, 
a hybrid approach where peptide segments are synthesized on solid-phase and 
chemically coupled in solution is the usual way to produce longer peptides. One 
needs to carefully select ligation positions, i.e. the segments obtained by solid-
phase methods should be of similar size and have Gly or Pro at the C-terminus 
to avoid racemization. Side chains should be adequately protected, and the 
peptides should be soluble. If racemization occurs or side chains react, product 
purification becomes troublesome and expensive. An elegant chemical method 
for synthesis of long peptides (>200 amino acids) is native chemical ligation². 
It allows coupling of unprotected peptide segments in buffered solutions. 
However, it is not applicable on industrial scale due to the instability of thioester 
precursors and long reaction times with diluted substrate solutions. Due to the low 
environmental impact, ribosomal expression and production of the recombinant 
peptides by fermentation would be a promising low-cost green technology for 
large-scale peptide production. However, high development costs are involved 
because production strains need to be developed and isolation must be 
optimized for each new peptide sequence. Also, there is a sequence limitation 
because only proteinogenic amino acids can be incorporated in a straightforward 
manner³. As a result, ribosomal peptide synthesis is only explored in the late 
drug development stage. Another recombinant method sometimes applied 
on industrial scale involves non-ribosomal peptide synthetases (NRPs). These 
multimeric enzyme complexes are naturally involved in the production of a large 
diversity of short peptides, which very often contain non-proteinogenic amino 
acids. These systems are exploited for production of antibiotics such as β-lactams 
and cyclosporins⁴. Although modification of the peptide scaffold by engineering 
NRPS modules or domains is possible, such as incorporation of D-amino acids 
and peptide cyclization, the engineering of an NRPS for production of a specific 
target peptide remains a complicated task. Chemoenzymatic peptide synthesis 
(CEPS) is an attractive alternative approach for the production of medium to 
long-sized peptides. Enzymatic coupling of chemically synthesized peptide 
segments combines advantages of solid-phase synthesis (e.g. incorporation of 
non-natural amino acids) with enzymatic ligation of peptide segments (lack of 
racemization, no need for protection groups, use of an aqueous phase with better 
solubility of peptides).  Enzymatic ligation reactions in CEPS are also regio- and 
stereospecific, thereby reducing the necessity of expensive and troublesome 
HPLC purification steps and reducing overall production costs. Development 
of improved peptide coupling enzymes is crucial for the future success of 
chemoenzymatic peptide synthesis as addressed in this thesis. Indeed, since the 
properties of the catalyst determine to a large extend the feasibility of practical 
application, the discovery and engineering of better proteases is an intensive 
field of research. In this project we have chosen a genome mining approach 
to obtain novel enzymes for peptide synthesis. Chapter 2 gives an overview of 
the properties of known enzymes that have been used in peptide synthesis and 
activation. In general, hydrolytic enzymes such as proteases can be employed 
as catalysts for peptide bond formation either under thermodynamic or kinetic 
control⁵. Thermodynamic control is a reversal of hydrolysis and all proteases 
regardless of their mechanistic class can ligate peptides according to this 
principle. An example is the thermolysin –catalyzed production of aspartame on 
industrial scale⁶. As an alternative, proteases of the serine or cysteine hydrolase 
class can form a covalent bond with an activated precursor (acyl donor) and 
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catalyze peptide synthesis following kinetic principles. This requires that the 
acyl-enzyme intermediate is preferentially cleaved by a nucleophilic peptide 
that acts as acyl acceptor. Reactions proceeding under kinetic control tend to 
be faster and higher conversions can be achieved with less enzyme than during 
thermodynamically controlled conversions. A variety of alternative nucleophiles 
such as amides, peroxides, hydrazine, alcohols or hydroxamic acids can be used 
as acyl acceptor, thereby expanding the biocatalytic scope of these proteases⁷.  
Many classical proteases have been successfully used in peptide synthesis, but 
intensive medium and substrate engineering are required. The latter involves 
selection of coupling sites for peptide segment condensation, and selection of 
leaving groups if kinetically controlled synthesis is applied. Strongly activating 
leaving groups, i.e. carboxamidomethyl (OCam) and its derivatives, can expand the 
application scope of proteases⁸. Some reactions can be done in the presence of 
cosolvents to increase peptide solubility or in neat organic solvent to suppress 
peptide hydrolysis. Neat organic solvents may change enzyme selectivity, and 
broaden the range of reactions that can be performed⁹. However, enzyme activity 
in neat organic solvents is usually very low10 and efficient conversion requires 
solvent-compatible enzymes which show both decent stability and activity 
under near-anhydrous conditions.  The main side reaction of protease-catalyzed 
peptide synthesis under aqueous conditions is hydrolysis. The goal of the reaction 
and enzyme engineering studies described in other chapters is to maximize the 
versatility of coupling reactions while keeping hydrolytic side reactions minimal. 
In Chapter 3 we explored the use of genome mining for discovery of thermostable 
homologs of the classical protease subtilisin E. Subtilisins were selected because 
of their broad specificity and expected stability. It was assumed that thermophilic 
organisms contain enzymes that can tolerate harsh conditions such as elevated 
temperature or exposure to cosolvents and that may have increased activity in 
neat organic solvents as compared to their mesophilic counterparts. In particular 
hyperthermophiles, thermophiles and some bioremediation organisms were 
selected as target organisms. From 73 hits (36 organisms) of genes encoding 
putative proteases, 50 were selected as possible targets as the properties of the 
encoded enzymes were not previously described. Cloning and expression were 
performed in a mesophilic host that is easy to grow (Escherichia coli) and for 
which suitable cloning techniques exist. Another advantage of using a mesophilic 
host is that enzyme isolation can be based on the difference in thermostability 
between host proteins and the target thermozyme: a single heat treatment step 
may be used for purification (Chapter 4). Although successful in the sense that 
we discovered new enzymes, it was also evident that individual expression and 
testing of putative proteases identified by genome mining required a considerable 
experimental effort, with rather unpredictable revenues. Better bioinformatic 
tools could possibly focus experimental work on the most promising enzymes. 
Unfortunately, at this moment it is still impossible to predict directly from the 
protein sequence or via homology modeling whether a putative subtilase will be 
expressed and active in a selected host, and if the catalytic properties of such an 
enzyme will be attractive. In our expression experiments two bottlenecks occurred. 
First, cloning of GC-rich sequences by PCR amplification and restriction cloning 
was successful for only 46% of the genes. With the progress of affordable DNA 
synthesis this problem will be less important in the future. Protein processing and 
secretion were other critical steps, and these will remain important for obtaining 
active protease. A plate screening protocol for functional expression in E.coli 
was applied; it is based on including a protease substrate into plates (skim-milk 
agar plates) on which colonies producing active subtilase could be recognized 
by formation of a clearance halo. In addition, small-scale liquid culture screening 
was developed to identify production conditions for novel subtilases. In each 
screening method, a heating step was applied to enable protease activation by 
processing. The full preprosequence of 24 putative subtilases was cloned into 
pBAD or pET-based vectors. From these 24 cloned genes in E. coli, nine active 
subtilases were detected by plate screening and one enzyme was found in small-
scale liquid culture screening. Although they were expected to be promising as 
hyperthermophilic proteases, none of the archaeal subtilases could be obtained by 
recombinant expression in E. coli cells. If produced in E. coli, subtilase expression 
was modest in all cases (5-50 mg per L of culture). Despite these limitations, in 
total ten putative extremophilic subtilases were expressed using E. coli and found 
to be active. In the following chapters, the expression and biochemical properties 
of four novel subtilases are described.
In Chapter 4 biochemical characterization of a novel thermostable and cosolvent-
tolerant serine protease from Coprothermobacter proteolyticus termed 
proteolysin is reported. Recombinantly produced in E. coli, proteolysin could be 
purified to near homogeneity from crude cell lysate by a single heat-treatment 
step. Higher levels (20 mg/L) where obtained with maltose-binding protein tag 
(MBP-tag) fused to the N-terminus of the target enzyme. Although several enzyme 
forms with different degrees of processing could be identified in the total cell 
lysate, the heating step led to a single protein band. During heat-processing the 
C-terminal hexahistidine tag and part of the linker were autocatalytically removed, 
leading to the conclusion that the C-terminal tag cannot be used to facilitate the 
purification. The enzyme has a broad pH tolerance and is active at temperatures 
of up to 80°C, much higher than optimal growth temperature of C. proteolyticus 
(63°C). In addition, proteolysin shows good activity and stability in the presence 
of organic cosolvents, detergents and dithiothreitol, and remains active in 6 M 
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guanidinium hydrochloride. The findings suggest a positive correlation between 
thermostability and cosolvent tolerance. The function of the putative Cys182-
Cys201 disulfide bond was investigated. By disrupting the disulfide bond by 
replacing cysteines with alanine, a more active variant with similar thermostability 
was obtained, albeit in lower yields. The enzyme prefers hydrophobic amino acid 
residues at the P1 substrate-binding subsite, and is a candidate for applications 
in proteomics where protein digestion under harsh conditions is required. The 
efficiency of this protease in peptide synthesis in neat organic solvent was 
regrettably not sufficient for further exploration.
Chapter 5 addresses chemoenzymatic peptide synthesis in neat organic 
solvents. Two novel thermostable subtilisin-like proteases obtained by genome 
mining, DgSbt from Deinococcus geothermalis and TaqSbt from Thermococcus 
aquaticus Y51MC23. Both were recombinantly expressed in E. coli at 25-50 mg/L 
culture and characterized. The enzymes were highly thermostable (apparent 
unfolding temperatures 90°C and 70°C, respectively) and a single heat-treatment 
step yielded purified enzyme. The catalytic efficiencies in standard hydrolytic 
reactions were one order of magnitude lower than of subtilisin Carlsberg and 
similar to values observed for other thermostable subtilases. TaqSbt and DgSbt 
also showed exceptional stability in the presence of 20 mM EDTA, 10% (w/v) 
SDS, Tween 20 (10% w/v), urea and guanidinium hydrochloride (GdmHCl, s6M). 
The tolerance of these new subtilases to chaotrophic agents was superior to the 
recently engineered chaophilic subtilisin E variant for the use in diagnostic kits11. 
Hyperthermophilic Tk-SP from the archaeon Thermococcus kodakaraensis is 
another reported protease with high thermostability, but low expression levels 
(0.8 mg/ L culture12) limit further biocatalytic application of Tk-SP. In addition, 
the novel subtilases DgSbt and TaqSbt catalyzed efficient peptide bond synthesis 
at 80°C and 60°C in neat acetonitrile with excellent conversion (>90%). Active 
enzyme preparations for use in organic solvents were prepared directly from 
cleared heat-treated cell lysates, thus minimizing the downstream processing 
by precipitation and rinsing with isopropanol, followed by drying. The enzymes 
also tolerated high levels of N,N-dimethylformamide (DMF) as a cosolvent (40%-
50% v/v), which improved substrate solubility and gave good conversion in 5+3 
peptide condensation reactions. In conclusion, DgSbt and TaqSbt are useful 
biocatalysts for short peptide synthesis when high temperature and high DMF 
concentrations are required. For industrial application of these subtilases in 
peptide synthesis, their expression level has to be further improved, since rather 
large amounts of IPRED are required (20% (w/v) and higher) for good conversion. 
A promising start may be production in Pichia pastoris, where an expression 
level of 1g/L was achieved for another thermophilic subtilase called aqualysin I13.
Enzymes with high tolerance towards organic solvents could expand the 
applicability of biocatalysts in various industrial processes. In Chapter 6 we report 
recombinant production in E. coli, purification and biochemical characterization 
of the serine protease from Pseudomonas mendocina strain ymp, termed PmSbt. 
The precursor of PmSbt has 38% sequence identity to subtilisin E and consists of 
an N-terminal presequence and prodomain, the mature domain and a C-terminal 
domain. With the incorporated C-terminal hexahistidine tag, purification using 
immobilized metal affinity chromatography was possible with a yield of 10 mg 
of purified protein/L of medium. Deletion of the C-terminal domain (PmSbtdel) 
revealed its role in facilitating enzyme secretion in the E. coli host. This calcium-
activated mesophilic enzyme had an optimal pH of 8.0 and a temperature optimum 
at 46°C. Out of three putative disulfide bonds, only the S-S bond in the C-terminal 
domain (Cys479-Cys490) could be disrupted without a negative effect on 
functional expression. Both PmSbt and PmSbtdel aggregate unless glycerol is 
added to 20% (v/v). Bioinformatic analysis and structural inspection identified 
two segments in the mature domain that may be responsible for the aggregation 
propensity. The isolated protease PmSbt exhibits remarkable stability in DMSO 
and DMF (50% v/v) for as long as 14 days. For PmSbt, the extraordinary stability 
in organic solvents was not accompanied by a high thermostability as found for 
other thermostable proteases described in this thesis. 
We tested the synthetic properties of PmSbt on the hexapeptide precursors 
of the bioactive PHM27 peptide, an agonist of the human calcitonin receptor 
involved in calcium homeostasis12. Surprisingly, PmSbt showed kinetic preference 
for water as nucleophile in the presence of 50% (v/v) of DMF or DMSO, leading 
to fast ester hydrolysis, after which a thermodynamically controlled peptide 
coupling occurred. Thus, in the presence of organic cosolvent (50% v/v DMF 
or DMSO) the equilibrium was shifted to the synthetic product with 60% 
conversion after 48 h. Due to the organic solvent tolerance, PmSbt can accept 
non-activated precursors in thermodynamically controlled peptide synthesis 
reactions in higher yields than reported for other serine proteases (i.e. trypsin)13. 
With required prolonged reaction times the chance for byproduct formation 
grows. Besides medium engineering to improve the peptide product yield, also 
engineering studies aimed in understanding and improving catalytic properties 
of the PmSbt would be desired. From the bioinformatics studies segments with 
high aggregation tendency and three loops forming the substrate-binding site 
were suggested as targets for the further engineering studies. When synthesizing 
peptides in aqueous conditions, the use of thiol-subtilisins is advantageous and 
allows efficient segment coupling. Chemoenzymatic peptide synthesis in aqueous 
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medium has many advantages: the solubility of unprotected peptides is excellent 
and there is no need for side-chain protective groups. Chapter 7 is dedicated to 
peptiligase, a highly engineered subtilisin BPN’ that is capable of peptide synthesis 
in aqueous media. The production, characterization, and the substrate scope are 
reported. The enzyme is a variant of a hyperstable calcium-independent mutant of 
subtilisin BPN’, with the catalytic Ser212 mutated to Cys and Pro216 converted to 
Ala. Peptiligase catalyzes exceptionally efficient peptide coupling in water with a 
surprisingly high synthesis over hydrolysis (S/H) ratio. The S/H ratio of the peptide 
ligation reaction is correlated to the substrate length and proved to be >100 for 
the synthesis of a 13-mer peptide, which corresponds to >99% conversion to 
the ligated peptide product and <1% hydrolytic side-reactions. Furthermore, 
peptiligase does not require a particular recognition motif resulting in a broadly 
applicable and traceless peptide ligation technology. Peptiligase is very robust, 
easy to produce in Bacillus subtilis, and its purification is straightforward. It shows 
good activity and stability in the presence of organic cosolvents and chelating or 
denaturing agents, enabling the ligation of poorly soluble (hydrophobic) or folded 
peptides. In addition, peptiligase is able to efficiently catalyze head-to-tail peptide 
cyclization reactions, as shown for Microcin J25 cyclic variant. This enzyme could 
be useful for the industrial synthesis of diverse (pharmaceutical) peptides.  
To summarize, five novel subtilases are characterized in this thesis, and four of them 
could be applied in CEPS under different conditions.  A biocatalyst for each reaction 
medium (water, neat organic solvent and water-cosolvent system) is provided (Figure 1).
FIGU RE  1 . 
Biocatalysts for chemoenzymatic peptide synthesis 
explored in this thesis.
In the past decade the field of chemoenzymatic peptide synthesis has been 
oriented towards the use of hydrolases in nonaqueous environments, focusing 
on minimizing the main side reaction, (i.e. hydrolysis of substrates or product). 
Approaches using substrate or medium engineering have been in demand for 
novel organic-solvent tolerant subtilases. Several novel subtilases have been 
selected in this work and were tested in hydrolytic and synthetic reactions under a 
variety of conditions. Thermostable subtilases obtained by genome mining of the 
extremophiles proved to be robust enzymes that can be produced in a mesophilic 
host and can be easily purified in a single heat-processing step. As such, they can 
be used as hydrolases under harsh reaction conditions or they can be precipitated 
by an organic solvent and used as powder preparations for the synthesis of short 
peptides in mixtures of anhydrous organic solvents (Chapters 4-5). Of particular 
interest for various applications is the novel subtilase described in Chapter 6 
with superb tolerance to DMF and DMSO, allowing thermodynamically controlled 
peptide synthesis. Despite recent advances in the nonaqueous enzymology, the 
possibility of enzymatic peptide coupling in aqueous solution would offer many 
advantages. Increased peptide solubility in buffered solutions and no side-chain 
protective groups would allow enzymatic coupling of very long peptide segments. 
Thiol-subtilisins16 and selenol-subtilisins17 have been designed as the ligases for 
the aqueous chemo-enzymatic peptide synthesis.
From the new biocatalysts presented in this thesis, peptiligase, a highly-
engineered thiol-subtilisin has the potential to establish chemoenzymatic peptide 
synthesis technology as the preferred method for synthesis of (pharmaceutical) 
peptides and proteins in a cost-efficient and environmental friendly method. We 
have demonstrated high coupling efficiencies (high S/H ratios) of peptiligase-
catalyzed ligations, especially for long unprotected peptides in buffered solutions. 
These kinetically controlled reactions employing an activated acyl donor and a 
suitable nucleophilic acyl acceptor are fast and require only a small amounts 




at its C-terminus as Cam-Leu ester⁸. The nucleophile used is in the form of an 
amide. Peptiligase has six substrate binding pockets that play a role in substrate 
recognition and catalysis. The next step would be to investigate the substrate 
range of peptiligase and to improve the scope accordingly by enzyme engineering 
methods such as structure-guided rational design, directed evolution and 
computational design. It is highly unlikely that one single peptiligase variant will 
efficiently couple all possible combinations of the substrate amino acid sequence 
space, thus engineering will focus on producing a toolbox of ligases covering the 
diversity of practically relevant ligation sequences. 
One could describe those enzymes as “restriction ligases”, designed for a specific 
combination of acyl-donor and nucleophile. Such enzymes could allow one-pot 
peptide assembly reactions and beside applications in pharmaceutical industry, 
they might be used in synthesis of novel materials, in particular self-assembling 
biopolymers18.  
Besides synthesis of the known peptide sequences, modification reactions 
leading to diversification in structure and biological behavior are also of 
increasing interest. Modified synthetic peptides could act as prodrugs or as 
dual-action pharmaceuticals. Bioactivity and pharmacokinetics may be modified 
by making peptide conjugates, peptides containing either D-amino acids or 
β-amino acids, or by designing cyclic and constrained peptides19. As shown in 
Chapter 7, peptiligase is able to cyclize an 21-mer linear peptide exclusively 
as a head-to-tail cyclic form using high substrate concentrations and short 
reaction times. Other attractive applications would emerge if peptiligase could 
be redesigned for various recognition sequences allowing traceless peptide 
sequence modifications and labeling. Such traceless peptide modifications are 
currently impossible using ligases like sortase20, butelase21 or trypsiligase22  since 
they require specific recognition sequence motif. Selective ligases will also make 
it possible to couple unprotected peptide segments produced by fermentation, 
opening the door towards protein- and antibody-drug conjugates. 
In conclusion, protein engineering of subtilisin and thiol-subtilisin variants has 
considerable protential, even though almost 25 years have passed since subtiligase 
was discovered. The peptide ligase (peptiligase) described in this thesis is a robust, 
thermostable enzyme with high synthesis/hydrolysis ratio, potentially providing 
a key to successful industrial chemoenzymatic peptide synthesis technology. 
Further engineering studies combined with the ever improving possibilities of in-
silico design should enable tailoring of the biocatalysts to fit the reaction needs. 
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Nederlandse Samenvatting
Het gebruik van peptiden en eiwitten als medicijnen, voedingsadditieven en 
ingrediënten voor cosmetica wordt steeds prominenter. De markt voor therapeutische 
peptiden groeit constant en de verwachting is dat deze groter dan $25 miljard 
zal zijn binnen twee jaar. Het aantal therapeutische peptiden in ontwikkeling 
groeit, evenals hun lengte, complexiteit en de vraag naar grotere hoeveelheden. 
Een algemene technologie voor de productie van peptiden bestaat niet. 
Hedendaagse methoden voor peptideproductie zijn chemische synthese, 
productie in recombinante systemen en chemo-enzymatische synthese. De 
geprefereerde synthese route hangt af van de sequentie, lengte en eigenschappen 
van de peptide. Hoofdstuk 1 geeft een kort overzicht van deze methoden.
Chemo-enzymatische peptide synthese (CEPS) is een alternatieve methode voor 
de productie van middelgrote tot grote peptiden. Enzymatische koppeling van 
chemisch gesynthetiseerde peptidesegmenten combineert de voordelen van 
vastefasesynthese (bijvoorbeeld het inbouwen van niet-natuurlijke aminozuren) 
en enzymatische ligatie (geen racemisatie, geen beschermende groepen en het 
gebruik van een vloeibare fase met beter oplossend vermogen voor peptiden). 
Enzymatische ligaties in CEPS zijn regio- en stereospecifiek, waardoor het 
gebruik van meervoudige HPLC zuiveringsstappen en daarmee ook de kosten 
worden gereduceerd.
In het vorig decennium was de chemo-enzymatische peptide synthese gericht 
op het gebruik van hydrolytische enzymen in niet-waterige omstandigheden, met 
als doel het voorkomen van de meest dominante nevenreactie: hydrolyse van 
zowel producten als substraten. Toepassingen die gebruik maken van substraat 
of medium engineering waren erg in trek voor het synthetiseren van nieuwe 
enzymen die tolerant waren voor organische oplosmiddelen. Verscheidene 
subtilisine-achtige enzymen (subtilases) zijn geselecteerd in dit onderzoek 
(hoofdstuk 3) en zijn getest in hydrolyse- en synthesereacties onder een variatie 
van omstandigheden. Thermostabiele subtilases, verkregen door genome 
mining van extremofielen, blijken robuuste enzymen te zijn die in een mesofiele 
gastheer geproduceerd kunnen worden en daarna ook makkelijk kunnen worden 
gezuiverd met een enkele hitte behandelingsstap. Dergelijke enzymen kunnen 
dan worden gebruikt als hydrolases onder extreme reactie omstandigheden. Ze 
kunnen ook worden geprecipiteerd door een organisch oplosmiddel en gebruikt 
worden als poederpreparaten voor synthese van korte peptiden in mengsels van 
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watervrije organische oplosmiddelen (hoofdstukken 4 en 5). Van bijzonder groot 
belang is de nieuwe subtilase die door de grandioze DMF en DMSO tolerantie 
thermodynamisch gecontroleerde peptidesynthese mogelijk maakt, zoals 
beschreven in hoofdstuk 6. Ondanks de recente ontwikkelingen in watervrije 
enzymologie zou de enzymatische peptidesynthese in waterige oplossingen 
vele voordelen hebben. De verhoogde oplosbaarheid van peptiden in gebufferde 
oplossingen en de afwezigheid van beschermende groepen voor de zijketens 
zou de koppeling van zeer lange peptiden mogelijk maken. Thiol-subtilisines 
en selenol-subtilisines zijn ontworpen als ligases voor chemo-enzymatische 
peptidesynthese in waterige oplossingen.
Van alle nieuwe biokatalysatoren die beschreven worden in dit proefschrift, 
heeft peptiligase, een sterk geëngineerde thiol-subtilisine, de potentie om 
een chemo-enzymatische peptidesynthese technologie te bewerkstelligen 
als geprefereerde methode voor synthese van (farmaceutische) peptiden en 
eiwitten op een kostenefficiënte en milieuvriendelijke manier (hoofdstuk 7). Wij 
hebben hoge koppelingsefficiënties (hoge S/H ratio’s) verkregen voor peptiligase 
gekatalyseerde ligaties, met name voor lange, onbeschermde peptiden in 
gebufferde oplossingen. Deze kinetisch gecontroleerde reacties, die een 
geactiveerde acyl-donor en een geschikte nucleofiele acyl-acceptor vereisen, 
zijn snel en hebben maar een kleine hoeveelheid enzym nodig. De acyl-donor is 
over het algemeen N-terminaal beschermd en C-terminaal geactiveerd met een 
Cam-Leu ester. Een amine wordt gebruikt als nucleofiel. Peptiligase heeft zes 
substraatbindingsholtes die een rol spelen in substraatherkenning en katalyse. 
De volgende stap zou het onderzoek naar de substraatrange van peptiligase zijn 
en het verbreden van deze range met gerichte evolutie (directed evolution) en 
computational design. Het is zeer onwaarschijnlijk dat een enkele peptiligase-
variant genoeg zal zijn om alle mogelijke combinaties van peptidesubstraten te 
kunnen koppelen, dus de engineering zal zich focussen op het construeren van 
een ligase-toolbox die in staat is om alle mogelijke, praktisch relevante sequenties 
te kunnen koppelen. Deze enzymen zouden als “restrictie ligases” beschreven 
kunnen worden, ontworpen voor een specifieke combinatie van acyl-donor en 
nucleofiel. Met deze enzymen zouden one-pot-reacties voor peptide-assemblage 
mogelijk worden gemaakt die, naast toepassing in de farmaceutische industrie, 
ook gebruikt kunnen worden voor nieuwe materialen, zoals zelf-assemblerende 
biopolymeren.
Naast synthese van bekende peptidesequenties ontstaat er ook een steeds 
grotere interesse in modificatie reacties die leiden tot een grotere variatie in 
structuur en biologisch gedrag. Bio-activiteit en farmacokinetiek kunnen worden 
gemodificeerd door het maken van peptide conjugaties en peptiden die niet 
natuurlijke aminozuren bevatten of door de ontwikkeling van cyclische peptiden. 
Zoals is laten zien in  hoofdstuk 7, is peptiligase in staat om een lineaire peptide 
van 21 aminozuren kop-staart te cycliseren als enige product, gebruikmakende 
van een hoge peptideconcentratie en korte reactietijden. Andere interessante 
toepassingen zullen opkomen als de substraatspecificiteit van peptiligase kan 
worden uitgebreid en zo een grote variëteit van peptiden met verschillende 
herkenningssequenties gekoppeld kunnen worden door één enzym. Dit maakt 
“traceless” modificatie mogelijk: peptiden modificeren en labelen zonder dat 
een herkenningssequentie nodig is. Deze techniek is nog niet mogelijk, omdat 
de huidige ligases en transpeptidases een herkenningssequentie motief nodig 
hebben (sortase, butelase, trypsiligase). Selectieve peptide ligases zullen 
ook de onbeschermde koppeling van peptide segmenten mogelijk maken die 
geproduceerd zijn door fermentatie. Dit opent de deur naar eiwit en antilichaam-
medicijn-conjugaten. 
Concluderend, blijkt dat de protein engineering van subtilisine en thiol-subtilisine 
varianten veel potentie heeft, zelfs nu er al 25 jaar verstreken is sinds de ontdekking 
van het eerste enzym subtiligase. De peptide ligase (peptiligase) die in dit 
proefschrift wordt beschreven, is een robuust, thermostabiel enzym met een hoge 
synthese/hydrolyse ratio en kan de sleutel tot succesvolle industriële chemo-
enzymatische peptidesynthese technologie zijn. Verdere engineeringstudies, 
in combinatie met de voortschrijdende in silico designtechnieken, zouden het 
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